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Abstract
Abstract
Tetanus toxin is internalised at the neuromuscular junction into vesicular 
carriers undergoing fast retrograde transport to the spinal cord. We determined the 
pH regulation o f this compartment in living motor neurons using a chimera o f the 
tetanus toxin binding fragment (TeNT He) and a pH-sensitive variant o f the green 
fluorescent protein (ratiometric pHluorin). We have demonstrated that moving 
retrograde carriers display a narrow range o f neutral pHs, which is kept constant 
during transport. Stationary TeNT Hc-positive organelles instead exhibit a wide 
spectrum o f pHs, ranging from acidic to neutral. This distinct pH regulation is due to 
a differential targeting o f the vacuolar (H*) ATPase (vATPase), which is not present 
on moving TeNT He compartments. Accordingly, inhibition o f the vATPase does not 
affect axonal retrograde transport o f  TeNT He. However, a functional vATPase is 
required for early steps o f TeNT He trafficking following endocytosis, and it is 
localised to axonal vesicles containing TeNT He- Altogether, these findings indicate 
that the vATPase plays a specific role in early sorting events directing TeNT He to 
axonal carriers, but not in their subsequent progression along the retrograde transport 
route. This novel regulatory role for vATPase in a sorting event linked to retrograde 
transport adds to the numerous functions o f this protein complex. Hydrogen peroxide 
inhibits the vATPase localised to synaptic vesicles, which leads to a disturbed 
trafficking o f neurotransmitters. Increased levels o f toxic oxygen radicals have been 
detected in mice overexpressing human mutant Cu/Zn superoxide dismutase 
(SOD 1093A) found in patients with familial amyotrophic lateral sclerosis (ALS). 
These mice develop motor neuron degeneration and muscle paralysis as observed in 
ALS patients. Evidence suggests that defects in axonal transport play an important 
role in neurodegeneration. We show that retrograde axonal transport defects are 
already present in motoneurons o f S 0D 1G93A mice during embryonic development. 
Surprisingly, crossing S 0D 1G93A mice with mice, which have a single point mutation 
in the dynein motor complex (Loa) delays disease progression and significantly 
increases life span o f Loa/SO DlG93A mice. Moreover, we observed a complete 
recovery in axonal transport o f these mice, which may be responsible for 
amelioration o f the symptoms. We propose that impaired axonal transport is a prime 
cause o f neuronal death in neurodegenerative disorders such as ALS.
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Chapter 1.1: Introduction - Clostridium Neurotoxins
1 Introduction
1.1 Clostridium Neurotoxins
1.1.1 The origins and the effects
Over the last 100 years the molecular determinants o f tetanus and botulism and 
the molecules responsible for their symptoms, the Clostridium neurotoxins (CNT), 
have been studied intensely. Despite their fairly recent fame, the clinical effects are 
known since the beginning o f the medical literature. Hippocrates described the 
symptoms o f a sailor affected by hyper-contraction of skeletal muscle, which he 
termed tetcxvoa  (tetanus) for tension. Tetanus was considered a neurological disease 
until the end o f the nineteenth century, when a potent neurotoxin produced by 
Clostridium tetani, named tetanus neurotoxin (TeNT), was identified as the sole 
causative agent o f this disease. In sensitive animals TeNT induces a spastic paralysis, 
which is often fatal due to cardiovascular or respiratory failure. The same period also 
saw the first description of botulism, a general muscle weakness, followed by the 
isolation of Clostridium botulinum  and its neurotoxins (botulinum neurotoxins, 
BoNTs) (Fig. 1.1).
The isolation o f toxigenic strains o f C. tetani and C. botulinum and studies on 
their intracellular activity and their synaptic targets revealed important insights into a 
multifunctional machinery. CNT are able to recognise neurons with high affinity, 
enter the cytosol and modify synaptic function. The description of CNT and the 
examination o f their molecular mechanisms o f action are central to several 
disciplines, including microbiology, pharmacology, physiology, biochemistry and
25
Figure 1.1: Clinical symptoms of tetanus and botulism
A) A child suffering of spastic paralysis caused by tetanus toxin. The facial muscles 
and muscles of the legs, feet, arms and hands are persistently contracted (photo from 
http://www.immunizationed.org/Tetanus.asp). B) A six week old baby with flaccid 
paralysis as an effect o f infant botulism. Note the loss of muscle tone in the region of 
the head and neck (photo from http://www.wrongdiagnosis.com/phil/html/infant- 
botulism-food-poisoning/1935 .html).
Chapter 1.1: Introduction - Clostridium Neurotoxins
medicine. Furthermore, these neurotoxins are used as molecular tools to dissect 
intracellular trafficking and regulated secretion in a variety o f cells. Recently, BoNTs 
have been used increasingly in human therapy, mainly for pathologies caused by 
synaptic hyper-activity and as cosmetic agents.
CNT are highly toxic substances; the mouse Lethal Dose 50% (LD 50) ranges 
between 0.1 and 1 ng kg"1 of body weight. Different animals show a vast range of 
sensitivity to TeNT and BoNTs. Mammals, except rats, are among the most receptive 
species, whereas birds, reptiles and amphibians show resistance to CNT to different 
degrees (Payling-Wright, 1955; Gill, 1982). The time o f onset of paralysis after CNT 
intoxication depends on the species, dose and route o f application. However, a delay 
ranging from several hours up to days is always present between infection with CNT 
and expression o f the earliest clinical symptoms.
1,1.2 Trafficking o f clostridium neurotoxins
After entering the general blood circulation, CNT bind to pre-synaptic 
membranes o f the neuromuscular junction (Fig. 1.2). The highly neuro-specific 
binding and the explicit enzymatic activity o f CNT contribute to the low LD50 values 
and to limited spreading near the site of CNT injection in vivo. Following binding, 
CNT are internalised into motor neurons and other nerve terminals. BoNTs remain at 
the neuromuscular junction and block the release o f the excitatory neurotransmitter 
acetylcholine, causing a flaccid paralysis. In contrast, TeNT is retrogradely 
transported to the motor neuron soma located in the spinal cord, where it 
accumulates in the ventral horn o f the grey matter. Once in the spinal cord, TeNT is 
released into the extracellular medium and internalised by adjacent inhibitory 
intemeurons, where it blocks inhibitory neurotransmitter release. This impairs the
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Figure 1.2: Distinct trafficking of TeNT and BoNTs in vivo
Scheme of the anatomical connections between skeletal muscles, spinal cord motor 
neurons and their afferent cells. M otor neurons control skeletal m uscles w ith a 
specialised synapse termed neuromuscular junction (NMJ). The axon is wrapped by a 
myelin sheet and can reach a length of a meter or more in large mammals. A) After 
entering the general circulation, CNT bind to the presynaptic term inal and are 
internalised. BoNTs remain at the neuromuscular junction. In contrast, TeNT enters 
specialised transport carriers directed towards the motor neuron soma located in the 
spinal cord. B) Microtubule-based motors (cytoplasmic dynein and kinesins) play a 
major role in axonal transport. However, actin dependent motors are also relevant for 
this process, indicating a functional connection between microtubule and actin-based 
transport. C) Once in the spinal cord, TeNT is released into the extracellular medium 
and internalised into adjacent inhibitory intemeurons, where it cleaves VAMP. This 
impairs the balance between inhibitory and excitatory afferents on the motor neurons, 
and causes spastic paralysis. Adapted from Bohnert et al., 2006.
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balance between inhibitory and excitatory afferents on the motor neuron, leading to 
un-coordinated muscle contraction causing spastic paralysis. Despite the different 
clinical symptoms and intracellular targeting o f TeNT and BoNTs, their mode o f  
action is similar. All CNT block neurotransmission by cleaving soluble NSF 
attachment protein receptors (SNARE) involved in neuro-exocytosis.
TeNT can bind sensory as well as adrenergic neurons, which show a similar 
retrograde uptake. Although excitatory synapses do not appear to be compromised in 
the early stages o f TeNT intoxication, they may be inhibited at later time points. The 
preference o f inhibitory versus excitatory synapses remains when TeNT is directly 
applied to the central nervous system. The neurodegenerative and epileptogenic 
effects o f TeNT, which result from unopposed release o f glutamate from excitatory 
central synapses, may be a result o f the TeNT intoxication characteristics.
1.1.3 Structure-function relationships
1.1.3.1 Primary Structure o f CNT
As expected from their similar mechanisms of action, members o f the CNT 
family share a high degree o f sequence and structural homology (Fig. 1.3). CNT are 
produced as single-chain, inactive polypeptides of 150 kDa, which are cleaved by 
endogenous or exogenous proteases (DasGupta, 1994; Weller et al., 1989). This 
specific cleavage produces two chains, a 100 kDa heavy chain (H-chain) and a 50 
kDa light chain (L-chain). These chains remain associated via non-covalent protein- 
protein interactions and a conserved inter-chain disulphide bond, which is essential 
for neurotoxicity (de Paiva et al., 1993; Schiavo et al., 1990a). The H-chain can be 
further subdivided into two different fragments, the 50 kDa amino-terminal part (H n)
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Figure 1.3: Structure of CNT
A) Schematic representation o f CNTs. The active holotoxins are formed by a 50 kDa 
L-chain linked via a disulfide bond to a 100 kDa H-chain. B) Crystal structure o f  
BoNT/A. The binding domain is highlighted in red, the translocation domain in green 
and the catalytic domain, coordinating a zinc atom, in blue. The catalytic domain is 
formed by a mixture o f |3-strands and a-helices. The translocation domain consists of  
two long a-helices. The amino terminal part o f Hc displays two seven-stranded 13- 
sheets (Hcn), whereas the carboxy-terminus adopts a modified p-trefoil fold. Repro­
duced from Lacey et al., 1998.
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and the 50 kDa carboxy-terminal part (He) (Bizzini et al., 1977; Helting and Zwisler, 
1977; Neubauer and Helting, 1981).
1.1.3.2 Crystal structure o f CNT
The existence o f a catalytic, translocation and binding domain o f CNT was 
confirmed by crystallisation and structural determination o f BoNT/A (Lacy et al., 
1998; Stevens et al., 1991), BoNT/B (Swaminathan and Eswaramoorthy, 2000), 
BoNT/D L-chain (Arndt et al., 2006), BoNT/E L-chain (Agarwal et al., 2004b), 
BoNT/F L-chain (Agarwal et al., 2005), BoNT/G L-chain (Arndt et al., 2005) and the 
TeNT L-chain and TeNT He domain (Breidenbach and Brunger, 2005; Rao et al., 
2005; Umland et al., 1997). The H-chains o f CNT are structurally distinct with the 
exception o f a large loop in the amino-terminal part o f the TeNT H-chain, which is 
wrapped around the perimeter o f the L-chain (Umland et al., 1997).
1.1.3.3 The heavy chain
The He domain, which is responsible for the neurospecific binding o f CNT 
(Bizzini et al., 1977; Halpem and Neale, 1995; Herreros et al., 2000a), is composed 
o f two distinct sub-domains, rich in (3-structure and of roughly the same size. The 
amino-terminal sub-domain (H cn ) has structural analogies with the carbohydrate 
binding moiety o f plant lectins and other oligosaccharide-binding proteins (Umland 
et al., 1997). The carboxy-terminal portion (H cc) of the H-chain adopts a modified 13- 
trefoil fold, which is present in several proteins involved in recognition- and binding- 
functions, such as trypsin inhibitors (Umland et al., 1997). The entire He domain 
remains masked from the rest o f the molecule, so that all the surface loops are 
accessible and therefore available for binding. Comparison of the crystal structures
31
Chapter 1.1: Introduction - Clostridium Neurotoxins
of different He domains showed that the main differences between CNT reside in the 
loops o f Hcc, where the sequence is poorly conserved (Umland et al., 1997). The 
removal o f the amino-terminal portion Hn or H cn domains o f the H-chain does not 
affect toxin binding (Herreros et al., 2000a), while deletion o f only a few residues 
from the carboxy-terminus o f He abolishes the interaction with neuronal cells 
(Halpem and Loftus, 1993). This is due to the role o f the carboxy terminus in 
ganglioside binding as demonstrated by the work o f Sinha et al. (Sinha et al., 2000) 
and Rummel et al. (Rummel et al., 2003).
1.1.3.4 The light chain
The L-chain is the catalytic domain, responsible for the intracellular activity o f  
the toxin (Ahnert-Hilger et al., 1989; Bittner et al., 1989; Mochida et al., 1989; 
Penner et al., 1986; Poulain et al., 1988; Weller et al., 1991) and contains the 
catalytic zinc atom, essential for CNT endopeptidase activity. One zinc atom is 
bound to the L-chain o f TeNT, BoNT/A, /B and /F (Schiavo et al., 1992a; Schiavo et 
al., 1992b; Schiavo et al., 1993a), whilst BoNT/C binds two atoms o f  zinc with 
different affinities (Schiavo et al., 1995). Heavy metal chelators are effective in 
removing the bound zinc to generate inactive apo-neurotoxins (Bhattacharyya and 
Sugiyama, 1989; Schiavo et al., 1992a).
The structure o f BoNT/A, /B and /E light chains suggests that substrate 
recognition cannot occur at the active sites o f these CNT because their catalytic 
pocket organisation and geometries are nearly identical (Agarwal et al., 2004a; Lacy 
et al., 1998). The catalytic site is located deep in the structure o f the protein, 
accessible only by a large groove, which accommodates the substrate. In BoNT/A, 
the entry to the channel is partially blocked by the large loop wrapping the L-chain,
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and by the translocation domain itself (Lacy et al., 1998). Biochemical and 
mutagenesis studies have identified two critical residues in BoNT/A, H222 and 
H226, where the zinc atom is held in place. These residues are located in the 
sequence H-E-X-X-H, the characteristic zinc endopeptidase motif (Jongeneel et al., 
1989; Schiavo et al., 1992a; Schiavo et al., 1992b; Wright et al., 1992).
1,1.4 Neurospecific binding
CNT binding has been examined using morphological and biochemical 
techniques in different systems like primary neuronal cultures, cell lines and various 
membrane preparations (Halpem and Neale, 1995; Schiavo et al., 2000). CNT bind 
to the presynaptic membrane o f cholinergic nerve terminals (Halpem and Neale,
1995) and TeNT may also bind to sympathetic and adrenergic nerve fibres (Rossetto 
et al., 2001). In vitro, CNT are capable o f binding to a variety o f non-neuronal cells, 
but only at concentrations several orders o f magnitude higher than those clinically 
relevant. In contrast, in vivo binding o f  CNT is absolutely neurospecific and only 
requires concentrations in the sub-nanomolar range (Halpem and Neale, 1995; 
Simpson, 2000). The determinants o f  this high-affinity neurospecific binding are 
encoded within the He domains, as recombinant He fragments can significantly delay 
paralysis in mouse phrenic nerve hemi-diaphragm induced by the parental toxins 
(Lalli et al., 1999).
/. 1.4.1 CNT binding to polysialogangliosides
CNT bind to polysialogangliosides, in particular to members o f the Gib series 
(GDib, GTib and GQib) (Halpem and Neale, 1995; Montecucco, 1986) with BoNTs 
and TeNT containing one or two oligosaccharide-binding sites respectively within
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the carboxy-terminal part o f the He domain (Figueiredo et al., 1997; Rummel et al., 
2003; Rummel et a l, 2004b). Two carbohydrate interaction sites in TeNT He, a 
sugar-binding pocket and a sialic acid-binding site, were shown to bind 
simultaneously to one ganglioside molecule (Rummel et al., 2003). The binding of  
CNT to polysialogangliosides is physiologically relevant, because mutations in the 
carbohydrate binding pockets decrease affinity to the neuronal membrane (Louch et 
al., 2002; Rummel et al., 2003; Rummel et al., 2004b). Pre-incubation of  
neuromuscular junction preparations with Gib offers protection from BoNT- 
dependent inhibition o f neurotransmitter release and partially abolishes retrograde 
transport o f TeNT (Stoeckel et al., 1977). Also, the removal o f sialic acid residues 
from the membrane surface with neuraminidase decreases but does not abolish CNT 
activity (Bigalke et al., 1986). In addition, impairment o f ganglioside biosynthesis 
leads to a reduced CNT activity in vivo (Kitamura et al., 1999; Williamson et al.,
1999). Niemann suggested a model in which polysialogangliosides act as peripheral 
receptors for TeNT, mediating its retrograde transport to the central nervous system, 
where it binds to a second and different acceptor (Niemann, 1991). Although 
appealing, this model suffers from the drawback o f the low affinity and low  
specificity o f polysialogangliosides as the only TeNT receptor in the periphery, 
where a high-affinity interaction is required to account for the extremely low doses 
o f TeNT causing clinical symptoms in vivo. In addition, lack of binding competition 
between TeNT and BoNTs and their absolute neurospecificity make it unlikely that 
gangliosides are the unique binding determinant for CNT. Accordingly, specific 
protein co-receptors have been identified for some o f the CNT. For example, 
BoNT/A, /B and /G interact with synaptotagmins I and/or II (Dong et al., 2003;
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Dong et al., 2006; Mahrhold et al., 2006; Rummel et al., 2004a), which function as 
calcium-sensors at the synapse.
Recently, it has been reported that BoNT/A interacts with synaptic vesicle 
protein SV2 isoform C, but not with isoforms A and B. Specific binding o f  BoNT/A 
to the phrenic nerve occurs at the fourth luminal loop o f SV2 isoform C (amino acids 
454-579) and the presence o f  recombinant SV2C(454-579) extends the paralytic 
half-time o f BoNT/A in a dose dependent manner (Mahrhold et al., 2006). 
Furthermore, Dong et al. have shown that amino acids 529-566 o f the largest SV2 
luminal loop o f isoform C contain the toxin interaction domain and pre-incubation o f  
BoNT/A with recombinant SV2C(529-566) reduces its binding to neurons (Dong et 
al., 2006). Additionally, in SV2 isoform A and B double knockout hippocampal 
neurons, which do not express SV2C, BoNT/A binding is abolished. However, 
transfection and expression o f SV2 isoforms A, B or C in these neurons recovers 
BoNT/A binding (Dong et al., 2006). The inconsistencies between the studies o f  
Mahrhold et al. and Dong et al. are difficult to understand and might be caused by 
the different protein concentrations used by each group. However, these findings 
suggest that SV2 acts as the protein receptor for BoNT/A.
1.1.4.2 BoNT binding to synaptotagmins
BoNT/B and /G bind to the intraluminal portion o f glycosylated synaptotagmin 
I and II in a ganglioside-dependent manner (Nishiki et al., 1996; Rummel et al., 
2004a). During neurotransmitter release, this region is exposed to the extracellular 
milieu and it becomes accessible to large extracellular ligands. Thus, BoNTs might 
use synaptic vesicle endocytosis and recycling for their entry into motor neurons. 
Moreover, the acidification o f synaptic vesicles, which is necessary for their
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reloading with neurotransmitters, might mediate the acid-driven insertion o f the 
heavy chain into the synaptic vesicle membrane (Koriazova and Montal, 2003; 
Schiavo et al., 2000) and the translocation o f the L-chain into the neuromuscular 
junction cytoplasm. However, the role o f synaptotagmins as physiological BoNT 
receptors remains controversial because antibodies against this synaptotagmin 
domain fail to antagonise the binding and activity o f BoNT/B at the neuromuscular 
junction (Bakry et al., 1997). Moreover, competition experiments have clearly 
demonstrated that different BoNT serotypes do not share the same receptor (Evans et 
al., 1986; Habermann and Dreyer, 1986).
1.1.4.3 TeNT binding to GPI-anchoredptotein(s)
TeNT binds to one or more glycosylphosphatidylinositol (GPI)-anchored 
protein(s) o f ~15 kDa (Herreros et al., 2000b). One o f these proteins was identified 
as Thy-1 in nerve growth factor (NGF) differentiated phaeochromocytoma (PC 12) 
cells. However, it is unlikely to be the main protein receptor in vivo because Thy-1 
knock out mice retain sensitivity to TeNT (Herreros et al., 2001). In contrast, pre­
treatment with a phosphatidylinositol-specific phospholipase, which cleaves the lipid 
anchor o f GPI-anchored proteins, in the presence o f cycloheximide (a protein 
synthesis inhibitor), protects neurons from TeNT intoxication (Munro et al., 2001). 
The fact that cycloheximide needs to be present for toxin protection implies a rapid 
turnover o f GPI-anchored proteins under these experimental conditions.
GPI-anchored proteins, cholesterol, gangliosides and other sphingolipids are 
enriched in microdomains o f the plasma membrane, termed lipid rafts. They act as 
platforms for signalling, ligand recognition, sorting and endocytosis (Pike, 2003; 
Tsui-Pierchala et al., 2002). In addition, lipid rafts provide efficient and dynamic
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means for receptor clustering and ligand oligomerization, including virulence factors 
(Abrami et al., 2003). Consequently, lipid microdomains are exploited by pathogens 
and virulence factors for their entry into host cells (Abrami et al., 2003; Duncan et 
al., 2002).
1.1.4.4 CNT binding apparatus
The complexity o f the CNT receptors, which are composed o f multiple lipid 
and protein components, together with the high affinity o f CNT for the neuronal 
membrane, has led to the recent proposal that arrays o f presynaptic receptors (APRs) 
are involved in CNT binding (Montecucco et al., 2004a) (Fig. 1.4). APRs are 
suggested to be dynamic entities that share several features with lipid rafts. Due to 
their high concentration at the neuromuscular junction and their lateral mobility, 
gangliosides are suggested to be the initial binding factors. They would act as 
‘antennae’ to capture CNT on the presynaptic membrane and allow subsequent 
clustering with other molecules o f the APR, thus leading to a virtually irreversible 
binding. In addition to gangliosides, an APR would contain additional lipids such as 
cholesterol, one or more GPI-anchored protein(s) and transmembrane protein(s). 
They may also include signalling molecules that upon binding trigger the 
internalisation and/or sorting o f CNT to specific synaptic structures. According to 
this model, the APR recognised by BoNTs would be expected to guide them inside 
vesicles that acidify within the neuromuscular junction, whereas the APR binding 
TeNT would likely sort the neurotoxin into an endocytic vesicle undergoing 
retrograde transport along the axon. Upon sorting in the soma of the motor neuron, 
TeNT would then be released into the intersynaptic space, where it could enter
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Figure 1.4: Binding and endocytosis of C N T  via arrays of presynaptic receptors 
(APRs)
It is proposed that all CNT require polysiologangliosides (G) and other lipid compo­
nents (A ) for binding. A ) The initial membrane interaction o f  CNTs is with  
polysiologangliosides (G). This fast and reversible process o f medium affinity can 
occur inside or outside an APR. B) Lateral movement within the membrane will 
eventually trap CNT inside an APR. Here, CNT can interact with additional recep­
tors, leading to a high affinity interaction complex o f CNT with the presynaptic 
membrane. The additional receptors may include signalling molecules which induce 
CNT-APR complex internalisation. C) TeNT binding to an unidentified molecule (Z), 
leads to formation o f  a carrier directed to the retrograde axonal transport route. 
BoNTs binding to the luminal domains o f  e.g. synaptotagmin (S) in the case o f  
BoNT/B and /G or SV2 in the case o f BoNT/A, leads to BoNTs internalisation and 
neuroparalysis. X, Y, and Z represent unidentified transmembrane proteins. Adapted 
from Montecucco et al., 2004.
Chapter 1.1: Introduction - Clostridium Neurotoxins
inhibitory intemeurons, possibly via synaptic vesicle endocytosis (Matteoli et al., 
1996).
To reach its final destination, TeNT has to bind to and enter two different 
neurons: a peripheral motor neuron and an inhibitory intemeuron in the spinal cord. 
In this regard, several proteins are taken up and transported efficiently by motor 
neurons when linked to recombinant TeNT He (Coen et al., 1997; Fishman et al., 
1990; Francis et al., 1995; Miana-Mena et al., 2002). The identification o f the 
receptors for TeNT present on motor neurons will provide crucial information on this 
trafficking pathway leading from the neuromuscular junction to intemeurons, 
offering new insights for the delivery o f biological and pharmacological agents into 
the spinal cord.
1.1.5 Internalisation
Because the catalytic activity o f the L-chains is directed towards intracellular 
targets, this toxin domain must at least reach the cytosol. In vivo, CNT do not enter 
the cytosol directly via the plasma membrane but are endocytosed by the cell into 
vesicular compartments. Electron microscopy studies have shown that, after binding, 
CNT enter the lumen of vesicular structures in a temperature- and energy-dependent 
process (Critchley et al., 1985; Parton et al., 1987). In dissociated spinal cord 
neurons, gold-labelled TeNT is found first in coated pit structures at the cell surface, 
and then in a variety o f vesicular and tubular structures as well as multivesicular 
bodies and, to a lesser extend, synaptic vesicles (Parton et al., 1987). In contrast, 
Montesano et al. found that in liver cells TeNT accumulates in uncoated pits and 
non-clathrin coated vesicles. These discrepancies are difficult to reconcile and are
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probably a consequence o f the different cell system and the high concentration used 
by one group (Montesano et al., 1982).
1.1.5.1 Nerve stimulation enhances CNT intoxication
It is well established that nerve stimulation facilitates intoxication by CNT 
(Habermann et al., 1980; Kryzhanovsky, 1958; Ponomarev, 1928; Schmitt et al., 
1981; Wellhoner et al., 1973). Following membrane depolarisation, TeNT 
colocalises with synaptic vesicle markers in hippocampal neurons (Matteoli et al.,
1996). In agreement with these findings, recent studies showed that TeNT uptake is 
dependent on presynaptic activity in motor neurons in vivo (Miana-Mena et al.,
2002), and that BoNT/A and /E enter neurons in a calcium- and stimulation- 
dependent manner (Keller et al., 2004). Generally, a high rate o f neuroexocytosis 
correlates with a high rate o f synaptic vesicle recycling via endocytosis, the two 
processes being tightly coupled (Murthy and De Camilli, 2003). Thus, a possible 
explanation for the faster onset o f paralysis induced by CNT under nerve stimulation 
is that they enter the synaptic terminal inside the lumen o f synaptic vesicles. The 
accessibility o f the internal lumen o f synaptic vesicles to extracellular agents during 
neurotransmitter release was demonstrated by the binding and uptake o f antibodies 
specific for luminal epitopes o f a synaptic vesicle protein (Kraszewski et al., 1995; 
Matteoli et al., 1992; Mundigl et al., 1995). According to this hypothesis, CNT might 
use synaptic vesicles as Trojan horses to gain entry to central nervous system 
neurons.
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1.1.5.2 Endocytosis o f CNT
Several distinct mechanisms o f endocytosis have been described (Conner et al.,
2003), o f which clathrin-mediated internalisation is to date the best characterised. 
Additional pathways include caveolin-dependent endocytosis, as well as several 
clathrin- and caveolin-independent mechanisms. Though there may be additional 
ways o f retrieval, the role o f  clathrin-mediated endocytosis in synaptic vesicle 
recycling is well established (Murthy and De Camilli, 2003). Therefore, it is likely 
that CNT exploit the pathway o f clathrin-mediated endocytosis for their entry into 
the neuron in which they block neurotransmitter release. This is an attractive model 
to explain the endocytosis o f CNT in central neurons, but it is unlikely that synaptic 
vesicle recycling is responsible for the uptake o f TeNT at the neuromuscular 
junction. In fact, three experimental findings are in contrast with this hypothesis. 
First, high frequency stimulation increases the rate o f intoxication but not the binding 
o f TeNT to the neuromuscular junction (Schmitt et al., 1981). If the toxin receptor is 
exposed during neuroexocytosis to allow the toxin to bind and then be endocytosed, 
an increase in the stimulation rate should also increase the total number o f binding 
sites present at the neuromuscular junction. Second, TeNT is not active on a 
neuromuscular junction maintained at 18°C even in the presence o f high-frequency 
stimulation and massive neurotransmitter release, whereas it is fully inhibitory at 
25°C (Schmitt et al., 1981). Third, the uptake and retrograde transport o f TeNT 
occurs in neuromuscular junctions intoxicated with BoNT/A, where neurotransmitter 
release is completely blocked (Habermann and Erdmann, 1978). The latter fact is in 
agreement with the notion that retrograde transport o f various substances, including 
horseradish peroxidase, is not impaired in silenced neuromuscular junctions
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(Kemplay and Cavanagh, 1983; Kristensson and Olsson, 1978). In addition, 
experiments performed in motor neurons indicate that there is very limited 
colocalisation between TeNT and synaptic vesicle markers (Lalli, 2002), thus 
indicating that the pathway o f internalisation and intracellular trafficking o f  TeNT 
may be very different in peripheral and central neurons. Recent data suggest that in 
spinal cord motor neurons, TeNT is also internalised via a clathrin-dependent 
pathway, which is however, distinct from synaptic vesicle endocytosis (Deinhardt, 
2005).
1.1.6 Translocation of CNT through vesicle membranes
The different trafficking and targeting o f TeNT and BoNTs indicate that 
neurotoxin internalisation and translocation o f the L-chains are not directly linked. In 
order to display their catalytic activity, the L-chains o f CNT have to cross the vesicle 
membrane to reach the cytosol. CNT have to be exposed to a low pH to induce nerve 
intoxication (Matteoli et al., 1996; Simpson, 1982; Simpson et al., 1994; Williamson 
and Neale, 1994), even though the application o f L-chains to the cytosol is sufficient 
to block neurotransmitter release (Ahnert-Hilger et al., 1989; Bittner et al., 1989; 
Mochida et al., 1989; Penner et al., 1986; Poulain et al., 1988; Weller et al., 1991). It 
is therefore likely that an acidic pH is crucial to enable the active subunit to 
translocate through the vesicle’s membrane into the cytosol (Montecucco et al.,
1994).
Studies on model membranes and in cell cultures have shown that low pH 
induces a conformational change in CNT from a hydrophilic neutral to a 
hydrophobic acidic form (Beise et al., 1994; Montecucco et al., 1994). This transition 
enables both the H- and L-chains to penetrate into the hydrophobic core o f the lipid
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bilayer (Boquet and Duflot, 1982; Cabiaux et al., 1985; Menestrina et al., 1989; 
Montecucco, 1986; Montecucco et al., 1989; Schiavo et al., 1990b). At low pH, CNT 
form a cation-selective ion channel in planar lipid bilayers with conductances o f a 
few tens o f picosiemens that are permeable to molecules smaller than 700 Da. CNT 
channels may be formed by oligomerisation of the amino-terminal part o f the H- 
chain (H n) (Donovan and Middlebrook, 1986; Menestrina et al., 1989; Schmid et al., 
1993; Shone et al., 1987). The channel is composed of a loop interacting with the L- 
chain and a central body containing two very long 105 A a-helices as the main 
structural units. These helices are flanked by a short amphipathic segment, which is 
able to form channels with similar properties to the holotoxin (Montal et al., 1992; 
Oblatt-Montal et al., 1995). It was proposed that the channel is formed by a toxin 
tetramer bringing four o f these amphipathic segments into strict proximity with their 
hydrophobic residues lining the lumen o f the pore (Montal et al., 1992; Oblatt- 
Montal et al., 1995). This is in agreement with the three-dimensional image 
reconstruction o f the channel formed by BoNT/B in phospholipid bilayers (Schmid 
et al., 1993). Although the function o f this domain in the membrane insertion and L- 
chain translocation is well described (Donovan and Middlebrook, 1986; Shone et al.,
1987), the exact mechanism(s) involved are still poorly understood.
Both H- and L-chains are supposed to change conformation at low pH. The 
amphipathic segment 659-681 o f BoNT/A increases the permeability o f lipid 
bilayers, implicating this fragment in pore formation (Oblatt-Montal et al., 1995). In 
the structure, the sequence corresponding to this peptide adopts a |3-strand-like 
conformation and lies against the two main a-helices. This may suggest the 
involvement o f this portion of the molecule in a pH-dependent conformational
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change, causing the exposure o f previously hidden hydrophobic surfaces. The 
translocation complex o f the BoNT H-chain and L-chain is thought to be a trans­
membrane chaperone similar to the protein translocation channels o f the ER, 
mitochondria and chloroplasts (Koriazova and Montal, 2003). This translocation 
complex is a dynamic structural device that prevents aggregation and achieves 
translocation o f the L-chain. One o f the stable conformations o f the L-chain is a 
molten globule, a firm, partially folded protein state found in mildly denaturing 
conditions such as low pH (Bychkova et al., 1988; van der Goot et al., 1991). The L- 
chain o f BoNT/A acquires a novel molten globule-like enzyme conformation at 37°C 
and pH 6.0 that exhibits maximum endopeptidase activity against SNAP-25 (Kukreja 
and Singh, 2005).
For channel formation, the heavy chain forms a hydrophilic trans-membrane 
cleft nesting the passage o f the partially unfolded L-chain with its hydrophobic 
segments facing the lipids. The cytosolic neutral pH induces the L-chain to refold 
and regain its water-soluble neutral conformation following reduction o f the 
interchain disulfide bond. Cytosolic chaperones may be involved in facilitating the 
exit o f the L-chain from the vesicle membrane and in promoting its cytosolic 
refolding (Ratts et al., 2003). The latter process is complicated by the absolute 
requirement o f zinc for L-chain catalytic activity. The protonation of the histidines 
coordinating the zinc ion at low pH is expected to release the metal atom, which has 
to be acquired again in the cytosol. Comparison of the X-ray absorption spectrum of 
TeNT, thermolysin and astacin suggests a new pattern o f zinc coordination in TeNT: 
one water molecule, two histidines, and Y242 (Morante et al., 1996). Thermolysin 
has four (two histidines, one glutamate, one water) and astacin five (three histidines,
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one water, one tyrosisne) metal ligands. Replacement o f the zinc atom o f TeNT with 
manganese or cobalt produced a highly active VAMP2 cleaving enzyme. In contrast, 
copper and iron replacement o f the zinc atom in TeNT shows only limited 
proteolytic activity. This order o f proteolytic activity differs from other 
metal loproteases such as thermolysin and astacin and it was therefore suggested that 
CNT constitutes a new family o f metalloproteases (Tonello et al., 1997).
As the L-chain is released into the cytosol, the transmembrane hydrophilic cleft 
o f the H-chain tightens up to reduce the surface area o f hydrophilic protein exposed 
to the hydrophobic core o f the membrane. However, this process is not complete, 
leaving a channel across the membrane likely to be responsible for the ion 
conducting properties o f CNT. Pore formation is therefore a consequence and not a 
prerequisite o f membrane translocation (Schwab et al., 2000).
1.1.7 Intracellular zinc-endopeptidase activity
The catalytic nature o f CNT was discovered following the observation that the 
L-chains contain the H-E-X-X-H binding motif o f zinc-endopeptidases (Kurazono et 
al., 1992; Schiavo et al., 1992a; Schiavo et al., 1992b; Wright et al., 1992). 
Following this observation, it was soon demonstrated that TeNT was blocking 
acetylcholine release at Aplysia californica synapses via a zinc-dependent protease 
activity (Schiavo et al., 1992a).
CNT are remarkably specific proteases. Only three targets, all members o f the 
SNARE superfamily (Bock and Scheller, 1997), have been identified. TeNT and 
BoNT/B cleave VAMP (or synaptobrevin) at the same site and BoNT/D, /F and /G 
cleave VAMP at different peptide bonds (Schiavo et al., 1992c; Schiavo et al., 1994; 
Schiavo et al., 1993b; Schiavo et al., 1993a; Yamasaki et al., 1994b; Yamasaki et al.,
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1994c); BoNT/A and /E cleave SNAP-25 (synaptosomal-associated membrane 
protein o f 25 kDa) at two different sites and BoNT/C cleaves both syntaxin and 
SNAP-25 (Binz et al., 1994; Blasi et al., 1993a; Blasi et al., 1993b; Foran et al., 
1996; Osen-Sand et al., 1996; Schiavo et al., 1993b; Schiavo et al., 1993c; Schiavo et 
al., 1995; Vaidyanathan et al., 1999; Williamson et al., 1996) (Fig. 1.5).
SNARE proteins have been implicated as crucial components in most, if  not 
all, intracellular membrane trafficking events (Chen and Scheller, 2001; Jahn and 
Sudhof, 1999). In eukaryotic cells, molecules need to be delivered to their correct 
intracellular destinations without compromising the structural integrity o f cellular 
compartments. To achieve this, transport vesicles bud from a donor organelle and 
then dock and fuse with a target membrane. SNARE were originally divided into v- 
SNARE and t-SNARE, based on their vesicle or target membrane location (Sollner 
et al., 1993). SNARE are currently classified into Q- and R-SNARE, depending on 
the presence o f either glutamine or arginine in a central position o f the SNARE motif 
(Jahn and Sudhof, 1999).
Studies on yeast and mammalian SNARE, anchored to liposomes, have 
reinforced the concept that the specificity of membrane fusion events relies on a 
precise pattern o f v-SNARE-t-SNARE interactions (Bonifacino and Glick, 2004). 
Unique receptors o f SNARE are found in different specific cellular compartments, 
suggesting that SNARE are functionally involved in all vesicle trafficking steps in 
endocytic cells. Although the specificity o f intracellular membrane fusion is 
associated with the biophysical properties o f SNARE, a better spatial and temporal 
control o f SNARE-mediated fusion is provided by additional regulatory systems,
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Figure 1.5: Schematic structure of SNARE proteins cleaved by CNT
VAMP (green) is a type-II membrane protein anchored to synaptic vesicles by a sin­
gle trans-membrane domain. VAMP is characterized by a short intraluminal domain, 
a conserved 60 residue long cytosolic portion, which is able to form coiled coils and 
a poorly conserved amino terminus. SNAP-25 (blue) is bound to the presynaptic 
membrane by several palmitoylated cysteines located in the middle o f the molecule. 
Syntaxin (red) is anchored by a single transmembrane domain to the neuronal presyn­
aptic plasma membrane. The amino terminal part is cytosolic and only a few residues 
protrude into the intersynaptic cleft. The arrows indicate the sites of CNT cleavage. 
Adapted from Bohnert et al., 2006.
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such as Rab guanine triphosphatases (GTPases) and other proteins helping vesicle 
tethering and/or SNARE activation.
1.1.7.1 SNAP-25
SNAP-25 was originally described as the major palmitoylated protein in the 
central nervous system (Hess et al., 1992; Oyler et al., 1989; Wilson et ah, 1996). As 
shown in Figure 1.5, this protein lacks a classical trans-membrane segment and its 
membrane binding is thought to be mediated by the palmitoylation o f several 
cysteines in the middle o f the polypeptide chain (Hess et ah, 1992; Veit et ah, 1996). 
SNAP-25 interacts with the other t-SNARE, syntaxin, and with VAMP to form the 
synaptic SNARE complex, which constitutes the core o f the neuroexocytic apparatus 
(Sollner et ah, 1993). The SNAP-25 family contributes two of the four a-helices that 
compose the SNARE complex. Upon interaction with syntaxin, SNAP-25 forms a 
three-helix bundle complex, which may act as a VAMP/synaptobrevin receptor on 
the plasma membrane (An and Aimers, 2004). In addition, SNAP-25 forms a 
stochiometric complex with the synaptic vesicle calcium sensor synaptotagmin (Bai 
and Chapman, 2004; Schiavo et ah, 1996), and this interaction is believed to be 
important in a late step o f the calcium-dependent phase o f neurotransmitter release 
(Baneijee et ah, 1996). The interaction o f synaptotagmin with SNAP-25 explains 
why vesicles can dock (but not fuse) to the plasma membrane when either syntaxin 
or VAMP are inactivated. In the absence o f Ca2+, the synaptotagmin/SNAP-25 
complex binds to VAMP and syntaxin, implying a role for synaptotagmin in core 
complex formation (An and Aimers, 2004; Schiavo et ah, 1997). Furthermore, 
syntaxin and SNAP-25 form a complex in a Ca2+ dependent manner in vivo, a 
process requiring only the amino-terminal SNARE m otif o f SNAP-25.
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SNAP-25 is conserved from yeast to humans (Wilson et al., 1996) and is 
required for axonal growth during neuronal development and for nerve terminal 
plasticity in the mature nervous system (Geddes et al., 1990; Osen-Sand et al., 1993). 
It is expressed in the nervous system in two developmentally regulated isoforms 
(SNAP-25A and B), with the B form predominating in adult nervous tissue. A 
shorter (SNAP-23) isoform is also known, which can participate in secretion but it 
does not support an exocytotic burst (Sorensen et al., 2003). SNAP-23 is required for 
exocytosis in mast cells, implying a crucial role o f this isoform in promoting 
membrane fusion (Guo et al., 1998).
1.1.7.2 Syntaxins
Syntaxins are widely distributed throughout the cell and their function is 
required for a wide range o f intracellular trafficking pathways (Teng and Wang, 
2001). They belong to a family o f proteins that are tail-anchored (also called type IV 
membrane proteins) (Salaun et al., 2004). Syntaxins have an amino-terminal 
cytoplasmic domain that is membrane bound by virtue o f a single carboxy-terminal 
hydrophobic domain with no ectodomain (Borgese et al., 2003). Syntaxins constitute 
a large protein family with homologues in yeast and plants. There are 15 members o f  
the syntaxin family in the human genome, o f which four are located to the plasma 
membrane. Syntaxin 1 is mainly found on the neuronal plasmalemma (Bennett et al., 
1992; Inoue and Akagawa, 1992) and functions in regulated secretion and 
exocytosis. Syntaxin 2 and 3 also function in exocytosis, whereas syntaxin 4 is 
involved in glucose transporter trafficing in adipocytes.
Syntaxin 1 is associated with calcium channels in the active zones (Atlas, 
2001; Stanley, 1997). It interacts in a calcium-dependent manner with some isoforms
49
Chapter 1.1: Introduction - Clostridium Neurotoxins
of the synaptic vesicle protein synaptotagmin (Sudhof, 1995) via a domain that is 
also responsible for the interaction with VAMP and a-SNAP (soluble NSF 
attachment protein) (Hayashi et al., 1995; Kee et al., 1995; Lin and Scheller, 1997). 
Together with SNAP-25, syntaxin 1 undergoes a recycling process in organelles 
indistinguishable from synaptic vesicles (Walch-Solimena et al., 1995). Disruption o f  
synaptic architecture by BoNT/C in central nervous system neurons activates distinct 
and neurodegenerative programs in the axo-dendritic network and in the cell bodies 
(Berliocchi et al., 2005). Syntaxins undergo a complex pattern of alternative splicing 
and expression during long-term potentiation, suggesting that syntaxins influence 
synaptic plasticity (Rodger et al., 1998). This differential expression could be 
important for a direct modulation o f calcium entry via selective interaction with 
specific calcium channels, in addition to the formation o f distinct SNARE complexes 
with different SNAP-25 and VAMP isoforms.
1.1.7.3 VAMP
VAMP is a protein o f 13 kDa localised to synaptic vesicles, dense core 
granules and synaptic-like microvesicles. VAMP is the v-SNARE prototype (Sudhof,
1995). Several isoforms have been identified, which are present in all vertebrate 
tissues. Their relative amount and distribution differs between tissues and cell-types 
(Rossetto et al., 1996; Rossi et al., 2004).
Structurally, VAMP can be divided in four functional domains (Baumert et al., 
1989). The amino-terminal portion is proline-rich and isoform specific, whereas the 
central portion of the cytoplasmic domain is highly conserved through evolution and 
contains the coiled-coil region responsible for SNARE complex formation (Lin and 
Scheller, 1997; Sutton et al., 1998). The protein is anchored to the membrane by a
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single trans-membrane domain, which is followed by a short and poorly conserved 
intra-vesicular portion. VAMP2, the major SNARE protein o f synaptic vesicles, is 
essential for two synapse-specific membrane trafficking steps: fast exocytosis for 
neurotransmitter release and fast endocytosis that mediates rapid reuse o f synaptic 
vesicles (Deak et al., 2004). Surprisingly, VAMP is not necessary for asynchronous 
neurotransmitter release, which is still present upon its cleavage by TeNT and 
BoNTs and in neurons derived from knock-out mice (Humeau et al., 2000; Schoch et 
al., 2001).
Several experimental data support a direct correlation between CNT-induced 
proteolysis o f SNARE and the inhibition o f neurotransmitter release. Recombinant 
VAMP, SNAP-25 and syntaxin are cleaved at the same peptide bonds as the 
corresponding cellular proteins, indicating that no additional endogenous factors are 
necessary for the proteolytic activity o f the CNT. Of the several isoforms o f SNARE 
proteins identified in different species and tissues, only some of them are susceptible 
to proteolysis by CNT. In general, a SNARE protein may be resistant to a neurotoxin 
because o f mutations at the cleavage site or in other regions involved in neurotoxin 
binding (exosites) (Breidenbach and Brunger, 2004).
1.1.8 Basis for clostridium neurotoxin recognition of SNARE proteins
Inspection of the sequence o f the three synaptic SNARE at the CNT cleavage 
sites reveals no conserved patterns that could account for the specificity o f these 
zinc-proteases for their intraneuronal targets. Hence, whereas the overall architecture 
of the active sites o f theses enzymes is expected to be similar, each CNT must differ 
in its detailed spatial organization in order to accommodate and hydrolyse such 
different peptide bonds.
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1.1.8.1 CNT symptoms derive from different sites o f intoxication
Biochemical studies have uncovered several unique features o f CNT. Short 
peptides encompassing the cleavage site are not cleaved, although they bind the 
toxin, whilst longer segments are cleaved (Foran et al., 1994; Yamasaki et al., 
1994a). Strikingly, TeNT and BoNT/B cleave VAMP at the same peptide bond 
(Q76-F77) (Schiavo et al., 1992c). For example, the minimal VAMP segment 
cleaved by BoNT/B spans amino acids 44-94 but is extended to 33-94 for TeNT 
(Foran etal., 1994).
Some CNT hydrolyse a peptide bond, leaving identical sequences elsewhere in 
the substrate untouched. Other CNT have some degree o f flexibility in terms o f the 
peptide bond cleaved. For instance, BoNT/B cleaves Q-F, present in the natural 
substrate VAMP, but is also able to hydrolyse peptides in which the above bond is 
substituted by N-F, A-F or Q-Y (Breidenbach and Brunger, 2004). BoNT/A and /C 
are poorly effective on isolated SNAP-25 and syntaxin, requiring the membrane 
insertion o f their substrates for full activity (Blasi et al., 1993b; Schiavo et al., 1995). 
BoNT/C binds two zinc atoms in highly purified preparations and cleaves membrane 
bound syntaxin 1A at peptide bond K253-A254 and syntaxin IB at K252-A253. 
Also, syntaxin isoforms 2 and 3 are cleaved by BoNT/C, but syntaxin 4 is unaffected 
by BoNT/C. Other K-A peptide bonds present in the carboxy-terminal region of 
syntaxin are unaltered by BoNT/C (Schiavo et al., 1995). These findings indicate that 
the toxin-substrate interaction requires some other structural elements o f the SNARE 
sequence o f syntaxin, such as a specific spatial organisation of the K-A peptide bond 
only gained via membrane insertion.
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1.1.8.2 Substrate recognition by CNT
Comparison o f the sequence o f synaptic SNARE proteins o f different species 
shows the presence o f a 10 residue long motif, termed SNARE motif (Rossetto et al., 
1994). This motif forms an a-helix with a negatively charged face flanked by a 
hydrophobic face (Rossetto et al., 1994; Washboume et al., 1997). Multiple copies o f  
this motif are present in syntaxin, SNAP-25 and VAMP and are proposed to act as 
CNT recognition sites. In fact, only peptides that include at least one SNARE motif 
are cleaved in vitro by CNT (Comille et al., 1997; Foran et al., 1994). The SNARE 
motif is exposed on the protein surface on native non-assembled SNARE proteins, as 
shown by the binding of anti-SNARE motif antibodies. These antibodies cross-react 
among the three SNARE and inhibit the proteolytic activity o f BoNT/B and /G 
(Pellizzari et al., 1996). CNT also cross-inhibit each other (Pellizzari et al., 1996), 
possibly by interacting with the SNARE motif. Extensive site-directed mutagenesis 
of VAMP and SNAP-25 demonstrates that different CNT bind different SNARE 
motifs (Pellizzari et al., 1997; Pellizzari et al., 1996; Washboume et al., 1997). 
Resistance to CNT in vivo is sometimes associated with species-specific SNARE 
motifs. In fact, Drosophila VAMP lacks one o f the three acidic residues in each 
SNARE motif, and is not cleaved by TeNT (Sweeney et al., 1995).
The molecular basis o f the substrate recognition by CNT is, however, still 
under debate. It is mainly thought that CNT use one or more regions o f substrate 
interaction distant from the enzymatic active sites, the exosites (Comille et al., 1997; 
Rossetto et al., 1994). The validity o f a reported co-crystal structure o f VAMP2 
bound to BoNT/B (Hanson and Stevens, 2000) has been questioned (Breidenbach 
and Brunger, 2004; Rupp and Segelke, 2001), mainly due to the lack o f observed
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electron density for the substrate and the improbable ligand stereochemistry. 
Recently, Breidenbach and Brunger reported a novel high-resolution structure o f a 
CNT L-chain in complex with its SNARE substrate (Breidenbach and Brunger,
2004). To overcome the inability to co-crystallise wild type BoNT/A L-chain with 
SNAP-25, an inactive variant (E224Q, Y366F) was used together with a truncated 
version (residues 141-204) o f SNAP-25. This SNAP-25 fragment adopted three 
types o f secondary structure in complex with BoNT/A: residues 147-167 formed a 
distorted a-helix, residues 168-200 were extended whereas residues 201-204 were 
involved in a distorted |3-sheet (Breidenbach and Brunger, 2004).
The amino-terminal helical region o f the SNAP-25 fragment interacts with the 
L-chain o f BoNT/A along the hydrophobic patch formed at the interface o f four a- 
helices (a-exosite) (Fig. 1.6). The carboxy-terminal portion of the SNAP-25 
fragment forms one strand of a distorted, three-stranded antiparallel (3-sheet at a 
region that is referred to as the |3-exosite. For BoNT/A substrate recognition, SNAP- 
25 has to be bound to a presynaptic membrane via its linker domain. In the 
membrane bound, non-complexed SNAP-25, the amino- and carboxy-terminal 
domains are unstructured or flexible. The binding of BoNT/A is probably initiated by 
helix formation at the a-exosite. Two anchor points along the extended portion o f  
SNAP-25, residues 170-172 and 192-193, and individual side chains in the nearby 
region are additional determinants o f substrate specificity. These anchor points 
reduce Km and enhance binding o f the |3-exosite, inducing conformational changes at 
the active site, which enables the endopeptidase to cleave its substrate (Breidenbach 
and Brunger, 2004).
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Figure 1.6: Model of BoNT/A substrate recognition
A) Palmitoylation sites mediate the interaction o f SNAP-25 with the presynaptic 
membrane. The amino-term inal and carboxy-term inal domains o f  SNAP-25 are 
unstructured or flexible. B) To initiate BoNT/A binding to SNAP-25, helix formation 
at the carboxy-terminal part o f the substrate enables the binding of the BoNT/A a -  
exosite. This initial binding assists the formation o f anchor points along the substrate 
(blue notches), which are further determinants o f substrate specificity. C) The anchor 
points reduce Km and increase substrate binding to the |3-exosite. The (3-exosites have 
limited substrate specificity but are fundamental for activity. The SNAP-25 binding 
to the [3-exosite induces conformational changes at the active site (AS) o f BoNT/A, 
which lead to substrate cleavage. SNAP-25 cannot be cleaved when in complex with 
other SNARE, since complexed SNAP-25 is restricted to a a-helical conformation. 
Adapted from Breidenbach and Brunger, 2004.
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BoNT/A can cleave small peptides (residues 192-206 of SNAP-25), which only bind 
to one anchor point in addition to the (3-exosite, but at reduced kcJ K m (Sukonpan et 
al., 2004). The lack o f anchor points might therefore explain the different minimal 
residue segments of VAMP cleaved by BoNT/B (amino acids 44-94) and TeNT 
(amino acids 33-94) (Foran et al., 1994). Therefore, most o f the enzyme-substrate 
interface serves to provide a substrate specific boost to kcJ K m by reducing Km 
(Breidenbach and Brunger, 2004). These findings also explain the inability o f 
BoNT/A to cleave SNAP-25 when in complex with other SNARE, because then the 
carboxy-terminal domain o f SNAP-25 is in a complete helical conformation and 
cannot bind to the BoNT/A a-exosite.
In conclusion, these studies suggest that multiple recognition sites on the 
SNARE proteins determine the specificity of the CNT for their targets. This binding 
is followed by interactions with other regions o f the sequence that are different for 
each SNARE, including the segment containing the peptide bond to be cleaved. The 
relative contribution of these interactions for the specificity and strength o f CNT 
binding to each SNARE remains to be determined.
1.2 Axonal transport in spinal cord motor neurons
Axons can reach a length o f up to several meters imposing major cross talk 
problems between the peripheral segments o f the axon and its soma (Fig. 1.7). To 
facilitate communication over these distances, neurons have developed an efficient 
and highly regulated transport system, which is essential for survival and growth 
(Goldstein and Yang, 2000). Axonal transport was first observed in transected axons 
and then confirmed in ligation experiments (Cajal, 1928; Waller, 1852; Weiss and
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Figure 1.7: Scanning electron microscopy image of a cultured rat motor neuron
Cultured rat motor neurons have a relatively large soma with a single long axon 
(arrow) and highly branched dendrites (arrowheads). Courtesy of Steve Gschmeissner, 
Cancer Research UK.
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Hiscoe, 1948). More recent metabolic radiolabelling studies clearly defined two 
types o f transport systems, fast and slow. The fast component (0.1-5 pm/s) is mainly 
used for vesicle and organelle transport, and for secreted molecules like 
neurotrophins. The slow component (1-50 nm/s) is responsible for the transport o f 
microtubules, neurofilament components, cytoplasmic proteins and metabolic 
enzymes (Vallee and Bloom, 1991). Neurotrophins, their low affinity receptor 
(p75NTR) and several endocytic compartments use retrograde axonal transport from 
the synapse to the cell body to reach their final destination (Goldstein and Yang, 
2000; Lalli and Schiavo, 2002; Vallee and Bloom, 1991; Whitmarsh and Davis,
2001). Several pathogens, such as Herpes and Polio viruses are targeted to the cell 
body, where the virus replicates or enters latency (Bearer et al., 2000; Satpute- 
Krishnan et al., 2003). Dendrites also require an efficient transport system for soluble 
proteins, organelles and vesicles, cytoskeletal elements and even components o f the 
translation machinery (Tiedge and Brosius, 1996). However, to date little is known 
about the mechanisms and motor proteins involved in dendritic transport and will not 
be discussed further.
1.2.1 Mechanisms of neuronal transport
Crucial components o f the axonal transport machinery are motor proteins that 
use ATP to perform mechanical work. The main component of neuronal traffic is 
microtubule-based (Goldstein and Yang, 2000). However, actin dependent motors 
are also relevant for neuronal transport, suggesting a functional connection between 
microtubule- and actin-based transport (Bridgman, 1999; Kamal and Goldstein,
2000).
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Three families o f force generating ATPases (myosins, kinesins and dyneins) 
have been identified in neurons (Vale, 2003) (Fig. 1.8). Myosins move along actin 
filaments from the minus to the plus end. Kinesins and dynein are ATPases, which 
are stimulated by binding to microtubules. Most kinesins move towards the 
microtubule plus-end, whereas dynein moves in the opposite direction. Therefore, 
kinesins are thought to be responsible for anterograde transport (Griffin and Watson,
1988) and dynein for retrograde microtubule-based transport in axons (Schnapp and 
Reese, 1989; Vallee et al., 1989).
1.2.1.1 Myosins
The myosin family o f actin filament-based molecular motors consists o f at 
least 20 structurally and functionally distinct classes. Myosins play an important role 
in several intracellular functions like signal transduction, cell migration and 
adhesion, transport and localisation o f molecules and organelles, and tumor 
suppression (Krendel and Mooseker, 2005). Myosins have two light chains per head 
domain, which bind the heavy chains in the lever arm region between the head and 
tail domains. The carboxy-terminal domain, which contains a coiled-coil region, 
targets myosin to its cargo. The head domain contains the actin-binding site and 
consists o f a catalytic core, which is responsible for ATP binding and hydrolysis.
Several myosin classes (I, II, V, VI and IX) have been found in neurons and 
with the exception of class IX, all these myosins are implicated in neuronal or other 
intracellular transport (Bridgman, 2004). Myosin I motors are single headed and are 
unable to proceed in a continuous fashion along actin filaments and are thought to be 
highly abundant on organelles to ensure higher transport efficiency (Veigel et al., 
1999). Myosin V can dimerise and forms a two-headed protein facilitating
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The microtubule-dependent motors, conventional kinesin, dynein and actin- 
dependent myosin are shown. In general, the motors consist o f a dimer o f heavy 
chains (motor domains), a stalk and associated polypeptides. The nucleotide- and 
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progressive transport towards the plus end o f actin filaments. Studies on 
melanosomes identified myosin Va as a molecular motor for organelle transport. 
Myosin Va binding to cargo is mediated by a receptor complex on the melanosome 
containing Rab 27a and melanophilin/Slac2-a, a rabphilin-like effector protein (Wu 
et al., 2002). However, only Slac-2 homologues were found in brain and Slac-2c was 
shown to interact with myosin Va and myosin Vila (Fukuda and Kuroda, 2002). 
VAMP was also suggested to operate as a myosin V receptor, forming a syntaxin- 
VAMP-myosin V complex in a Ca2+ dependent manner (Ohyama et al., 2001). 
Myosin VI also forms as a dimer, but its progressive movement (Nishikawa et al.,
2002) is directed towards the minus end o f actin filaments in vitro (Wells et al., 
1999).
The movement o f myosins is a result o f a power stroke, generated using the 
lever arm that converts tiny changes in the conformation of the myosin catalytic 
domain to displacements o f the whole myosin molecule (Geeves and Holmes, 1999). 
The myosin step size is dependent on the length o f the lever arm. The non­
progressive muscle myosin II’s head domains do not work together and the 
interaction with actin is less than one tenth of an ATPase cycle. The lever arms of  
myosin II are relatively short and their swing generates a displacement o f 5-10 nm. 
Myosin V operates progressively using a long lever arm to enable a -3 6  nm step 
size, which corresponds to the pitch o f the actin helix (Rief et al., 2000). The 36 nm 
are made up by a 25 nm working stroke plus an 11 nm displacement via thermally 
driven diffusion (Veigel et al., 2002).
In axons, mitochondria move along both microtubules and actin filaments, 
possibly using all three motor protein families (Hollenbeck and Saxton, 2005).
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Myosin is thought to generate short-range movement o f mitochondria along actin 
filaments, whereas kinesin and dynein are responsible for long-range transport along 
microtubules.
1.2.1.2 Kinesins
The crystal structure o f kinesin and myosin has revealed remarkable 
similarities o f their core region in the motor domain. Despite having a substantially 
smaller motor domain than myosin and lacking amino acid sequence homology, a 
strong evolutionary relationship between kinesin super family proteins (KIFs) and 
myosin was suggested (Kull et al., 1996). KIFs are microtubule-dependent motor 
proteins, which are grouped in different classes: ‘conventional kinesins’ (N-kinesins) 
and ‘unconventional kinesins’ (C- and M-kinesins), depending on the position o f  
their motor domain. C-kinesins have a carboxy-terminal motor domain and walk 
from the microtubule plus-end towards the microtubule minus-end; N-kinesins have 
an amino-terminal catalytic domain and progress in the opposite direction, and M- 
kinesins have an internal core motor domain.
Conventional kinesin, or kinesin-1, is highly abundant in nerve cells and 
classically consists o f two amino-terminal head domains, responsible for attachment 
to microtubules and nucleotide binding, a central coiled-coil region, a neck linker, 
and a globular tail domain (Hirokawa et al., 1998). It is a strictly progressive motor, 
which moves for long distances along microtubules without detaching. During 
movement, one o f the two head domains binds to the microtubule, ATP then binds 
and is hydrolysed at this first head. Next, phosphate is released from the first head 
and ADP is released from the second head (Gilbert et al., 1998; Hackney, 1996). At 
the same time, the second head strongly binds to the microtubule, and only then does
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the first bound head dissociate (Klumpp et al., 2004). This starts the cycle again on 
the newly bound head and is best described as a hand-over-hand cycle (Yildiz et al., 
2004). Kinesin-1 makes on average about 100 steps, each 8 nm in length, before it 
dissociates from the microtubule.
In neurons, kinesin-1 is the major motor responsible for the transport o f  
organelles from the cell body to the nerve endings in both axons and dendrites. 
Kinesin is found to attach irreversibly to transported organelles (Schnapp et al.,
1992) and pharmacological inhibition o f kinesin slows both anterograde and 
retrograde axonal transport (Brady et al., 1990; Lalli et al., 2003). Moreover, 
mutations in kinesin heavy chain cause some forms o f motor neuron disease, 
including amyotrophic lateral sclerosis (ALS), by disrupting fast axonal transport in 
both directions (Hurd and Saxton, 1996). Also patients suffering from Charcot- 
Marie-Tooth disease type 2A, characterised by axonopathy, have a missense 
mutation in the ATP binding domain o f kinesin leading to decreased motility (Zhao 
et al., 2001). Taken together, the disruption o f kinesin activity leads to bidirectional 
transport defects. The impaired axonal transport is suggested to be caused by genetic 
interactions between kinesin-1, dynein, and dynactin complex, which may be 
mediated by communal accessory factors, such as the dynactin complex (Martin et 
al., 1999).
1.2.1.3 Dynein
Dyneins are the largest and most complex group o f motor proteins in 
eukaryotic cells. The 9+2 axoneme dyneins operate as non-progressive motors that 
propagate the bending motion o f cilia and flagella (Woolley, 2000), while 
cytoplasmic dynein is a progressive motor (King, 2000) responsible for the transport
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o f various organelles such as the nucleus, Golgi and endosomes, and for the 
organisation o f the mitotic spindle and chromosome segregation during mitosis. 
Unlike the myosins and kinesins, dyneins are multisubunit complexes o f one to three 
identical heavy chains and several intermediate and light chains (King, 2000). Each 
dynein head domain contains numerous ATP binding sites (Mocz et al., 1998). 
Cytoplasmic dynein contacts the microtubule via an antennae and the stalk interacts 
with dynein intermediate- and light-chains to bind the cargo (Gee et al., 1997). 
Antennae and stalks are both flexible and they mediate retrograde dynein progression 
along microtubules with an average step size o f 15 nm (Burgess et al., 2003).
Cytoplasmic dynein requires accessory proteins like the dynactin complex 
(Fig. 1.9) for in vivo functions and microtubule transport within axons (Ahmad et al., 
1998; Burkhardt et al., 1997). The dynactin complex mediates the binding o f  
cytoplasmic dynein with its cargo vesicle. This complex is an assembly o f  several 
subunits: p l50Glued, p l35Glued, p62, p50/dynamitin, p27, p24, actin-related protein 1 
(Arpl), actin, actin-capping protein a-subunit, and actin-capping protein (3-subunit 
(Hirokawa et al., 1998). A 37-nm Arpl-actin filament resembling the backbone of  
the dynein-dynactin complex is the possible cargo-binding domain o f the dynactin 
complex. p l50Glued controls the binding o f the dynactin molecule to dynein and 
microtubules (Schroer et al., 1996). The dynein intermediate chains interact with the 
amino-terminal o f p l50Glued, which forms a heterodimer with p l35Glued (Vaughan and 
Vallee, 1995). Dynamitin is thought to be the main binding-regulator between 
pl50Glued and Arpl-actin, and the dynein intermediate chain is possibly linked via the 
pl50Glued-Arpl-actin complex to its cargo (Hirokawa et al., 1998). Furthermore, 
disruption o f the dynamitin complex by overexpressing p50/dynamitin resulted in
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Figure 1.9: The dynein-dynactin complex
Cytoplasmic dynein is linked via the dynactin complex to cargo membranes. 
pl50glued connects dynein and Arpl with microtubules. Arpl intercats with actin and 
spectrin on cargo membranes. See text for details. Adapted from Hirokawa et al., 
1998.
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abnormalities in microtubule-based axonal transport leading to a late onset o f motor 
neuron disease (LaMonte et al., 2002).
Cytoplasmic dynein was shown to bind directly to a neurofilament fragment 
and is therefore thought to play a role in the short-duration retrograde movement o f  
neurofilaments undergoing slow anterograde transport along axonal microtubules 
(Wagner et al., 2004). Furthermore, it was suggested that some neurofilaments enter 
axons as cargo o f microtubules that undergo transport. Dynein is thought to control 
both axonal retrograde neurofilament transport and anterograde neurofilament 
delivery from the soma to the axon (Motil et al., 2006). Dynein may also regulate 
other molecular motors because its inhibition affects the contribution o f kinesins and 
myosins to retrograde transport (Lalli et al., 2003).
1,2.2 Transport of clostridial neurotoxins
In contrast to BoNTs, which remain at the synaptic site, TeNT carriers are 
recruited to the retrograde axonal transport pathway towards the motor neuron cell 
body located in the spinal cord (Stockel et al., 1975). TeNT He carriers are shared by 
NGF and its low affinity neurotrophin receptor p75NTR (Lalli and Schiavo, 2002). 
Despite the importance o f these axonal compartments in health and disease, not 
much is known about their molecular and biophysical composition. Recently, we 
developed an assay based on fluorescently-labelled TeNT He to visualise and 
analyse the axonal retrograde transport in motor neurons in real time (Lalli and 
Schiavo, 2002).
Using this probe, three classes o f TeNT carriers were detected: round vesicles, 
tubules (Lalli and Schiavo, 2002) and ‘vesicle clusters’ (termed trains), which have a 
pearl chain-like morphology. Vesicles and trains progress discontinuously with
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frequent pauses during their transport. In contrast, tubules display an overall faster 
and more continuous movement (Bohnert and Schiavo, 2005; Lalli and Schiavo,
2002). Kinetic analysis revealed striking similarities between TeNT He carriers and 
TeNT holotoxin transport in vivo (0.8-3 .6 pm/s) (Bohnert and Schiavo, 2005; 
Schiavo et al., 2000). These findings allowed us to use the non-toxic fragment TeNT 
He as a tool to dissect neuronal transport. TeNT requires myosins for retrograde 
axonal transport. In particular motor neurons from myosin Va-null embryos display a 
slower TeNT retrograde transport than their wild type counterparts (Lalli et al.,
2003). Legs at odd angles (Loa) mice, which bear a homozygous mutation in the 
motor protein dynein (F580Y) in a region that is involved in binding to intermediate 
chains and in homodimerisation, exhibit axonal transport defects and motor neuron 
degeneration (Hafezparast et al., 2003). Similar transport defects were observed in 
Cral mice, which have a point mutation in the dynein heavy chain (Y1055C) that is 
located in the homodimerisation domain (Hafezparast et al., 2003). Overexpression 
o f p50/dynamitin leads to the degradation o f the dynamitin complex and results in 
reduced retrograde axonal transport (Deinhardt, 2005).
1.3 The vacuolar ( f t ) A TPase
Vacuolar (H+) adenosine triphosphatases (vATPases) are highly abundant 
multi-subunit proton pumps composed o f a peripheral domain (Vi) responsible for 
ATP hydrolysis and a trans-membrane domain (Vo) for proton pumping. vATPases 
were first discovered in plants and yeast, and later in all eukaryotes (Nelson, 1992b). 
Some specialised cells use vATPases in their plasma membrane for proton extrusion. 
vATPases on intracellular membranes are responsible for organelle acidification,
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crucial for many cellular and physiological processes. vATPases are fundamental 
enzymes and their dysfunction disturbs organelle performance and often leads to cell 
death (Nishi and Forgac, 2002).
1.3.1 Structure o f vA TPases
The superfamily o f ATPases is subdivided into three classes: the P-Type 
ATPases (Na+/K+-ATPases, H+/K+-ATPases, Ca2+-ATPases), mitochondrial F- 
ATPases and vATPases (Myers and Forgac, 1993). vATPases are composed o f a 
peripheral V) domain o f  eight subunits (A to H) and a trans-membrane Vo domain 
with five subunits (a, c, c1, c", d). vATPases are evolutionary and structurally related 
to F-ATPases (Fillingame, 1997) and the sequence o f the nucleotide binding and 
proteolipid subunits are similar (Bowman and Bowman, 1996). However, the 
vATPase is clearly different from the F-ATPase both in size and structural features 
(Fig. 1.10; Table 1.1, adapted form Nishi and Forgac, 2002).
Table 1.1: Subunit composition of the vATPase
Domain Subunit Molecular 
Weight TkDal
F-ATPase
homolog
Subunit function/location
V! A 70 P Catalytic site, regulation
B 60 a Non-catalytic site
C 40 ? Peripheral stalk
D 34 Y Central stalk
F 14 e Central stalk
G 13 B Peripheral stalk
H 50 ? Peripheral stalk
Vo E 33 ? Stator o f rotating proteolipid ring
a 100 A Stator o f rotating proteolipid 
ring in vATPase/H+ transport
d 38 ? Cytoplasmic side o f Vo
c 17 C H+ transport
c' 17 C H+ transport
c" 21 c H+ transport
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Figure 1.10: Structural comparison of vATPases and F-ATPases
The peripheral Vj domain o f vATPases is responsible for ATP hydrolysis and proton 
pumping. Protons are translocated through the integral VQ domain from the cyto­
plasm into the vesicular lumen. F-ATPases synthesises ATP using the proton move­
ment from the extracellular side through the F0 domain to the cytoplasm. The proton 
translocation is likely to be a rotary m echanism  for both pumps. Adapted from 
Kawasaki-Nishi et al., 2003, modified according to Compton et al., 2006.
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1.3.1.1 Structure and function o f the Vj domain
The hexagonal head o f the catalytic Vi domain is an ATP-driven rotary motor, 
composed o f catalytic and non-catalytic subunits (Yoshida et al., 2001). The catalytic 
sites are primarily located on the A subunits (Gruber et al., 2001). The amino acid 
sequence o f the vATPase A subunits is -25%  identical to the F-ATPase subunits (3 
and both contain the glycine-rich consensus sequence common for ATP binding 
proteins (Walker et al., 1982). Mutations in the vATPase subunit A and the F- 
ATPase subunit |3 lead to significant losses in enzyme activity (MacLeod et al., 
1998; Weber and Senior, 1997).
The non-catalytic nucleotide binding sites are located on the B subunits o f the 
vATPase head domain and they have a high degree o f sequence homology with the 
a-subunits o f F-ATPases. Mutation o f the yeast vATPase subunit B results in a 
complete loss o f vATPase activity and proton transport, and has a partial effect on 
vATPase assembly (Liu et al., 1996). The function o f the non-catalytic sites remains 
unknown but they are suggested to have a regulatory role in vATPase activity 
(Vasilyeva and Forgac, 1996).
The vATPase subunit D connects the Vi and Vo domain. Because o f the high 
a-helical content o f this subunit it is thought to be the homologue o f the F-ATPase 
subunit y. Therefore, subunit D and its interacting subunit F have been placed in the 
shaft (Xu et al., 1999). Random and site-directed mutagenesis o f subunit D suggests 
that it plays a role in coupling proton transport with ATP hydrolysis.
Subunit E was found to be necessary for the assembly o f the peripheral Vi 
domain (Doherty and Kane, 1993). The high a-helical content o f this subunit 
(Bowman et al., 1995) suggests that, like subunit D, it is homologous to the F-
70
Chapter 1.3: Introduction - The vacuolar ( IT)  ATPase
ATPase subunit y and might be a part o f the stalk region. It was also proposed that 
subunit E plays a role in the hook, which is considered a part o f the shaft (Nelson and 
Harvey, 1999). Furthermore, in yeast cells the stability o f subunit E is dependent 
upon interaction with subunit G (Tomashek et al., 1997). Recently, the E subunit was 
placed in the Vo domain, close to subunits a and d. Subunits E and a are thought to 
act as a stabiliser interfacing with the rotating proteolipid ring. However, the 
interactions o f subunit E with subunits a and d await experimental confirmation 
(Compton et al., 2006).
Subunit G in vATPases appears to be homologous to the b subunit o f F- 
ATPases. The major difference is the lack o f a membrane-spanning region in the G 
subunit (Hunt and Bowman, 1997). Short deletions in subunit G and subunit b do not 
severely disrupt ATPase function (Charsky et al., 2000). It is thought that subunit G 
plays a similar role as subunit b in F-ATPases by forming the peripheral stalk.
1.3.1.2 Structure and function o f the Vo domain
The Vo domain is responsible for proton pumping across membranes and 
consists o f five subunits, three o f which are highly hydrophobic. These subunits (c, c' 
and c") are homologous to each other and to the subunit c o f the F-ATPase (Hirata et 
al., 1997). The vATPase subunits c and c' contain four trans-membrane helices, 
whereas subunit c" contains five trans-membrane helices. Subunits c and c' have a 
carboxyl group in the fourth trans-membrane helix, which is responsible for proton 
pumping, whereas subunit c" has the carboxyl group in the third trans-membrane 
helix. F-ATPases need only one subunit for proton translocation. In contrast, all 
three subunits are essential for vATPase function in yeast (Hirata et al., 1997). The 
deletion o f subunit c o f vATPase in mice leads to an arrest o f development at an
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early embryonic stage (Sun-Wada et al., 2000). Besides having a highly specific 
binding site for the vATPase inhibitors Concanamycin A and Bafilomycin A l in 
subunit c (Bowman et al., 2004), it was shown that this subunit associates with the 
transforming bovine papillomavirus E5 oncoprotein (Goldstein et al., 1991). This 
suggests that the vATPase c subunit may play several roles in cells.
The vATPase subunit a contains nine putative trans-membrane domains, an 
amino-terminal hydrophilic domain towards the cytoplasmic side and a carboxy- 
terminal hydrophobic domain exposed to the lumen (Leng et al., 1999). The Vo 
domain might have a similar function in proton translocation as the Fo domain, 
because mutagenesis experiments have revealed that R735, located in the seventh 
trans-membrane segment o f vATPase subunit a, is absolutely necessary for proton 
transport (Leng et al., 1998).
The d subunit o f the vATPase is a hydrophilic protein without putative trans­
membrane domains (Nelson, 1992a). This subunit remains tightly bound to the Vo 
domain upon dissociation o f Vi (Adachi et al., 1990). It has been suggested that 
subunit d might play a role in coupling proton transport and ATP hydrolysis (Nishi et 
al., 2003).
1.3,2 Assembly of vATPases
The formation o f a functional enzyme complex requires the association o f all 
vATPase subunits (Nishi and Forgac, 2002). The Vo and Vi subunits can form a 
complex independently from each other (Graham et al., 2003). The peripheral 
domain requires the association o f all Vi subunits prior binding to the membrane 
domain. Following synthesis, the Vo subunits are inserted into the endoplasmic 
reticulum (ER) membrane where they are arranged with the help o f three non-subunit
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proteins VMA12, VMA21 and VMA22 (Fig 1.11). Cells lacking only one o f these 
assembly factors are unable to form the Vo domain as it cannot exit the ER for the 
Golgi or vacuolar membranes. A quality control system associated with the ER 
monitors the vATPase assembly process into multi-subunit complexes and 
selectively retains and degrades subunit a if  the Vo complex assembly is incorrect 
(Graham et al., 2003; Hill and Cooper, 2000). In yeast cells, Vo domains lacking an 
integral membrane subunit are found in the cytosol and are not inserted into 
membranes.
1.3.3 Functions of vATPases
1.3.3.1 Membrane fusion
The fusion o f yeast vacuoles is dependent on a proton gradient generated by 
vATPases. This gradient is necessary for trans-SNARE  pairing and vesicle docking 
to pre-synaptic membranes (Ungermann et al., 1999). However, synaptic vesicle 
endocytosis and release is not affected by inhibition o f the catalytic subunits o f  
vATPases (Zhou et al., 2000). It was proposed that the Vo domain o f vATPases is 
involved in membrane fusion, especially proteolipid subunit c (Peters et al., 2001) 
(Fig. 1.12). After SNARE mediated docking, the Vo vATPase domain promotes 
membrane fusion, forming a closed-off channel. The radial expansion o f this protein 
pore is thought to be a mechanism for intracellular membrane fusion. In addition, the 
neuronal vATPase subunit a l, which is necessary for synaptic vesicle exocytosis in 
Drosophila synapses, was suggested to play a role in proteolipid formation 
(Hiesinger et al., 2005). Mutations in the Vo subunit al disable synaptic vesicle 
acidification, impair neurotransmitter release and synaptic vesicle recycling.
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Figure 1.11: Assembly of vATPase
The hydrophobic Vma21p is located in the ER membrane and assists the assembly o f 
the VQ subcomplex. The dilysine-motif in the carboxy-terminal domain o f Vma21p 
indicates that it cycles between the ER and Golgi. Vma21p might escort the assem­
bled vATPase complex out o f the ER and after dissociation from the vATPase it is 
retrieved back to the ER. V m al2p and Vma22p form an assembly complex that inter­
acts with vATPase subunit a in the ER. Upon vATPase-exit from the ER, V m al2p 
and Vma22p dissociate from the assembled vATPase domain and remain in the ER. 
From the Golgi, fully assembled vATPases are transported to their destinations. 
Adapted from Graham et al., 2003.
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Figure 1.12: Role of vATPase in synaptic vesicle reloading and membrane fusion
Synaptic vesicles use the electrochemical gradient, generated by the vATPase, for re­
loading. vATPases have been suggested to function as a checkpoint in synaptic vesi­
cle fusion, allowing only fully loaded vesicles to dock and prim e, which m ight 
explain the quantal neurotransmitter release. Adapted from Weimer and Jorgensen, 
2003.
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However, the function o f vATPases in fusion events remains controversial because 
disrupting the proteolipid genes by a mutation in the subunit c o f the vATPase o f  
Saccharomyces cerevisiae does not produce fragmented vacuoles, a phenotype 
expected from a block in vacuolar membrane fusion (Umemoto et al., 1990). If the 
Vo domain plays a role in vacuole fusion, then the lack o f subunit c should prevent 
fusion and yeast vacuoles should appear fragmented. However, more work is 
required to attribute a role to vATPases in membrane fusion.
1.3.3.2 Receptor recycling
vATPases have many functions in intracellular membrane transport and in 
plasma membranes o f specialised cells. Functional vATPases are required for 
intracellular receptor recycling since the uncoupling o f endocytosed receptors and 
their ligands requires low-pH compartments (Tawfeek and Abou-Samra, 2004). 
Receptor extemalisation back to the plasma membrane and delivery o f  endosomal 
content to lysosomes is dependent on functional vATPases (Johnson et al., 1993; 
Tawfeek and Abou-Samra, 2004). However, it has been shown that receptor 
internalisation and the formation and maturation o f multivesicular endosomes is not 
affected by the inhibition o f vATPases (van Deurs et al., 1996). Receptor recycling 
and receptor exocytosis control the receptor density on plasma membranes and 
thereby the cells' sensitivity for ligand binding. Ligand degrading carriers depend on 
acidic luminal pH, generated by vATPases, to recruit the small GTP-binding protein 
ADP-ribosylation factor (ARF1) to their plasma membrane. ARF1 then mediates the 
association o f the coatamer to endosomes in a pH dependent fashion, thereby 
signalling the onset o f degradation (Gu and Gruenberg, 2000).
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1.3.3.3 Synaptic vesicle reloading
After neurotransmitter secretion, the messenger proteins are rapidly removed 
from the synaptic cleft by specific enzymes or by re-uptake. For neurotransmitter 
recycling, synaptic vesicles are re-filled with monoamines and acetylcholine, 
glutamate and y-aminobutyrate using specific transporters. The vesicular carrier re­
loading is a H+-dependent transport o f neurotransmitters (Parsons, 2000). The proton 
gradient and membrane potential generated by vATPases in synaptic vesicles are 
crucial for this process (Nelson, 1991) (Fig. 1.11). Anionic glutamate uptake is 
driven by the positive charged membrane on the inside o f the vesicle. Monoamines 
and y-aminobutyrate need the pH gradient across the synaptic vesicle membrane for 
their uptake (Moriyama et al., 1992). Hydrogen peroxide was shown to inhibit the 
vATPase, resulting in a defect o f synaptic vesicle reloading with glutamate and a 
down-regulation of neurotransmitter release (Wang and Floor, 1998). vATPases are 
also considered as regulators to ensure that only fully re-loaded synaptic vesicles 
dock or prime to pre-synaptic membranes. Once vesicle re-filling is completed, the 
electrochemical proton gradient dissipates, leading to dissociation o f the V) and Vo 
vATPase domains. Under these conditions, Vo domains on vesicle membranes are 
unmasked and ready to interact with a Vo domain on the pre-synaptic membrane, 
then forming a fusion pore (reviewed in Morel, 2003).
1.3.3.4 Intracellular parasites
There are two predominant entry pathways o f viruses into animal cells, a pH- 
independent and a pH-dependent pathway. The pH-independent pathway is used by 
enveloped viruses like human and simian immunodeficiency viruses, hepatitis B 
virus, and Sendai virus, which can cause pneumonia in mice and respiratory disease
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in humans (Daecke et al., 2005; Hagelstein et al., 1997; McClure et al., 1990; 
Ramalho-Santos and de Lima, 2001). These viruses bind to specific receptors that 
trigger a direct fusion o f viral and cellular membranes at extracellular pH. Entry o f  
the pH-dependent virus requires acidic pH for fusion to cell membranes. Some 
examples for pH-dependent entry are influenza virus, vesicular stomatitis virus and 
encephalitis causing West Nile virus (Chu and Ng, 2004; Guinea and Carrasco, 1995; 
McClure et al., 1990).
The low pH of intracellular compartments is a defence mechanism o f cells 
against intracellular parasites. For instance, the immune system's macrophages 
supplement the normal pH regulatory machinery in inflamed areas with vATPases on 
their plasma membranes to enhance proton extrusion and to maintain pH 
homeostasis (Brisseau et al., 1996). Furthermore, after ingestion o f living 
Mycobacterium bovis into wild type mice macrophages, phagosomes show an 
enhanced ability to fuse with vATPase-containing late endosomes and lysosomes, 
creating an acidic phagosomal environment that reduces intracellular mycobacterial 
replication. Additionally, mice with a mutation in the natural resistance-associated 
macrophage protein (Nrampl), an integral membrane protein recruited to phagosome 
membranes upon virus ingestion, have a higher vulnerability to mycobacterial 
infections (Hackam et al., 1998). Nevertheless, some parasites managed to adapt to 
this acidic environment using their own vATPases to extract excess protons. Coxiella 
burnetti, which is responsible for a zoonosis characterised by atypical pneumonia, 
has its maximal metabolic activity at pH 4.7 to 4.8 and it was suggested that this 
bacterium has adapted to growth under acidic conditions. Chlamydia trachomatis, 
the leading cause o f infectious blindness, replicates within a non-acidic vacuole,
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which is disconnected from the endocytic pathway (Heinzen et al., 1996). It has also 
been demonstrated that Mycobacterium tuberculosis arrests the maturation o f its 
phagosome at a stage where the phagosome interacts with early and late endosomes, 
but not with lysosomes (Clemens and Horwitz, 1996). The malaria parasite 
Plasmodium falciparum  exports its vATPase to the host erythrocyte plasma 
membrane, which could play a role in the pH regulation of infected cells (Marchesini 
et al., 2005). These findings imply that vATPases play a major role in pH 
homeostasis in response to viral infections.
1.3.3.5 Specialised cells
One o f the main functions o f the kidney is to filter 180 to 200 litres o f blood a 
day and to reabsorb and regenerate bicarbonate, which is used to buffer acids 
generated by metabolism. Kidney cells involved in the acid-base transport contribute 
to an overall body homeostasis by expressing vATPases on their plasma membrane 
which respond to acidosis and alkalosis with the secretion o f protons (Gluck et al., 
1996).
Osteoclasts are specialised macrophages that continually degrade bone 
substance during skeletal remodelling and growth via proton pumping (Chatterjee et 
al., 1992). High levels o f vATPases are located on the apical plasma membrane o f  
osteoclasts. Osteoclasts attach themselves to the bone matrix and form a sealed off 
cavity into which protons are secreted. Then osteoblasts rebuild the bone substance 
and repair minor damage. If the cavity cannot be formed by osteoclasts due to an 
impaired vATPase activity, patients suffer from osteoporosis (Frattini et al., 2000). 
Therefore, vATPases have been suggested to be an interesting target for the 
treatment o f skeletal diseases.
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vATPases on the plasma membrane o f certain tumor cells function in a similar 
fashion to osteoclasts. Tumor cells secrete lysosomal enzymes into the extracellular 
matrix to degrade surrounding tissue connections, driving tissue invasion. These 
secreted lysosomal enzymes' highest activity is at low pH, and the vATPases o f  
tumour cells pump protons into the extracellular space to facilitate invasion. Indeed, 
blocking vATPase activity has been shown to decrease the migration and invasion of  
highly metastatic cells (Sennoune et al., 2004; Stevens and Forgac, 1997).
1.3.4 pH regulation by vA TPases
Most studies o f vATPase functions have been performed in yeast, urinary 
bladder preparations, or membrane vesicles obtained from the brain and kidney. 
Plant vATPases were also studied intensely and they show a high functional 
similarity.
Intracellular pH is regulated by the transport o f H+ across organelle 
membranes. In urinary epithelia, luminal cell membranes have a low permeability for 
H+ equivalents and a high electrical resistance compared to the basolateral cell 
membranes. Therefore, changes in H+ concentration are a result o f active proton 
pumping across luminal membranes, which depends on trans-epithelial 
electrochemical potential differences (Al-awqati et al., 1977).
The rate o f active proton pumping into the lumen build by urinary epithelial 
cells is decreased when the lumen was acidified from pH 7.0 to 4.0 or charged 
electrically positive. But the proton pump rate reaches a maximum when the pH o f  
the luminal compartment is changed from 7.0 to 9.0 or when it becomes negatively 
charged. The association between H+ transport rate and H+ gradient or electrical 
gradient results in a sigmoidal relationship (Andersen et al., 1985). The proton
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transport rate across membranes depends on several factors: urine acidification in the 
mouse bladder is regulated by the proton-pumping rate o f vATPases and in turtles it 
is regulated via the number o f vATPases on luminal membranes (Gluck et al., 1982; 
Tomochika et al., 1997). Carbon dioxide stimulates the exocytosis o f acidic vesicles 
of urinary epithelial cells and promotes H+ transport. Therefore, it is thought that 
intracellular reserves o f vesicles containing vATPases rapidly fuse with the luminal 
membrane upon carbon dioxide stimulation, thereby enhancing H+ secretion across 
the whole epithelium (Gluck et al., 1982). The supply o f protons and metabolic 
energy to the pumps also controls the vATPase activity (Schwartz and Steinmetz, 
1977).
Additionally, the proton transport rate can be adjusted via the rate o f ATP 
hydrolysis and its coupled H+ translocation. The vATPase function o f vacuoles from 
Saccharomyces cerevisiae was characterized by their current-voltage relationship at 
different pH gradients in the presence o f ATP, ADP and Pi or the absence o f ATP. 
The coupling ratio o f transported protons over hydrolysed ATP molecules was 
dependent upon the pH difference across the vacuolar membrane, being 2H+/ATP at 
a pH difference o f four pH units and increasing to >4H+/ATP for small or zero pH 
gradients. Other experiments indicate that the coupling efficiency o f vATPases in the 
brain can be altered by the presence o f Mg2+ or Ca2+ (Crider and Xie, 2003).
Glucose was identified as a regulator o f the vATPase, in that the removal o f  
glucose from the culture medium o f pig kidney epithelial cells markedly reduces 
vATPase dependent proton translocation. Supplementing the medium with glucose 
induced a concentration-dependent reactivation of the vATPase and pH recovery 
(Nakamura, 2004). The process o f reversible disassembly o f the V) and Vo domains
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does not involve new protein synthesis or signal transduction pathways (Kane, 1995; 
Parra and Kane, 1998). However, glucose-triggered vATPase assembly in vivo is 
thought to be controlled by a protein complex termed 'regulator o f the (H+) ATPase 
of vacuolar and endosomal membranes' (RAVE), which associates with the Vi 
domain (Seol et al., 2001). Furthermore, vATPase disruption requires functional 
microtubules, but are not required for its reassembly, therefore suggesting that both 
processes are most likely independently controlled (Xu and Forgac, 2001). The 
factors responsible for these variable stoichiometries remain largely unknown. Some 
findings point out that subunit A o f the vATPase Vi domain and subunit a o f the Vo 
domain might be involved in the coupling o f H+ transport and ATP hydrolysis. ATP 
hydrolysis is mainly mediated by the A subunit in the vATPase head domain (Gruber 
et al., 2001) and site directed mutagenesis o f the yeast subunit A alters proton 
transport and vATPase activity (Shao et al., 2003). However, the expression o f  
different a subunit isoforms in yeast vacuoles resulted as well in changes o f proton 
translocation (Kawasaki-Nishi et al., 2001).
The catalytic function o f the clathrin-coated vesicle vATPases can be 
inactivated by the formation of intramolecular disulfide bonds between cysteins in 
the A subunit, which can be blocked by ATP and high ionic strength (Feng and 
Forgac, 1994). The mechanism for disulfide-bond formation in vivo is not known. 
However, proton transport and vATPase activity are inhibited by the nitric oxide- 
generating reagent S-nitrosoglutathione (SNG) and are regained upon treatment with 
dithiothreitol. Nitric oxide might therefore act as a negative regulator o f vATPase 
activity in vivo via a redox mechanism (Forgac, 1999). Accordingly, the vATPase in 
bovine brain synaptic vesicles is highly sensitive to inhibition by hydrogen peroxide,
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a metabolic byproduct o f autooxidation, superoxide dismutase and other oxidative 
enzymes. Also, glutamate uptake by synaptic vesicles is impaired by hydrogen 
peroxide, down-regulating transmitter release (Wang and Floor, 1998).
Furthermore, vacuolar acidification can be controlled through the regulation of  
counterion conductance, which appears to occur via chloride channels. Chloride 
channel activity in both endosomes and clathrin-coated vesicles is modulated by 
phosphorylation (Bae and Verkman, 1990; Mulberg et al., 1991). Treatment o f  
coated vesicle membranes with alkaline phosphatase leads to a decrease o f chloride 
channel activity and ATP-dependent acidification o f coated vesicles. Protein kinase 
A (PKA) and MgATP are able to reverse this process suggesting that chloride 
conductance in coated vesicles is modulated by a PKA-dependent phosphorylation, 
which affects vATPase-dependent acidification (Mulberg et al., 1991).
1.4 Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease 
characterised by the progressive degeneration and loss o f motor neurons (Rowland 
and Shneider, 2001) resulting in paralysis and eventually death. ALS was described 
first by the neurobiologist Jean-Martin Charcot in 1869. Until today it is still 
incurable and its precise aetiology remains unknown. Genetic mutations in copper- 
zinc (Cu/Zn) superoxide dismutase (SOD1), which lead to aberrant oxidative 
damage, were identified as a primary cause o f familial cases o f ALS (FALS) (Rosen,
1993).
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1.4.1 Characteristics of ALS
Neuronal death in upper motor neurons leads to a general muscle weakness, 
whereas a loss in lower motor neurons induces muscle atrophy and paralysis (Mulder 
et al., 1986). The neuronal death in ALS is selective since neurons controlling the 
bladder and eye movement are mainly excluded from degeneration (Mannen et al., 
1977). Motor neuron disease onset is usually between 50 and 60 years o f age but 
some rare cases o f juvenile disease have been reported (Aggarwal and Shashiraj, 
2006). ALS is fatal within one to five years o f onset largely due to the failure o f the 
respiratory system. On average one to three in 100,000 people develop the disease. 
90-95% of ALS cases are sporadic (SALS), whereas only 5-10% are familial. 15- 
20% of FALS cases carry a mutation in the enzyme SOD1, which leads to oxidative 
damage (Shaw, 2005). The clinical symptoms o f SALS and FALS are identical, 
however, there are some differences in their pathology. The age of onset in FALS is 
a decade earlier than in SALS and it starts more frequently in the lower extremities 
(Mulder et al., 1986). Motor neuron loss during disease progression is characterised 
by reactive gliosis (Leigh and Swash, 1991), cytoplasmic neurofilament 
accumulations (Hirano et al., 1984), problems in glutamate handling and defects in 
protein folding (Bruijn et al., 1998). At late stages o f ALS, large axonal swellings 
and a significant degeneration and loss o f myelin fibres occur (Delisle and Carpenter, 
1984).
1.4.2 SOD1 mutations
Inheritance o f FALS is usually autosomal dominant, though autosomal 
recessive and X linked heredity can also occur. Six inherited adult onset FALS
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related diseases have been found, but only the identity o f four altered genes or 
proteins (ALS2, VAPB, TAU and SOD1) have been revealed to date (Shaw, 2005). 
The mutant gene-product o f ALS2  is likely to be a guanine exchange factor for an 
unidentified G protein o f a recessive inherited form o f ALS linked to chromosome 2 
(Yang et al., 2001). A missense point mutation within the major sperm protein 
domain o f human vapB (VAMP associated protein gene B, VAPBP56S) is 
associated with a dominant inherited form o f motor neuron disease, ALS8 
(Nishimura et al., 2004). The mutation for dementia-ALS is probably located on the 
chromosome arm 17q, distal to microtubule associated protein TAU (Wilhelmsen et 
al., 2004). Patients with autosomal dominant motor neuron disease have mutations in 
the SOD1 gene on chromosome 21q22.1 (Rosen, 1993). SOD1 is a 153 amino acid 
homodimer responsible for convertion o f superoxide, which is produced primarily by 
errors o f oxidative phosphorylation in mitochondria, to water and hydrogen peroxide 
(Longo et al., 1996) (Fig. 1.13). This catalysis is mediated by a copper atom, which 
is alternately reduced and oxidised by superoxide. Several mutations were found in 
the SOD1 gene, including missense mutations and deletions or insertions, leading to 
a frame-shift that produces premature stop codons (Andersen et al., 2003; Jackson et 
al., 1997; Orrell et al., 1997). Mutant SOD1 is thought to have a different 
conformation than wild type SOD1. The less tightly folded mutant SOD1 enzyme 
allows better access o f aberrant substrates to the active copper atom. Hydrogen 
peroxide, which is under normal conditions transformed to water by glutathione 
peroxidase or catalase, can act as an abnormal substrate for reduced SO Dl-C u1+, 
generating highly reactive hydroxyl radicals (Wiedau-Pazos et al., 1996). 
Peroxynitrate, which can form spontaneously from nitric oxide and superoxide, is
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2 H + + C V  2H 20 2 — ca ta la se  ^
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B) Peroxidase hypothesis (W ied au -P azos et al., 1996) 
H20 2
SO D -C u1+ ^  ►  SO D -C u 1+-'OH + OH’
▼
OH
C) Peroxinitrite hypothesis I (B eckm an et al, 1993) 
0 2‘ + NO’  ►  -QONO
SO D -C u1+ M ^  S 0 D  CU2+
OH' + N 0 2-Tyr-Protein H-Tyr-Protein
D) Peroxinitrite hypothesis I: backward catalysis (E stev ez  et al., 1999)  
(Zn-) SO D -C u2+ o
^ixidised
(Zn-) SO D -C u1+ --------------------------------  ►  (Zn') S 0 D -C u 2+. . .0 2-
^-NO
reduced
N 0 2-Tyr-Protein M ----------------------------------------- (Zn') SO D -C u2+...ONOQ -
Figure 1.13: Wild type and mutant SOD1 chemistry
A) SOD 1 catalyses the dismutation of superoxide ('0 2') into oxygen ( 0 2) and hydro­
gen peroxide (H20 2). Hydrogen peroxide is further processed by the enzymes cata­
lase or glutathione peroxidase to nontoxic by-products. B) Peroxide could also act as 
a substrate for the reduced SODl-Cu1+ and might create the highly reactive hydroxyl 
radical, starting a cascade o f peroxidation. C) The aberrant substrate peroxynitrite 
(ONOO") can form spontaneously from superoxide and nitric oxide and yields 
tyrosine nitration. D) Reduced mutant zinc-deficient SODl-Cu1+ is thought to run the 
conventional catalytic step backwards, converting oxygen to superoxide. The pro­
duced superoxide could then react with freely diffusing nitric oxide to generate 
peroxynitrite, promoting protein nitration and intracellular damage. Adapted from 
Cleveland and Rothstein, 2001.
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also an aberrant substrate for mutant SOD 1, leading to tyrosine nitration in proteins 
(Beckman et al., 1993), which is an irreversible alteration that can modify protein 
function. Crow et al. found that some SOD mutants have a 30-fold decreased affinity 
for their zinc atom. Neurofilament L-chain is thought to promote the formation of  
zinc-depleted SOD in motor neurons because it is able to bind multiple zinc atoms 
with sufficient strength to remove zinc from mutant and wild type SOD. The removal 
of zinc from wild type SOD leads also to a higher rate o f tyrosine nitration (Crow et 
al., 1997). Additionally, oxygen could re-oxidise zinc-deficient SOD-Cu1+, creating 
superoxide (Estevez et al., 1999).
Blood samples o f ALS patients at early disease stages indicate a loss o f SOD1 
activity, which has therefore been implicated in playing a central role in the disease 
(Deng et al., 1993). However, a transgenic mouse expressing the FALS-linked 
human S0D 1G93A mutant develops progressive motor neuron disease despite 
elevated SOD1 activity levels (Gurney et al., 1994). Furthermore, three more strains 
that express different SOD1 mutants caused ALS with elevated or unchanged SOD1 
enzyme activities (Bruijn et al., 1997; Ripps et al., 1995; Wong et al., 1995). In 
contrast to these findings, mice with a complete deletion o f the SOD1 gene have 
normal lifespans and do not develop motor neuron disease (Reaume et al., 1996). 
The levels o f SOD1 activity do not correlate with disease in mice or humans because 
some mutant enzymes such as S 0D 1G37R retain full dismutase activity (Borchelt et 
al., 1994). A chronic increase o f wild type SOD1 has either no effect on disease or 
accelerates it (Bruijn et al., 1998; Jaarsma et al., 2000). Therefore, ALS is 
presumably not due to the loss o f enzymatic function of mutant SOD 1 but to a gain 
o f toxic properties that are independent of SOD1 activity.
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1.4.3 Effects o f mutant SOD 1 expression
1.4.3.1 Oxidative stress
Even though S0D1 redox activity is not involved in the disease, some studies 
have linked the pathogenesis o f ALS to oxidative stress because oxidative damage to 
proteins in neurons o f SALS and FALS is increased and this has been suggested to 
contribute to neuronal death (Ferrante et al., 1997; Shaw et al., 1995b). The 
progressive cellular accumulation o f highly reactive oxygen species that induce bio- 
molecular damage is also regarded as a main cause o f aging. But in contrast to age- 
dependent increase o f vitamin E levels, oxidative stress in mutant SOD1 mice leads 
to a depletion o f vitamin E. Nutritional delivery o f vitamin E delays disease onset 
and slows disease progression, but the lifespan o f SOD1 mutant mice is unaffected 
(Gurney et al., 1996). Mutations in SOD1 are thought to alter its structure, allowing 
easier access for abnormal substances to the active copper ion commencing the 
production o f free radicals (Shaw, 2005). Zhang and Zhu showed that ALS-linked 
SOD1 mutants adopt different conformations from the wild type protein in living 
cells. Motor neuron-like cells expressing mutant SOD1 are more susceptible to 
hydrogen peroxide induced cell death compared to cells expressing wild type SOD1 
(Zhang and Zhu, 2006). Also the enzymatic activity o f the vATPase is blocked by 
hydrogen peroxide, leading to limited neurotransmission (Wang and Floor, 1998). 
However, several findings raise questions about the copper-dependent toxicity o f  
SOD1 mutants, since deleting the gene encoding the copper chaperone for SOD1 and 
SOD1 depletion does not show any effect on disease phenotype in SOD1 mutant 
mice (Reaume et al., 1996; Subramaniam et al., 2002).
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1.4.3.2 Exitotoxicity o f glutamate
Excitotoxicity is caused by the excessive release o f excitatory 
neurotransmitters, causing damage to nerve and glial cells and is thought to 
contribute to some neurodegenerative diseases (Fig. 1.14). Glutamate, the most 
common excitatory neurotransmitter, usually generates motor neuron injury when 
released at abnormally high levels (Heath and Shaw, 2002). Interestingly, glutamate 
levels are elevated in 60% o f ALS patients, and high glutamate concentrations 
correlate with spinal onset o f the disease, further impaired limb function and an 
increased rate o f muscle deterioration. Therefore, glutamate levels are considered to 
reflect the intensity o f cell damage in the spinal cord (Spreux-Varoquaux et al.,
2002). Increased expression o f EAAT2, the protein responsible for glutamate 
reuptake, protects neurons from glutamate induced cytotoxicity and cell death in 
vitro. Double transgenic mice overexpressing EAAT2 and S0D 1G93A show a delay in 
onset o f muscle weakness and in the loss o f motor neurons, but onset o f paralysis, 
body weight reduction or lifespan does not improve compared to SOD1G93a 
littermates. Hence, the loss o f EAAT2 may contribute to, but does not cause, motor 
neuron degeneration in ALS (Guo et al., 2003). In contrast, the inhibition o f EAAT2 
does not affect glutamate uptake in human neuroblastoma cells transfected with 
SOD1G93a. The glutamate uptake in S0D 1G93A expressing neuroblastoma cells is 
reduced and is probably caused by the oxidative inactivation of the glutamate 
transporter subtypes EAATj and EAAT3 (Sala et al., 2005). Both riluzole (reduces 
glutamate release) and gabapentin (lowers presynaptical glutamate synthesis) extend 
the lifespan o f SOD1 mutant mice, although, disease onset remains unaltered by
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Figure 1.14: Mutant SOD1 accumulates during aging and inhibits removal of 
damaged proteins
Released glutamate from intemeurons or upper motor neurons triggers firing o f lower 
motor neurons. Lower motor neurons then release acethylcholine (ACh), generating 
muscle contraction. SOD1 accumulates during aging and leads to mutant SOD1 
aggregates. Chaperone activity is lost and removal o f damaged protein is inhibited 
because proteasomes are suffocated with SOD1 aggregates. Neurofilaments become 
disorganised, inhibiting axonal transport and caspase 1 is persistently activated. 
Adapted from Cleveland and Rothstein, 2001.
Chapter 1.4: Introduction - Amyotrophic lateral sclerosis
riluzole. These findings imply that oxidative damage caused by mutant SOD1 
triggers slow or weak excitotoxicity that can be partially inhibited by drugs (Gurney 
et al., 1996).
1.4.3.3 A role for mitochondria in ALS
Evidence suggests that mitochondrial dysfunction is involved in ALS 
pathogenesis. Morphological and biochemical abnormalities in mitochondria have 
been described in SALS cases, and in transgenic FALS mouse models expressing 
mutant SOD1. The mitochondrial abnormalities begin prior to the clinical and 
pathological onset o f the disease, suggesting that mitochondrial dysfunction may be 
involved in the pathogenesis o f ALS. Mutant SOD1 has been shown to localise to 
mitochondria, forming abnormal aggregates (Manfredi and Xu, 2005). Additionally, 
mitochondria o f ALS patients appear swollen and motor neuron nerve terminals 
contain increased calcium levels, resulting from an impairment o f the calcium- 
buffering function of mitochondria (Siklos et al., 1996). Mice injected with IgG from 
ALS patients display similar abnormalities. The overall amount o f mitochondrial 
DNA is lowered in spinal cords o f ALS patients, but this mitochondrial DNA shows 
high levels o f mutations. Moreover, decreased activity o f the mitochondrial marker 
citrate synthase, and lowered activities o f the respiratory chain complexes I+III, 
II+III, and IV are detected (Wiedemann et al., 2002). Mutant SOD1 has been found 
to trigger the activation o f the apoptosis cascade via the release o f cytochrome c in 
mitochondria, and neuronal cell death occurrs without mutant SOD1 aggregate 
formation in the cytoplasm (Takeuchi et al., 2002a). Furthermore, minocycline (an 
inhibitor o f microglial activation) and cytochrome c release from mitochondria 
delays disease onset and extends survival in ALS mice (Zhu et al., 2002). SOD1
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mutants also have an increased denitrosylase activity that leads predominantly to a 
reduction o f mitochondrial intracellular protein and peptide S-nitrosylation, a 
modification o f cysteines by nitric oxide. This is thought to disrupt the function and 
localisation o f proteins that are regulated by S-nitrosylation (Schonhoff et al., 2006). 
These findings imply that mutant SOD1 may directly damage mitochondria.
1.4.3.4 Neuroskeletal alterations in ALS
Defects in slow anterograde axonal transport are one o f the earliest pathologies 
detected in SOD1 mutant mice (Williamson and Cleveland, 1999). In SALS and 
FALS neurofilament accumulations have been found in cell bodies and proximal 
axons o f motor neurons (Hirano et al., 1984). Neurofilaments are composed o f light 
(NF-L), medium (NF-M), and heavy (NF-H) polypeptides. They play an important 
role in cell architecture and differentiation. Transgenic mice producing elevated 
levels o f neurofilaments in motor neurons have swollen perikarya with unusually 
localised nuclei, axonal swellings, and severe skeletal muscle atrophy. The 
accumulation o f neurofilaments in motor neurons can trigger a neurodegenerative 
process and could be an important intermediate in the pathogenesis leading to 
neuronal death (Xu et al., 1993). In ALS patients, NF-H subunit accumulation in 
neuronal perikarya and widened axons have been detected, which suggests a possible 
role o f this subunit in the pathogenesis o f ALS (Mendonca et al., 2005). The deletion 
of NF-L extends the lifespan of SOD1 mutant mice, despite a loss o f motor neurons 
in early postnatal development (Williamson et al., 1998). However, the 
overexpression o f NF-H in mutant SOD1 also slows disease progression and 
increases the lifespan o f S0D 1G37R mice by up to 65%. The protective effect o f NF- 
H protein against SOD1 toxicity in spinal root axons and motor neurons in
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S0D 1G37R/NF-H double heterozygotes mice has been confirmed (Couillard-Despres 
et al., 1998). Furthermore, SOD1G93a mice overexpressing either NF-L or NF-H 
display a late onset o f symptoms and have a longer lifespan than S0D 1G93A mice on 
a wild type background (Kong and Xu, 2000). The contradictory findings that 
increased neurofilament expression and neurofilament deletion both have a 
beneficial role on disease progression can be explained by the fact that increased 
accumulation o f neurofilaments in the motor neuron soma or reduced neurofilament 
content minimises the axonal neurofilament amassing in SOD1 mutants and 
therefore eases axonal transport (Lobsiger et al., 2005). Neurofilament 
phosphorylation sites act in motor neuron cell bodies as phosphorylation sinks that 
diminish faulty cyclin-dependent kinase 5 (Cdk5) regulation induced by mutant 
SOD1 (Nguyen et al., 2001). Accordingly, Lobsiger et al. showed that elimination of  
the NF-M and NF-H phosphorylation sites accelerate aberrant phosphorylation of  
other neuronal substrates, while at the same time leaving the overall neurofilament 
content unaltered. More surviving motor neurons and axons were found in SOD1 
mutant mice with deleted neurofilament phosphorylation sites than in SOD1 mutant 
mice with wild type neurofilaments. Removal o f the neurofilament phosphorylation 
sites slows damage developed within motor neurons, but SOD1 mutant damage 
within non-neuronal supporting cells reduces motor neuron functionality (Lobsiger et 
al., 2005). The accumulation o f neurofilaments in the soma is thought to be 
protective via a de-cluttering o f axons and improvement o f axonal transport, rather 
than by controlling the dysregulation o f Cdk5 activity. Mutations in neurofilaments 
are possible risk factors that may contribute to ALS pathogenesis in conjunction with
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one or more additional genetic or environmental factors, but are not significant 
primary causes o f ALS (Garcia et al., 2006).
1.4.3.5 Protein aggregation induced by mutant SOD1
Cytosolic protein aggregates appear to be common in SALS and FALS as well 
as transgenic mouse models expressing mutant SOD1 (Fig. 1.15). Mutant SOD1 has 
been found to promote cell death while the wild type SOD1 protein is anti-apoptotic. 
Both wild type and mutant SOD1 are directly linked to the anti-apoptotic protein 
Bcl-2 in vitro and in vivo. Increased expression o f Bcl-2 delays disease onset and 
prolongs the lifespan of mutant S0D 1G93A mice (Kostic et al., 1997). It is though that 
entrapment o f Bcl-2 by mutant SOD1 aggregates may deplete motor neurons o f this 
anti-apoptotic protein (Pasinelli et al., 2004). Inclusion bodies, mostly positive for 
ubiquitin, proteasomes, and Hsc70 were observed in spinal cords o f S 0D 1G93A, 
S0D 1G85R, and S0D 1G37R mutant mice. Although all aggregates were positive for the 
copper chaperone for SOD1, SOD1 itself was not consistently found in the 
inclusions. Therefore, the copper chaperone for SOD1 is most likely not responsible 
for aggregate formation. These inclusions might be sequestered into the ubiquitin- 
proteasome pathway and some chaperone proteins such as Hsc70 may be involved in 
formation and degradation of these inclusions (Watanabe et al., 2001). Transgenic 
mice, which express human S0D 1G93A have a decreased chaperoning activity in 
lumbar spinal cord. Increasing the level o f stress-inducible chaperone 70 kDa heat 
shock protein by gene transfer reduces formation o f mutant SOD 1-containing 
aggregates in cultured S0D 1G93A primary motor neurons. It is likely that the lack of 
molecular chaperones is directly involved in loss o f motor neurons in this disease 
(Bruening et al., 1999). SOD1 mutant protein aggregates are also thought to reduce
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Figure 1.15: Mutant SOD1 aggregates induce motor neuron death
SOD1 also damages astrocytes which are unable to recover synaptic glutamate using 
EAAT transporters and thus prevents repetitive motor neuron firing. This leads to ele­
vated calcium levels which activate caspase 3, which in turn induces motor neuron 
death. Adapted from Cleveland and Rothstein, 2001.
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proteasome activity, which is needed for normal protein turnover (Allen et al., 2003). 
Overexpression o f Hsp70 and Hsp40 improves neurite outgrowth as it suppresses 
cytoplasmic aggregate formation and cell death in a cultured neuronal cell model o f  
FALS (Takeuchi et al., 2002b). Furthermore, treatment o f S0D 1G93A mice with 
arimoclomol, a coinducer o f heat shock proteins, significantly delays disease 
progression and increases the lifespan of mice by 22% (Kieran and Greensmith, 
2004). These findings may provide a basis for Hsp in FALS treatment.
1.4.3.6 Non cell autonomous aspects o f ALS pathogenesis
How does mutant SOD 1 act in motor neurons and how does it elicit neuronal 
death? Motor neuron and astrocyte deaths are triggered by the sequential activation 
of caspase 1 and caspase 3, which are cysteine proteases implicated in apoptotic cell 
death that cleave numerous protein substrates that are carboxy-terminal to an 
aspartate residue. Several months after constant caspase 1 activation, neuronal death 
starts coincidentally with the activation o f caspase 3 (Pasinelli et al., 2000). 
However, since SOD1 is expressed ubiquitously, the toxicity o f mutant SOD1 may 
be caused by non-neuronal cells adjacent to motor neurons. If mutant SOD1 is 
expressed selectively in astrocytes or in neurons these mice do not develop motor 
neuron disease (Gong et al., 2000; Lino et al., 2002). Although the levels o f mutant 
SOD1 may not be high enough to affect motor neurons, these experiments suggest 
that disease development also requires mutant SOD1 damage in non-neuronal cells. 
Furthermore, mice selectively expressing SOD 1093A or S0D 1G37R in motor neurons 
were able to avoid neuronal degeneration and death when surrounded by normal, 
non-neuronal cells. The lifespan of these chimeric mice is more than doubled 
compared to mice expressing the two SOD1 mutants ubiquitously. These findings
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suggest that the death o f motor neurons is not a cell autonomous process, but 
depends on surrounding cells also expressing mutant SOD1 (Clement et al., 2003).
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2 Materials and Methods
2.1 Materials
2.1.1 Reagents and Media
Chemicals were purchased from the following companies unless stated 
otherwise: Amersham Biotech, Sigma, Fluka, BDH, Calbiochem; Molecular 
biological reagents were purchased from Qiagen, Promega, New England Biolabs 
and Clontech. AlexaFluor maleimides and Lysotracker Red DND-99 were from 
Molecular Probes.
Phosphate buffered saline (PBS), Hanks’ buffer, Dulbecco’s Modified Eagle’s 
Medium lacking phenol red, riboflavin, penicillin/streptomycin and folic acid 
(DMEMe ), PCR Mix and bacterial growth media (LB and 2YT) were all supplied by 
Cancer Research UK laboratory services.
2.1.2 Antibodies
The following Antibodies were used in this work for Western blot (WB) and 
immunofluorescence (IF):
Antigen Antibodyname
Supplier Di
ution
WB IF
DAMP a-DNP
Oxford Biomedical 
Research, Oxford (UK) 1:20
vATPase 
subunit E
a-31 kDa 
vATPase
S. Breton, Massachusetts 
General Hospital (MA) 1:4,000 1:300
vATPase 
subunit B 2E7
H. Sze, University of 
Maryland (MD) 1:100 1:10
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vATPase 
subunit E ATP6E GenWay 1:1000 1:100
vATPase 
subunit a
a - 116 kDa 
vATPase
Synaptic Systems, 
Goettingen (D) 1:3000 1:300
VAMP1 a-VAMP 1
Gift from Omella 
Rossetto, university o f  
Padua (I)
1:100
VSV-G
a-VSV-G-
5844,
polyclonal
Custom made anti body, 
Biogenes, Berlin (D) 1:80
VSV-G
a-VSV-G
P5D4,
mono­
clonal
Monoclonal antibody 
facilities, Cancer Research 
UK
1:300
Secondary 
antibody (WB)
HRP Amersham Bioscience 1:1000
Secondary 
antibody (IF)
Alexa-
Fluor Molecular Probes 1:300
2.1.3 Oligonucleotides
Oligonucleotides were obtained from the Cancer Research UK Oligonucleotide 
Synthesis Services. The following primers were used for the cloning and sequencing 
of pHluorin-TeNT Hc : 3 ’-CCGGGCACCAATTGAGCATCTGG; and 5’-
GGGCT GGC AAGCC ACGTTT GGT G
2.1.4 Bacterial strains
For the cloning o f pHluorin-TeNT He the E. coli strain TGI was used. GST- 
pHluorin, pHluorin and pHluorin-TeNT He were expressed in the E. coli strain 
FB810.
2.1.5 Animals
Time-mated Sprague-Dawley rats (E l4) were obtained from Charles River 
(UK). Time-mated littermate mice (E l3) o f wild type, Loa heterozygote, SOD1G93a
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hemizygote and Lotf/SODlG93A double heterozygote genotypes were provided by the 
Sobell Department o f Motor Neuroscience and Movement Disorders, Institute o f  
Neurology, London, UK (Kieran et al., 2005).
2.2 Methods
The experiments performed for transport studies on mouse and rat motor 
neurons were under licence from the UK Home Office (Animals Scientific 
Procedures Act 1986), following local ethical review. All superior cervical ganglia 
culture experiments were carried out under licence from the Canadian Home Office 
in Prof. R. Campenot's laboratory at the University o f Alberta, Edmonton, Canada.
2.2.1 DNA techniques
2.2.1.1 DNA agarose gel electrophoresis
Agarose gels were prepared by dissolving 1 to 1.5% agarose in TAE buffer (40 
mM Tris-OH, pH 8.0; 20 mM glacial acetic acid; 1 mM EDTA). Ethidium bromide 
was added to a final concentration of 0.5 pg/ml. DNA samples were mixed with lOx 
loading buffer (15% Ficoll 400, 0.25% bromphenol blue, 0.25% xylene cyanol) and 
electrophoresed at 20 V/cm in TAE buffer.
2.2.1.2 Gel purification of DNA fragments
Gel slices containing DNA fragments were isolated and purified using the 
QIAquick gel extraction kit (QIAGEN®) following the manufacturer's instructions.
2.2.1.3 Quantification o f DNA
DNA was diluted in water, placed in a cuvette with 1 cm path length and 
absorbances at 260 nm and 280 nm were measured in a spectrophotometer. A n  OD260
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of 1 corresponds to 50 pg/ml double stranded DNA and 33 pg/ml single stranded 
DNA. The ratio OD260/280 provides an estimate o f the purity o f DNA solutions and 
was usually ~1.7 for DNA preparations.
2.2.1.4 Preparation o f recombinant pGEX-4T- VSV-G-Kin-pHluorin-TeNT He
The pGEX-4T-VSV-G-Kin-TeNT He vector encoding the residues 855-1,314 
of TeNT was fused at its amino-terminus to a protein kinase A phosphorylation site, 
the vesiclular stomatitis virus protein G (VSV-G) epitope and glutathione-S- 
transferase (GST), followed by a thrombin cleavage site (Herreros et al., 2000b). The 
vector was linearised with Ndel. The insert was obtained by digesting the pGEX-2T- 
AF058694 construct (Miesenbock et al., 1998) with Agel. Vector and insert 
encoding ratiometric pHluorin were blunt ended using (3’ -» 5 ’ exo ) Klenow 
fragment o f DNA polymerase I and purified. The ligation was performed using 200- 
300 ng total DNA and 400 U T4 DNA ligase in a total volume o f 10 pi for 1 hour at 
room temperature. The molar ratio o f vector to insert was 1:5. After ligation, 1 pi o f 
the resulting pGEX-4T-3-VSV-G-kin-pHluorin-TeNT He construct was transformed 
into electro competent E. coli as described below (Fig. 2.1).
2.2.1.5 DNA sequencing
pGEX-4T-VSV-G-Kin-pHluorin-TeNT He DNA was purified using the 
QIAGEN® Plasmid Purification Kit from 100 ml overnight culture following the 
manufacturer’s instructions. For DNA sequencing -250  ng of DNA, 3.2 pM of 
primer and 8 pi o f BigDye® Terminator Cycle Sequencing Kit (Applied Biosystems) 
were brought to a volume of 20 pi with H2O. The primers for sequencing were the 
following for the 3 ’-end o f the sequence position 1890 to 1912: 3 ’- 
CCGGGCACCAATTGAGCATCTGG; and for the 5’-end of the sequence position
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Bsu 361 6945 
Bsa XI 6508 
Bsa XI 6508 
Sfo I 6492 
Nar I 6492 
Kas I 6492 
B beI 6492 
Hpa\ 6357 
EcoRV 6301 
S ss Hll 6264 
Psp OMI 6060 
Ban II 6060 
Apa I 6060 
Bst Ell 6034
264 Eco Nl
682 Swa
1158 Nco
1158 Sty
1221 Nde\
Mlu I 5853 1315 Pm/I
1434 DrapGEX-4T-3-VSV-G-KIN- 
phluorin-TeNT HcSs/API 5530Apa Bl 5530
Pfl Ml 5429
7154 bp 
Unique Sites
2182 Sac
2630 Ssf Z17I
A hdI 4344
Pst I 4103 2947 SfrBI 2947 Nsi I 
2947 Ppt/101 
2960 Spe I 
3134 Sa/I 
3139 Ava I 
3139 A///3877I 
3139 Sc/1 
3139 XhoI
3144 Not I
3145 E ag I 
3221 Pfo I
3321 Ttf)1111 
3426 Aa/ II 
3426 Zra\
B CNT H2N-| s-s
H
h n  I h ^ c o o h
'ntactivitylar translocati° n binding
thrombin 
cleavage site
pHluorin-TeNT Hc GST f t a o :  ( -C O O H
ratiometric
pHluorin
Figure 2.1: Scheme of Recombinant TeNT Hc
A) Graphic map of pGEX-4T-3-VSV-G-KIN-pHluorin-TeNT Hc . The pH-sensitive 
ratiometric GFP (green) was inserted in the expression vector pGEX-4T-3-VSV-G- 
Kin-Hc encoding GST (grey) followed by a thrombin cleavage site (arrow), the 
VSV-G epitope, and the Kinase site (yellow). TeNT Hc is labelled in red. Unique 
restriction sites are indicated. B) Scheme of clostridial neurotoxins and ratiometric 
pHluorin-TeNT Hc fusion protein.
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869 to 891: 5 ’-GGGCTGGCAAGCCACGTTTGGTG. The polymerase chain 
reaction (PCR) was done in a PTC-200 Cycler under the following conditions: initial 
denaturation at 96°C for 2 min, followed by 25 cycles o f denaturation at 96°C for 
30 s, annealing at 47°C for 15 s, and extension at 60°C for 4 min.
2.2.1.6 DNA preparation for sequencing
PCR products were precipitated using 2 pi 3 M NaOAc, pH 5.0 and 50 pi 95% 
ethanol. Samples were vortexed and placed on ice for 10 min. The DNA was pelleted 
in a bench top centrifuge at maximum speed for 30 min at 4°C. The pellets were 
washed with 250 pi 70% ethanol, centrifuged for 5 min at maximum speed and dried 
in a speed vac DNA concentrator. The sequencing was performed by Cancer 
Research UK facilities. Sequence alignment was performed using DNA strider 
(version 1.4f2).
2.2.2 Bacterial culture
2.2.2.1 Preparation of electro-competent bacteria
The E. coli strain FB810 was used for expression of GST-pHluorin and 
pHluorin-TeNT He. Cysteine-tagged TeNT He was expressed in the E. coli strain 
BL21. Bacteria were streaked from a frozen stock (25% glycerol, stored at -80°C) 
onto an agar plate containing 100 pl/ml ampicillin and incubated at 37°C overnight. 
A single colony from the agar plate was inoculated into 5 ml Luria-Bertani (LB) 
medium. After overnight incubation at 37°C and 250 rpm, 800 ml o f LB medium 
containing 100 pg/ml ampicillin was added. Cultures were grown at 37°C and 200 
rpm to an A6oo of 0.6, incubated on ice for 30 min and pelleted by centrifugation at
5,000 rpm for 20 min at 4°C using a JA10 rotor (Beckmann). The bacterial pellet
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was washed twice with 400 ml ice-cold water to reduce the ionic strength and 
resuspended in 40 ml ice-cold 10% glycerol. Electroporation competency was 
measured and only preparations that gave more than 108 colonies/pg supercoiled 
plasmid DNA in test transformations were used. Electro-competent bacteria were 
aliquoted and stored at -80°C for further use.
2.2.2.2 Bacterial transformation
50 pi o f E. coli strain FB810 was thawed and mixed with 50 to 500 pg DNA of  
pGEX-4T-3-VSV-G-kin-pHluorin-TeNT Hc, pGEX-2T-AF058694 or pGEX-4T-3- 
Cys-TeNT He and incubated for 1 min on ice. Mixtures were transferred into cold 2 
mm electroporation cuvettes (Equibio), and transformations were performed at 200 
Q, 25 pF and 2.5 kV in a BioRad E. coli pulser. Immediately after electroporation, 1 
ml of 4°C LB medium lacking antibiotic was added. Cell suspensions were placed 
into polypropylene tubes, shaken at 250 rpm for 30 min at 37°C and then plated onto 
pre-warmed LB-agar plates containing 100 pg/ml ampicillin. Picked colonies were 
grown in 1 ml LB medium for 1 hour, adjusted to 25% glycerol and stored at -80°C.
2.2,3 Protein techniques
2.2.3.1 Protein quantification
Protein concentrations were determined using the BIO-RAD Protein Assay 
Reagent (Bradford). Sample dilutions and IgG standards (1 to 10 pg) were diluted to 
a final volume of 40 pi in water and then incubated with 160 pi BIO-RAD Protein 
Assay Reagent concentrate diluted 1:4 at room temperature for 5 min. Absorption 
was measured at O D 5 9 5  in a plate reader (Molecular Devices).
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2.2.3.2 TCA precipitation
Protein samples were mixed with 0.05% sodium deoxycholate as a carrier, 
adjusted to 6.5% trichloracetic acid (TCA) and incubated for 30 min at room 
temperature. Precipitates were centrifuged for 10 min at maximum speed in a 
microfuge and pellets were resuspended in 5x SDS-PAGE sample buffer (20% 
glycerol, 5% P-mercaptoethanol, 1 to 5 mg bromphenol blue, 10% sodium dodecyl 
sulfate (SDS), 120 mM Tris-Cl, pH 6 .8). If the colour o f the sample buffer changed 
to yellow, ljil or more o f 1 M Tris-HCl pH 8.0 was added until the colour changed 
back to blue.
2.2.3.3 Protein extracts from tissues
Rat brains and rat spinal cords (E l4) were homogenised in lysis buffer (10 mM 
Tris-Cl, pH 8.0; 150 mM KC1; 1% NP40; 1 mM ethylendiamine-tetraacetic acid 
(EDTA); 1% glycerol; 1% Triton X-100; 0.1 mM dithiothreitol (DTT)) using a tissue 
grinder. The homogenate was vortexed for 30 min at 4°C and then centrifuged for 30 
min at 4°C at maximum speed in a microfuge. The supernatant was collected, 
quantified and snap-frozen.
2.2.3.4 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Protein samples were mixed with sample buffer (see above) and boiled for 3 
min or incubated at room temperature for 10 min. After a short spin to collect all the 
liquid at the bottom o f a 0.5 or 1.5 ml tube, samples were loaded on a 
polyacrylamide protean III™ minigel (BIO-RAD). These freshly-prepared gels 
consisted o f a separating gel ( 12% acrylamide [ratio o f acrylamide:bis-acrylamide 
37.5:1], 0.1% SDS, 375 mM Tris-Cl, pH 8 .8), overlaid with a stacking gel (4.5% 
acrylamide, 0.1% SDS, 125 mM Tris-Cl, pH 6 .8). Gels were polymerised with 3 mM
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ammonium persulphate (AMPS) and 0.1% N,N,N',N'-tetramethyl-ethylenediamine 
(TEMED). Samples were run at 20 mA in Running buffer (190 mM glycine, 0.1% 
SDS, 25 mM Tris-Cl, pH 8.3). When appropriate, proteins were fixed and stained 
with Coomassie staining solution (50% methanol, 10% acetic acid, 0.1% Coomassie 
Brilliant Blue) for 15 min at room temperature, followed by de-staining using 10% 
acetic acid in 10% isopropanol. Gels were dried in gel wrap (Merck).
2.2.3.5 Western blotting
Rat brain and rat spinal cord extracts (100 pg/lane) were incubated for 10 min 
at room temperature in sample buffer and separated on a 12% SDS gel. Using a BIO­
RAD wet blotting system, proteins were transferred onto nitrocellulose membrane 
(Schleicher & Schuell) at 4°C in 20 mM Tris-OH, 150 mM glycine, 20% methanol 
for 1 hour at 100 V or overnight at 30 V. The membrane was stained with Ponceau S 
to assess the efficiency o f protein transfer. Blots were blocked with blocking solution 
(5% skimmed milk (Marvel) in PBS) for at least 1 hour at room temperature 
followed by incubation with primary antibody diluted in blocking solution. 
Membranes were washed with PBS for 15 min and incubated with HRP-conjugated 
secondary antibody in blocking solution. After extensive washing in PBS, 
immunoreactivity was detected using enhanced chemiluminescence (ECL, 
Amersham Biosciences). The detection o f SOD1 proteins is described in Kieran et 
al., 2005.
2.2.3.6 Expression and purification o f GST-recombinant proteins
Bacteria from glycerol stocks were used to inoculate 2 ml o f 2YT medium (10 
g bacto-tryptone, 10 g yeast extract, 5 g NaCl in 1 1 H2O, pH 7.2) containing 100 
pg/ml ampicillin, incubated for 1 hour at 37°C and then diluted in 200 ml o f pre­
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warmed 2YT medium with 100 pg/ml ampicillin. The bacteria were grown overnight 
at 37°C and 200 rpm. The cell suspension was diluted in 1,800 ml o f pre-warmed 
2YT medium and grown to an A6oo o f 0.8-1.1 at 37°C and 200 rpm. 400 pM 
isopropyl-p-D-thiogalacto-pyranoside (IPTG) was added for protein induction. After 
4 hours incubation at 30°C and 200 rpm, the bacteria were centrifuged for 10 min at 
3,500 rpm in a JS-4.2 rotor (Beckmann) and the supernatant was discarded.
All the following steps were carried out on ice or at 4°C. The bacterial pellet 
was resuspended in pre-chilled PBS with 0.05% Tween 20 (PBST) and the bacteria 
suspension was centrifuged in a JA20 rotor at 3,500 rpm for 10 min. The pellet was 
washed again with PBST and centrifuged as before. The bacteria were resuspended 
in 15 ml resuspension buffer (PBST, 2 mM EDTA, 0.1% (3-mercapthoethanol, 0.5 
mM phenylmethanelsulphonyl fluoride (PMSF), 4 pg/ml pepstatin, 1 mM 
benzamidine). The cell suspensions were passed twice through a French Press (SLM- 
AMINCO) at 900 psi and the bacterial lysates were centrifuged for 15 min at 15,000 
rpm in a JA20 rotor followed by ultracentrifugation for 20 min at 40,000 rpm in a 
Ti70 rotor (Beckmann). The supernatants were mixed with 50% GSH-resin agarose 
(pre-swollen in PBST) at a ratio o f 1:20 and incubated for at least 1 hour with 
agitation at 4°C. The bacterial supernatants were then removed and the beads were 
washed with 25 ml PBST. GST cleavage was performed by incubating the beads in
2.5 ml TCB (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 2.5 mM CaCl2; 0.1% (3- 
mercapthoethanol) and 80 pi human thrombin (0.8 U/mg) for 30 min at 25°C. 
Supernatants were collected and the beads were washed with another 2.5 ml TCB 
and then with 2.5 ml TCB containing 0.5 M NaCl. The first two supernatants were 
pooled and thrombin was blocked by addition o f PEFA block (1:100, Roche), and
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PMSF (0.5 mM final concentration). The eluted fractions were concentrated in 20 
mM Hepes-NaOH, pH 7.4; 150 mM NaCl and 20% polyethylene glycol 20,000 until 
the volume o f the fractions was reduced to 1 ml. The protein solution was dialysed 
overnight against 20 mM Hepes-NaOH, pH 7.4 and 150 mM NaCl.
pHluorin-TeNT He required further purification by gel filtration on a 
Superdex™ 200 high resolution preparatory grade 10/30 column (Amersham). The 
column was equilibrated with a solution containing 20 mM Hepes-NaOH, pH 7.4 
and 150 mM NaCl at a flow rate o f 0.5 ml/min. The column was connected to a 
AKTA™ fast protein liquid chromatography system running Unicom™ 3.10 software 
(Amersham) and nm at 4°C. 0.5 ml fractions were collected and analysed by SDS- 
PAGE. The fractions containing protein were pooled, concentrated, quantified as 
described above and snap-frozen in liquid nitrogen.
2.2.3.7 Fluorescence excitation spectra o f pHluorin, GST-pHluorin and 
pHluorin-TeNT He
2.2.3.7.1 Calibration curve in solution
Samples containing 0.5 pM pHluorin, GST-pHluorin or pHluorin-TeNT He in 
50 mM sodium cacodylate, 100 mM NaCl, 1 mM CaCl2 and 1 mM MgCk were 
adjusted to the indicated pHs with NaOH or HC1. Excitation spectrums (350 to 500 
nm) were acquired using a 710 Photomultiplier Detection System (Photon 
Technology International) at a fixed emission of 508 nm. The background was 
subtracted from the emission intensities o f pHluorin-TeNT He, and the corrected 
emission values for the 405 nm excitation were divided by the corresponding 
emission intensities obtained by exciting at 488 nm R(405/488).
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2.2.3.7.2 Calibration curve ex vivo
Motor neurons were incubated with 40 nM pHluorin-TeNT He in neurobasal 
(GIBCO) medium for 30 min at 37°C in 7.5% CO2. The medium was then replaced 
with a buffer containing 120 mM KC1, 20 mM NaCl, 0.5 mM CaCE, 0.5 mM MgSC>4 
and 20 mM HEPES, adjusted to various pHs between 5.0 and 8.0 with NaOH or 
HC1. 20 min before imaging, the ionophores monensin and nigericin (both 10 pg/ml; 
Calbiochem) were added to equilibrate the intracellular pH to that o f the external 
buffer (Awaji et al., 2001). The emission intensities o f pHluorin-TeNT He 
compartments in axons and soma were measured for each pH at 508 nm upon 
excitation at 405 and 488 nm. The background was then subtracted and the corrected 
emission values for the 405 nm excitation were divided by the corresponding 
emission intensities obtained by exciting at 488 nm R(405/488).
2.2.3.8 Modification o f recombinant proteins
2.2.3.8.1 A lexaFluor-maleimide labelling o f  TeNT He
15 nMol o f Cysteine-tagged TeNT He was incubated in labelling buffer (20 
mM HEPES-NaOH, pH 7.4 and 100 mM NaCl) containing lOx molar excess o f tris- 
(2-carboxyethyl)phosphine hydrochloride and 25x molar excess o f AlexaFluor- 
maleimide (molecular Probes). The labelling was carried out overnight at 4°C and 
stopped by adding reduced glutathione (4 mM fmal concentration in Tris-HCl, pH 
8.0). TeNT Hc-AlexaFluor was purified using a PD-10 desalting column 
(Amersham) equilibrated with PBS followed by overnight dialysis against PBS. The 
degree o f labelling was calculated as follows:
(Abs/EC) x (MW/c) = moles dye/mol protein
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Abs: the absorption at the longest wavelength absorption maximum for each 
dye (493 nm for AlexaFluor488, 556 nm for AlexaFluor555 and 651 nm for 
AlexaFluor647); EC: molar extinction coefficient (72000 for AlexaFluor555,
158,000 for AlexaFluor555 and 265,000 for AlexaFluor647); MW: molecular weight 
of the protein (56,000 Da was used for TeNT He); C: protein concentration, 
determined as described before.
Fluorescent probes contained on average 2 moles of dye per mole of TeNT He.
2.2.3.8.2 Biotinylation o f  TeNT He
TeNT He was diluted to 1 mg/ml with PBS and incubated with a 20x molar 
excess o f EZ-link Sulfo-NHS-SS-biotin (Pierce) for 3 hours on ice. To stop the 
reaction and remove free biotin, the toxin was dialysed against PBS overnight at 4°C.
2.2.4 Tissue Culture
2.2.4.1 Motor neuron cell culture
2.2.4.1.1 Breeding protocol fo r  Sprague Dawley rat E 14 embryos
The gestation date o f the embryos was particularly important since the 
dissection became very difficult if  they were younger than E l4. The way we 
calculated the gestation date is the following: Light was switched on at 6.30 h and 
switched off at 18.30 h. Female and male rats were put together at 17.30 h. They 
were separated the next day at 8.00 h, which is considered as day zero. The 
development o f the embryos was timed from detection o f the vaginal plug.
I l l
Chapter 2: Materials and Methods
2.2.4.1.2 Preparation and suspension o f  dissociated spinal cord cells
One pregnant rat or mouse was used for each motor neuron preparation. The 
following procedure was intended for 5 spinal cords per centrifugation tube. 
However, during the metrizamide density gradient centrifugation, the equivalent o f
2.5 spinal cords was used per tube. For single mouse embryo cultures, cells have 
been plated directly after the first BSA cushion centrifugation.
The dissection o f embryonic spinal cords was according to Henderson et al. 
(Henderson et al., 1995). After the dissection, spinal cords were cut into small pieces 
and the fragments o f 5 spinal cords were transferred in 1 ml PBS into a 15 ml 
polysterene tube. Trypsin (0.025% final concentration) was added and the fragments 
were incubated at 37°C for 8 min. The tube was lightly shaken after the first 4 min. 
After trypsination, the spinal cord fragments were added to 800 pi neurobasal 
medium containing 100 pg/ml DNAse and 100 pi 4% BSA. 4% BSA solution was 
made by dissolving embryo-tested BSA in Leibovitz 15 medium (L-15, GIBCO) and 
dialysed against PBS for 24 hours at 4°C. The BSA solution was then dialysed for an 
additional 48 hours against L-15 medium, pH 7.3, at 4°C. Both dialyses were 
performed using Spectra/Por membranes with a 25 kDa cut off. The BSA solution 
was filter-sterilised and kept at -20°C until use.
The tube containing spinal cord fragments was agitated until the tissue 
fragments were disaggregated. The suspension was then triturated six times with a P- 
1000 tip. The spinal cord fragments were allowed to settle on the bottom o f the tube 
and the supernatant was transferred to a fresh tube. The remaining fragments were 
incubated in 900 pi neurobasal medium containing 100 pi 4% BSA and 20 pg/ml 
DNAse and triturated ten times with a P-1000 tip. Fragments were again allowed to
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settle and the supernatant was collected into a fresh polysterene tube. Spinal cord 
fragments left in the tube after the second DNAse treatment were discarded.
Using a long Pasteur pipette, a 1.5 ml 4% BSA cushion was applied to the 
bottom o f the tube containing the pooled supernatants. The tube was then centrifuged 
at 370g for 5 min at room temperature. The supernatant was removed and the pellet 
was resuspended in 1 ml neurobasal medium using a P-1000 tip. At this stage, cells 
were normally completely dissociated and an average o f 1 to 2 million cells per 
spinal cord were obtained. For crude preparations, the cells were plated in complete 
medium at this stage.
2.2.4.1.3 Density Centrifugation
1 ml neurobasal medium was added to the resuspended cells and mixed gently. 
1 ml o f the total 2 ml cell suspension was transferred to a new polysterene tube and a 
metrizamide cushion (6.5% in L-15 medium, pH 7.3) was applied to the bottom of  
the tubes. The sample was centrifuged at 755g for 15 min with the brake disengaged 
in order to reduce vibration, which disturbs the interphase between the metrizamide 
cushion and the cell suspension. Under these conditions, smaller cells pellet at the 
bottom of the tube, whereas larger cells remain at the interphase, forming an opaque 
band. The interphase was collected in a 1 ml volume and the supernatant was placed 
in a seperate tube. In order to prevent the formation of aggregates, pelleted cells were 
resuspended in 1 ml neurobasal medium and then diluted to 10 ml with additional 
neurobasal medium. The cells were collected by centrifugation through a 4% BSA  
cushion as described above, resuspended in complete medium and plated.
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2.2.4.1.4 Maintenance o f  motor neurons in culture
2.2.4.1.4.1 Acid wash o f coverslips
Coverslips were incubated in a 2:1 mixture o f concentrated nitric acid and 
concentrated hydrochloric acid overnight. The acid solution was then discarded and 
coverslips rinsed with distilled water, until the pH o f the washes was between pH 5.5 
and 6 .0 .
2.2.4.1.4.2 Coating o f coverslips and glass-bottom dishes
Glass-bottom dishes (MatTek) and acid-washed coverslips were coated with 15 
pg/ml polyomithine in sterile Milli-Q water for 2 hours. The solution was then 
removed and the dishes/coverslips air-dried in a sterile hood. When completely dry, 
they were covered with 30 pg/ml laminin in neurobasal medium and incubated for at 
least two hours in a humidified 7.5% CO2 atmosphere at 37°C.
Before plating the cells, the laminin solution was removed and replaced with 
complete neurobasal medium. 40,000 to 60,000 cells were plated on glass bottom 
dishes and 20,000 to 30,000 cells on coverslips. Motor neurons begin differentiating 
after a couple o f hours in culture. Two-thirds o f complete medium was replaced after 
3-5 days in culture. The culture was maintained in complete medium (neurobasal 
medium completed with lx  B27 supplement, 2% heat inactivated horse serum, 0.5 
mM L-glutamine, 25 pM |3-mercaptoethanol, 10 ng/ml ciliary neurotrophic factor 
(CNTF), 100 pg/ml glial cell derived neurotrophic factor (GDNF), 5 pg/ml 
penicillin-streptomycin (Pen/Strep), and 25 pM L-glutamic acid). The L-glutamic 
acid was only present during the first 3-5 days in culture.
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2.2.4.2 Superior cervical ganglia culture
2.2.4.2.1 Dissection o f  Superior Cervical Ganglia
Newborn Sprague-Dawley rat pups (P0-P2) were knocked gently on their head 
and briefly submerged in 70% ethanol. The head was removed just above the 
shoulders using sharp scissors and placed upside down on a dissection dish. The 
brainstem was pinned to the dish and the skin was peeled back and pinned to the 
front o f the head. The trachea and esophagus were held with forceps and glands and 
muscles were gently detached in order to expose the carotid bifurcation, along which 
lie the superior cervical ganglia. The superior cervical ganglia were removed with 
their pre- and post-ganglionic nerve trunks, placed into dissecting medium (L-15 
medium plus 0.6% glucose, 1% Glutamin, 1% Pen/Strep, 2 ppm 6,7-dimethyl- 
5,6,7,8-tetrahydropterine, 1 ppm glutathione) and transferred into a 15 ml 
polysterene tube.
2.2.4.2.2 Dissociation o f  superior cervical ganglia using collagenase
After the ganglia had settled to the bottom of the polysterene tube, the 
dissection medium was removed and ganglia were washed with 10 ml PBS. Ganglia 
were incubated with 1 mg/ml collagenase type 1 from Clostridium histolyticum  for 
25 min at 37°C. Trypsin was added at a final concentration of 0.09% and the 
incubation was continued for additional 5 min at 37°C. The ganglia were collected 
via a 2 min centrifugation at 160g, washed once with 10 ml PBS and then again with 
800 pil rat serum in 7 ml dissecting medium. After the fragments settled to the 
bottom o f the tube, the supernatant was discarded. Ganglia were dissociated by 
trituration with a Pasteur pipette in 800 pi dissecting medium. The cell suspension
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was pressed through a sterile cell strainer (Falcon) to remove remaining tissue 
clumps. The cells were collected via centrifugation at 250g for 3 min.
2.2.4. 2.3 Plating o f  superior cervical ganglia
Neurons were plated in plating medium (L-15 medium supplemented with 10 
ng/ml nerve growth factor (NGF), 1% rat serum, 2 ppm 6,7-dimethyl-5,6,7,8- 
tetrahydropterine, 0.5 ppm cytosine-|3-arabinofuranoside and 0.8% methylcellulose) 
at a density o f 5,000 cells per Campenot chamber as described below. The side 
compartments were filled before with the same medium containing 50 ng/ml NGF. 
Cells were incubated at 37°C in 5% CO2. One day after plating, the center 
compartment was filled with medium. Cultures were fed every 7 days by exchanging 
50-70% of the medium.
2.2.4.3 Motor neuron treatments
2.2.4.3.1 Fluid phase uptake
To monitor fluid phase uptake, motor neurons were incubated with 6 jiM GST- 
pHluorin in complete neurobasal medium for 1 hour at 37°C and 7.5% CO2, washed 
with DMEM9  supplemented with 30 mM HEPES-NaOH, pH 7.3 and immediately 
imaged by low-light time-lapse microscopy. Alternatively, motor neurons were 
transferred to neurobasal medium, incubated for further 30 min, washed and then 
imaged.
2.2.4.3.2 Transport studies
Motor neurons were incubated with 40 nM pHluorin-TeNT He or 40 nM TeNT 
Hc-AlexaFluor in complete medium for 30 min at 37°C followed by three washes 
with DMEM0 . Cells were placed onto the microscope stage contained within a
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humidified chamber maintained at 37°C. After 20 min, when the focus was stable, 
images were captured every 5 s.
2.2.4.3.3 Drug application
In selected samples where axonal transport o f TeNT Hc-AlexaFluor488 was 
visible, concanamycin A (ConA; Alexis) or bafilomycin A l (BafAl; Alexis) were 
added at a final concentration o f 10 and 0.5 nM, respectively, and the same field was 
imaged after 5, 15 and 30 min o f incubation. The functionality o f the proton-pump 
inhibitors was tested by applying 50 nM Lysotracker Red DND-99 (Molecular 
Probes) for 15 min on untreated motor neurons, or motor neurons pre-incubated with 
either 10 nM ConA for 15 min or 0.5 nM BafAl for 10 min and then imaged by 
confocal microscopy.
2.2.4.3.4 Binding and competition experiments
For binding studies cells were cooled on ice, washed with 0.2% BSA in Hanks' 
buffer (20 mM Hepes-NaOH, pH 7.4; 0.44 mM KH2P 0 4; 0.42 mM NaH2P 0 4; 5.36 
mM KC1; 136 mM NaCl; 0.81 mM M gS04; 1.26 mM CaCl2; 6.1 mM glucose) and 
incubated with 20 nM biotin-tagged TeNT He (a kind gift from Dr. K. Deinhardt) or 
40 nM pHluorin-TeNT He for 20 min in the above buffer. For competition 
experiments, motor neurons were pre-incubated with 2 pM of unlabelled TeNT He 
for 20 min on ice prior to addition o f AlexaFluor-conjugated TeNT He.
2.2.4.3.5 Immunofluorescence analysis
For immunofluorescence (IF) experiments, motor neurons were incubated with 
15 pM [3-(2,4-dinitroanilino)-3’-amino-N-methyldipro-pylamine] (DAMP; Oxford 
Biomedical Research; stock solution 3 mM) and/or 15 nM TeNT Hc-AlexaFluor-
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maleimide for 2 or 45 min in complete medium at 37°C. Cells were then fixed in 4% 
paraformaldehyde (PFA) and 20% sucrose in PBS, permeabilised with 0.1% Triton 
X-100 and blocked with 2% embryo-tested BSA, 0.25% porcine skin gelatine, 0.2% 
glycine and 15% foetal calf serum in PBS. Primary antibodies were diluted in 
blocking solution and incubated with the fixed cells for 45 min at room temperature. 
DAMP was detected using monoclonal a-DNP (Oxford Biomedical Research) for 45 
min at room temperature (Oxford Biomedical Research). After rinsing, AlexaFluor 
goat a-mouse, a-rabbit or a-chicken IgG (Molecular Probes) were diluted 1:300 in 
blocking solution and incubated for 30 min. After extensive washing, the coverslips 
were mounted with Mowiol 4-88 (Harco).
2.2.4.3.6 Endocytosis assays
Motor neurons were treated with 0.5 nM BafAl for 15 min at 37°C and then 
incubated for 30 min at 37°C with VSV-G-Kin-TeNT Hc (20 nM) or TeNT H c 
labelled with disulfide-linked biotin (30 nM). After VSV-G-Kin-TeNT He 
incubation, cells were fixed in 4% PFA in PBS and blocked with 2% embryo-tested 
BSA, 0.25% porcine skin gelatine, 0.2% glycine and 15% foetal calf serum in PBS. 
Rabbit a-VSV-G tag antibody (Biogenes) diluted 1:80 in blocking solution was 
incubated with the fixed cells for 30 min at room temperature. Cells were washed 
twice with PBS and then permeabilised with 0.1% Triton X-100 in blocking solution 
and blocked for further 30 min. Motor neurons were incubated with a primary mouse 
a-VSV-G antibody (1:300; Cancer Research UK) for 30 min, washed twice in PBS 
and incubated for 30 min with AlexaFluor goat a-mouse and a-rabbit IgG, diluted 
1:300 in blocking solution. After extensive washing with PBS, coverslips were 
mounted with Mowiol 4-88. Alternatively, motor neurons incubated with TeNT Hc-
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biotin were cooled on ice and then treated three times with ice-cold 20 mM MESNA 
in neurobasal medium (Gibco), pH 8.3 for 15 min to cleave the biotin moiety from 
surface-bound TeNT He. Cells were washed three times in neurobasal medium, pH
8.3, washed once in PBS, fixed in 4% PFA in PBS, permeabilised with 0.1% Triton 
X-100 and finally blocked in blocking solution. TeNT Hc-biotin was revealed using 
streptavidin-AlexaFluor488 1:500 in blocking solution. Cells were extensively 
washed in PBS and mounted in Mowiol 4-88.
2.2.4.4 Compartmented motor neuron cultures
2.2.4.4.1 Preparation o f  Collagen
Five tails o f two- to three-month old rats were washed in 70% ethanol for 30 
min followed by a 25 min wash in sterile water. The tails were then pulled under 
sterile conditions using two spencer clamps. Collagen fibres were cut and placed in 
100 ml o f 1:100 acetic acid in sterile water. The suspension was slowly stirred for 
two days at room temperature and brought to a volume o f 250 ml with dilute acetic 
acid (1:100). The resulting collagen solution was centrifuged at 1,1 OOg for 30 min 
and the supernatant stored at -20°C.
2.2.4.4.2 Preparation o f  culture dishes
35 mm plastic culture dishes were rinsed with collagen diluted 1:4 in Milli-Q 
water and were dried overnight with their lid on under sterile conditions. Sterile glass 
bottom tissue culture dishes (WillCo-Dish®, GWSt-5030; Glass thick: 0.17 mm; 0  
Dish/Glass: 50/30 mm) were coated with 250 pi collagen diluted 1:4 in Milli-Q 
water and air dried under sterile conditions.
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2.2.4.4.3 Preparation o f  a silicone syringe
A 1 ml glass, Luer Lok syringe (Popper & Sons, Inc.) fitted with a 20 gauge 
needle with a squared-off tip was filled with Dow Coming™ high-vacuum grease. 
The plunger was then inserted and pressure applied until silicone filled out the 
syringe and exited the needle. The filled applicator was sterilised via autoclaving.
2.2.4.4.4 Assembly o f  Campenot chambers
The compartmented chambers have been assembled under sterile conditions in 
a laminar flow hood. The coated plastic culture dishes and the collagen coating on 
the glass bottom dishes were scratched using a pinrake (Tyler Research). A drop of 
neurobasal medium was placed on the scratched area to wet the region. Alternatively, 
0.8% methylcellulose (TCI Europe) in neurobasal medium was used. A Teflon 
divider (Tyler Research) was held with a hemostat clamp and silicone grease was 
applied in a continuous line. The scratched culture dish was inverted quickly so as to 
not disturb the drop of medium. The dish was brought into position over the divider, 
dropped in place and lightly pressed to the divider to seat the grease. When the dish 
was seated, the hemostat was turned around and the dish was released. A dab of  
grease was placed at the entry o f the slot. Then a drop of neurobasal medium was 
placed on the scratched substratum in each side compartment so that the whole 
scratched region was wetted. The dishes were placed in a 37°C incubator overnight. 
The next day, the side compartments were filled with complete medium containing 
50 ng/ml CNTF and 500 pg/ml GDNF (Fig. 2.2). Alternatively, this medium was 
supplemented with 0.8% methylcellulose. The chambers were incubated for further 2 
hours at 37°C before the cells were plated into the middle compartment.
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Figure 2.2: Assembly of Campenot chambers
A) The bottom of the culture dish was scratched and the collagen coating was B) 
wetted with medium. C) Vacuum grease was applied to the Teflon divider and D) the 
inverted culture dish was settled on the divider and the chamber was E) again invert­
ed. F) Then a dab o f  grease was applied to the middle compartment and G) the 
scratched area in the side compartments was covered with medium. After overnight 
incubation of the culture system, the side compartments were filled and H) 2 hours 
later cells were plated in the middle compartment. I) The next day the surrounding 
area was filled with medium and J) after 2 to 3 days superior cervical ganglia or 5-9 
DIV motor neuron processes, could be detected in the side compartments.
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2.2.4.4.5 Plating o f  neurons in compartmented cultures
Motor neurons or superior cervical ganglia neurons were resuspended in 
complete medium and plating medium, respectively. Note that the growth factor 
concentration in the cell suspension is five times lower than in the side 
compartments, thus creating a growth factor gradient. Each assembled chamber was 
placed under a stereo microscope and a 1 ml syringe fitted with a 22  gauge needle 
was filled with the cell suspension. Then the cell suspension was slowly transferred 
into the middle compartment. After 24 hours in culture, the surrounding area was 
filled with complete medium, ensuring a medium bridge over the grease dab to the 
middle compartment.
2.2.4.4.6 Leakage control o f  compartmented chambers
Ten day old compartmented motor neuron cultures were incubated with 0.5-1 
pC [32p^ ATP in one of the side compartments. One chamber was incubated at 37°C 
and two at 4°C. After 2 hours, medium samples o f 50 pi were taken from the two 
side compartments and from the middle compartment. 5 ml of scintillation fluid 
(Ultima Gold; Perkin Elmer) was added to each sample, and radioactivity was 
quantified by scintillation counting on a Beckman LS6500.
2.2.5 Imaging techniques
2.2.5.1 Time-lapse low-light microscopy
For pHluorin-TeNT He, images were taken every 5 s with a Nikon Diaphot 
300 inverted microscope equipped with a Nikon xlOO, 1.3 NA Plan Fluor oil- 
immersion objective. Specimens were sequentially excited at 488 nm and then at 405
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nm for 333 ms using the excitation filters 485DF15, 4000DF10, the dicroic filter 
490-575DBDR, and the emission filter 528-633DBDR (Omega Optical). Images 
were acquired with a Hamamatsu C4742-95 Orcal cooled charge-coupled device 
camera (Hamamatsu Photonic Systems) controlled by the Kinetic Acquisition 
Manager 2000 software (Kinetic Imaging). Two channel series were processed with 
Lucida 4.0 (Kinetic Imaging). For time-lapse low-light microscopy o f TeNT Hc- 
AlexaFluor488-treated cells, images were acquired every 5 s with a Nikon Diaphot 
200 inverted microscope equipped with Nikon xlOO, 1.25 NA Plan DIC oil- 
immersion objective, using a standard Nikon FITC B-2A filter and exposure times 
between 111 and 222  ms.
2.2.5.2 Confocal microscopy
Fluorescent images were acquired using a Zeiss LSM 510 confocal microscope 
equipped with a Zeiss x63, 1.40 NA DIC Plan-Apochromat oil-immersion objective. 
A region o f interest was chosen and simultaneously excited using the 488, 543 and 
633 nm lines o f a krypton-argon and two helium-neon lasers, respectively. Prior to 
specimen imaging, the detector gain was set to black using control samples, which 
have been treated with secondary AlexaFluor antibodies only. Images were averaged 
eight times in each focal plane. For quantification purposes, the colocalisation macro 
of the LSM 510 software (Zeiss) was used following manufacturer’s instructions. For 
time-lapse confocal microscopy, images were taken every 5 s and averaged 2 times 
at each focal plane.
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2,2.6 Data quantification and statistical analysis
The Motion Analysis software (Kinetic Imaging) was used for carrier tracking. 
Only moving carriers that could be tracked for at least four time points were 
analysed. Single movements o f TeNT He carriers, which were determined by their 
relative position between two consecutive frames, were used to determine the speed 
of the carriers. Statistical analysis and curve fitting were performed using Microsoft 
Excel® in an Excel template created by Allan Brady, CFA. Single frame-images 
were processed for presentation in Adobe® Photoshop® 5.5. Kymographs were 
generated using MetaMorph (Universal Imaging Corporation ™) after rotation o f the 
image stack to align the neuronal process vertically. Vertical single line-scans 
through the centre o f each process were plotted sequentially for every frame in the 
time series.
124
Chapter 2: Materials and Methods
2.3 Supplemental Material
2.3.1 Description of Videos
3 .1 a -c : pH analysis of axonal re tro g rad e  tra n sp o rt ca rrie rs
Motor neurons were incubated with pHluorin-TeNT He for 30 min at 37°C, 
washed and imaged as detailed in Experimental Procedures. Samples were 
consecutively excited at 488 nm (Video 3.1a) and 405 nm (Video 3.1b). Video 3.1b 
was inverted to improve the contrast. The ratiometric movies R(405/488) (Video 
3.1c) were assembled using Lucida 4.0. The motor neuron cell body is located at the 
bottom. Frames were taken every 5 s with an exposure time o f 333 ms and 
correspond to a field o f 2.6 pm x 14.6 pm. Videos consist o f 5 frames played at 10 
frames/s.
3.2: Pearl-chain like carrier
A pHluorin-TeNT He pearl-chain like carrier is moving in a retrograde fashion 
along a motor neuron axon. Motor neurons have been incubated with 40 nM 
pHluorin-TeNT He for 30 min at 37°C, washed and imaged by low-light 
microscopy. The soma is located out o f view at the bottom of the image. The frames 
of the 488 nm channel have been inverted to improve their contrast. Intervals 
between the frames are 5 s with an exposure time of 333 ms. The image field 
corresponds to an area o f 8.1 pm x 34.1 pm. The Video consists o f 10 frames played 
at 10 frames/s. See also Figure 3.9.
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3.3a,b: TeNT Hc-488 enters acidic compartments in motor neuron somas
TeNT H c-488 (in green) and Lysotracker Red DND-99 display a partial 
colocalisation in stationary and oscillating organelles in a motor neuron soma. Motor 
neurons were incubated with 40 nM TeNT H c-488 and 100 nM Lysotracker for 30 
min at 37°C, washed and imaged by confocal microscopy. Video 3.3a is a dual 
colour movie (TeNT H c-488 in green, Lysotracker Red DND-99 in red) and Video 
3.3b is the corresponding differential interference contrast (DIC) movie. Note in the 
DIC movie, that a fibroblast growing below the motor neuron is responsible for the 
movement o f the soma. Intervals between the frames are 5 s, played at 10 frames/s. 
The image size is 70 pm x 70 pm.
3.4a-c: Real-time measurement of organelle acidification
During time-lapse low-light microscopy we monitored an intensity change o f a 
pHluorin-TeNT He positive organelle, which reflects the acidification o f this 
compartment. The organelle is in the top left comer o f the movie. pHluorin-TeNT He 
compartments in the centre do not increase their intensity, they lose some due to 
photobleaching. Motor neurons have been incubated with pHluorin-TeNT He for 30 
min at 37°C, washed and imaged. Video 3.4a shows the 488 nm movie, 3.4b the 405 
nm movie and the ratio (405/488) is shown in Video 3.4c. The intervals between 
single frames are 5 s, played at 10 frames/s with an image size o f 37.4 pm x 28.3 
pm.
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3.5a-e: Axonal retrograde transport is unaffected by vATPase inhibitors.
Video 3.5a shows a still phase image o f a motor neuron axon incubated with 
TeNT Hc-Alexa488 for 30 min at 37°C. The same field has been imaged by low- 
light time-lapse microscopy to monitor retrograde axonal transport o f TeNT He at 
t=0 (Video 3.5b, untreated sample) and at 5 min (Video 3.5c), 15 min (Video 3.5d) 
and 30 min (Video 3.5e) after treatment with 10 nM ConA. The motor neuron soma 
is located at the bottom. Frames were taken every 5 s with an exposure time o f 111 
ms and correspond to a field o f 5.98 pm x 64.2 pm. The videos consist o f 40 frames 
played at 10 frames/s.
3.6a,b: Disease progression in 120 day old SOD1G93a and Z,0a/SOD1G93A mice
Video 3.6a shows an example o f a S 0D 1G93A mouse at 120 days o f age. This 
mouse shows a slow movement, and when suspended by its tail it does not is not 
spread its toes, indicating that the hindlimb muscles are poorly innervated. Video 
3.6b shows an example o f a Loa/SODlG93A littermate o f the mouse seen in Video 
3.6a, also at 120 days o f age. This animal is much more active and moves freely 
around the bench. Furthermore, when suspended by the tail it displays the 
characteristic "Legs at odd angles" (Loa) reflex, and the hindlimbs are pulled in at an 
unusual angle. These movies were made by Dr. D. Kieran.
3.7a-h: Kinetic analysis of axonal transport in wild type, Loal+, SOD1G93a and 
Z,0a/SOD1G93A
The single frames in Movies 3.7a,c,e and g show the phase images o f cultured 
primary motor neuron axons o f wild type, Loa/+, S0D 1G93A and Z,o<2/SO D 1G93a,
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respectively. The corresponding videos (Movies 3.7b,d,f and h) show the retrograde 
axonal transport o f TeNT He carriers. Movies 3.7b,d,f and h display selected areas o f 
the corresponding kymographs in Figure 3.32. Primary motor neurons were 
incubated with TeNT Hc-Alexa488 for 30min at 37°C, then washed and imaged by 
low-light time-lapse microscopy. Cell bodies are located to the bottom. Frames were 
taken every 5 s with an exposure time o f 222 ms. Movies consist o f 200 frames 
played at 10 frames/s. The phase images and videos are 7.28 pm x 31.2 pm.
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3 Results
3.1 Tetanus toxin escapes acidification during transport
Retrograde axonal transport o f intracellular organelles is essential for neuronal 
growth and survival. Despite this fact, little is known about the molecular and 
biophysical properties responsible for its accurate function. Using tetanus toxin, 
which binds specifically to motor neurons at the neuromuscular junction and is 
internalised into vesicular carriers undergoing fast retrograde transport to the spinal 
cord, we have sought to fill this gap by determining the pH regulation o f this 
compartment in living motor neurons, since acidic pH triggers a conformational 
change in tetanus toxin, promoting its catalytic activity. Using a chimera o f the 
tetanus toxin binding fragment (TeNT He) and a pH-sensitive variant o f the green 
fluorescent protein (ratiometric pHluorin) we have demonstrated that moving 
retrograde carriers in motor neuron axons display a narrow range o f neutral pHs, 
which is kept constant during transport. In contrast, stationary TeNT Hc-positive 
organelles exhibit a wide spectrum o f pHs, ranging from acidic to neutral.
3.1.1 Ratiometric pHluorin as a functional pH  reporter
Axonal TeNT He carriers have been shown to avoid accumulating the 
acidotrophic probe Lysotracker Red DND-99 in their lumen, suggesting that these 
organelles escape acidification (Lalli and Schiavo, 2002). However, no conclusions 
could be drawn from previous work about the pH dynamics o f the retrograde 
transport compartment or its regulation in the axon and soma. To address this issue, 
we chose a strategy based on bacterially expressed ratiometric pHluorin fused with
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TeNT He. The ratiometric pHluorin was created by amino acid substitutions at key 
positions that facilitate switching between conformations, coupling changes in pH to 
alterations in the electrostatic environment o f the chromophore (Miesenbock et al., 
1998). Histidine is very sensitive to pH change in the physiological range; the 
imidazole ring has a 10% probability for carrying a positive charge at pH 7.0, which 
increases to 50% at pH 6.0. Therefore, histidines were introduced at positions 
flanking key residues that participate in the proton exchange events determining the 
protonation state o f Y 6 6 . The S202H substitution showed an alteration in the 
excitation peaks in response to different pHs and therefore provided a starting point 
for a combinatorial enhancement o f pH sensitivity (Miesenbock et al., 1998).
3.1.1.1 Structure o f  ratiometric pHluorin
Sequencing o f ratiometric pHluorin revealed that the construct is identical to 
the published pHluorin sequence except for the absence o f mutation L220F 
(Miesenbock et al., 1998). Moreover, Nehrke found that this mutation is not present 
in the pHluorin vector (Nehrke, 2003). The structure o f ratiometric pHluorin reveals 
a regular 11-stranded ^-barrel with a helix containing the chromophore Y 66  passing 
through its centre (Fig. 3.1). Several loops and two short a-helices cap the barrel. 
The ratiometric pHluorin contains numerous conservative mutations, which are 
characterised by a change in the DNA resulting in amino acid replacements with 
similar biochemical properties, and non-conservative mutations. The original 
mutation S202H as well as the substitutions E132D, S147E, N149L, N164I, K166Q 
and R168H are clustered on one side o f the barrel. The 1167V mutation is oriented in 
the opposite direction, pointing towards the inside o f the barrel. Which o f those
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Figure 3.1: Structure of ratiometric pHluorin
A) Ratiometric pHluorin is build by an 11 -stranded (3-barrel, with a helix containing 
the chromophore Y66 passing through the center o f the barrel. Several loops and two 
short a-helices cap the barrel. The ratiometric pHluorin contains the original muta­
tion S202H plus E132D, S147E, N149L, N164I, K166Q, and R168H, which are 
located on the outside o f the barrel. Mutation 1167V points to the inside.
B ) View o f  the central 
c a v ity  c o n ta in in g  th e  
chromophore Y 6 6 . The 
m utation 1 1 67V  points 
inside the barrel and lies 
in the close vicinity of the 
chromophore.
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mutations are necessary for pH sensitivity or the mechanism by which they transfer 
pH sensitivity is not described.
3.1.1.2 Fluorescence excitation spectra o f  GST-pHluorin
To test if GST-pHluorin displays the same spectral properties as described by 
Miesenbock (Miesenbock et a l, 1998), we diluted GST-pHluorin to a final 
concentration o f 0.5 pM in buffers ranging from pH 5.0-8.0 and monitored the 
excitation spectrum at an emission wavelength o f 508 nm. The background 
intensities obtained for the different pH buffers were subtracted from each curve 
(Fig. 3.2A). As expected, the fluorescence excitation spectrum o f GST-pHluorin 
shows two peaks, a lower one at 395 nm and a higher 470 nm. The 395 nm peak was 
more intense at a neutral pH and decreased at acidic pHs, whereas the 470 nm peak 
showed the opposite behaviour. The fluorescence spectra for the different pHs have 
one isosbestic point at 425 nm, which represents the wavelength at which the 
absorption spectra cross each other, and GST-pHluorin is transformed into another 
conformation. GST-pHluorin has similar spectral features as Miesenbock's isolated 
pHluorin and the isosbestic points are identical (compare Figs. 3.2B and 4.1).
The in vitro calibration curve o f GST-pHluorin was generated by plotting the 
ratios o f the emission intensities at 405 nm and 488 nm R(405/488) for each pH (Fig. 
3.2B). Our chosen excitation wavelengths did not correlate with the emission peaks 
shown in Figure 3.2A, as we were bound to use the filters 405 nm and 488 nm for the 
ratiometric imaging for low-light microscopy. However, the single ratiometric 
intensities R(405/488) for each pH were clearly separated from each other. The 
calibration curve displays a sigmoid shape, the trend line is described as 
y=-0.014x3+0.1923x2-0.4253x+0.7365, R2=0.9987.
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Figure 3.2: Optical properties of GST-pHluorin
A) Fluorescence excitation spectrum. Samples contained 0.5 pM GST-pHluorin in 50 
mM sodium cacodylate, 100 mM NaCl, 1 mM CaCl2, ImM MgCl2 were adjusted to 
the indicated pH with NaOH or HC1. Samples were excited with wavelengths 
ranging from 350 nm to 500 nm. The emission was monitored at 508 nm. The 
isosbestic point is indicatd with a pink dashed line Black dashed lines indicate the 
wavelengths used for the ratiometric calibration curve. B) In vitro calibration curve 
of GST-pHluorin. The emision values used for the invitro calibration curve resulted 
from the excitation wavelengths 405 nm and 488 nm, which are indicated with black 
dashed lines in Figure 3.2A. The ratios for each pH describe a sigmoid calibration 
curve with a best fit at y=-0.014x3+0.1923x2-0.4253x+0.7365, R2=0.9987.
Chapter 3.1: Results - TeNT escapes acidification during transport
3.1.1.3 GST-pHluorin is able to monitor p H  in cultured motor neurons
To determine if  GST-pHluorin is able to faithfully monitor pH in living cells, 
we tested it in organelles o f known pH values. Motor neurons were incubated in a 
high concentration of GST-pHluorin (6 pM) under conditions allowing the labelling 
of all endocytic compartments by fluid phase uptake. Following GST-pHluorin 
incubation for 1 h at 37°C, motor neurons were washed and either imaged 
immediately or after a 30 min chase in fresh neurobasal medium. In absence o f a 
chase, the labelled organelles (n=119) showed a broad pH spectrum, ranging from 
acidic to neutral (Fig. 3.3), which is in agreement with the heterogeneity observed 
experimentally in different endocytic compartments (Weisz, 2003). This distribution 
drastically changed after a 30 min chase, when mainly acidic structures were 
observed (n=96). About 70% of the organelles had a luminal pH below 5.5, 
reflecting the accumulation of GST-pHluorin in late endosomes and lysosomes 
(Weisz, 2003). These results confirm that GST-pHluorin can be used as a faithful pH 
reporter in our cellular system.
3.1.1.4 Untagged pHluorin could not be used as a p H  probe
Surprisingly, untagged pHluorin did not reveal the same spectral characteristics 
as described by Miesenbock (compare Figs. 3.4A and 4.1). pHluorin was expressed 
as a GST fusion protein and was released using thrombin cleavage. Upon dilution of  
0.5 pm pHluorin in buffers ranging from pH 5.0 to 8.0 (Fig. 3.4A), its fluorescence 
spectrum shows two peaks at 400 nm and 470 nm, but no clear isosbestic point. 
Whereas the behaviour o f the 400 nm peak is comparable with that observed for 
GST-pHluorin. The peak at 470 nm does not show a clear pH dependence. This
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Figure 3.3: GST-pHluorin is a functional pH probe for endosomal pH measure­
ment
Motor neurons were incubated with 6 pM GST-pHluorin in neurobasal medium for 1 
h at 37°C. Cells were washed an immediately imaged as described (filled bars). 
Alternatively, the incubation medium was replaced by neurobasal medium and incu­
bated for another 30 min (empty bars) prior to imaging. The endocytic compartments 
detected by fluid phase uptake o f GST-pHluorin displayed a broad range o f pH val­
ues, whereas upon 30 min o f chase, the probe was shifted to acidic compartments.
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Figure 3.4: Optical Properties of pHluorin
A) Fluorescence excitation spectrum. Samples contained 0.5 pM pHuorin in 50 mM 
sodium cacodylate, 100 mM NaCl, 1 mM CaCl?, 1 mM MgCl2 were adjusted to the 
indicated pH with NaOH or HC1. The emission was monitored at 508 nm. An 
isosbestic point could not be defined. Blacked dashed lines indicate wavelengths 
used for the ratiometric calibration curve. B) In vivo calibration curve. The ratio was 
build using the emission values of the excitation wavelengths 405 and 488 nm, which 
are indicated with black dashed lines in Figure 3.4A. The ratios for each pH describe 
a sigmoid calibration curve with a best fit at y=-0.0301x3+0.4183x2-1.3889x+2.2922, 
R2=0.998.
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results in a calibration curve characterised by a non-linear relationship between pHs 
5.0 and 6.25, generating ratios R(405/488) between 0.9 and 1.3 (Fig 3.4B). The 
reason for this unexpected physiochemical behavior o f isolated pHluorin is unclear. 
One possibility is that untagged pHluorin is unstable under the experimental 
conditions used both for the titration in solution and ex vivo. The GST tag most likely 
stabilises the pHluorin conformation and the spectral properties are never lost.
3.1.1.5 Cloning and Expression o f  TeNT H e fragm ents
The ability of GST-pHluorin to monitor intraluminal pH combined with the 
specificity o f TeNT He to target retrograde carriers allows us to measure pHs in this 
compartment in living motor neurons. The pH sensitive GFP (a gift from Gero 
Miesenbock, Memorial Sloan Kettering Cancer Centre, New York, USA) was 
inserted into the expression vector pGEX-4T-3-VSV-G-Kin-TeNT He, encoding 
GST, followed by a thrombin cleavage site, the VSV-G epitope and a 
phosphorylation site from protein kinase A (Fig. 2.1). The sequence o f the pGEX- 
4T-3-VSV-G-Kin-pHluorin-TeNT He construct was confirmed against the published 
TeNT Hc and pHluorin sequences, except for the absence o f mutation L220F in the 
latter. After expression of the fusion protein, the GST moiety was released by 
thrombin cleavage. The remaining 74 kDa pHluorin-TeNT He fusion protein was 
further purified by gel filtration.
3.1.1.6 Fluorescence excitation spectra o f  pHluorin-TeNT He
To investigate if  pHluorin-TeNT He retains the optical properties determined 
for GST-pHluorin, we analysed its spectral characteristics (Fig. 3.5A). The 
background intensities obtained for the different pH buffers were subtracted from
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Figure 3.5: Optical Properties of pHluorin-TeNT Hc
A) Fluorescence excitation spectrum. Samples containing 0.5 pM pHuorin-TeNT Hc 
in 50 mM sodium cacodylate, 100 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, adjusted 
to the indicated pH with NaOH or HC1. The isosbestic point is indicated with a pink 
dashed line. Black dashed lines indicate the wavelengths used for the calibration 
curve. B) In vivo calibration curve. The ratio was build using the emission values of 
the excitation wavelengths 405 and 488 nm, which are indicated with black dashed 
lines in Figure 3.5A. The ratios for each pH describe a sigmoid curve with a best fit 
at y=-0.0144x3+0.1948x2-0.5117x+1.0431, R2=0.999.
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each curve. As expected, the fluorescence excitation spectrum of pHluorin-TeNT He 
shows two peaks, a lower one at 395 and a higher 475 nm. The 395 nm peak was 
more intense at a neutral pH and decreased at acidic pHs, whereas the 475 nm peak 
showed an opposite behaviour, a lower signal at a neutral pH than at acidic pHs. The 
resulting fluorescence spectra for the different pHs have an isosbestic point 
corresponding to the excitation wavelength o f 418 nm, which is just slightly shifted 
towards a lower wavelength compared to GST-pHluorin and the published pHluorin 
(425 nm). Overall, pHluorin-TeNT Hc has similar optical properties as GST- 
pHluorin and the published pHluorin spectrum (Miesenbock et al., 1998).
3.1 .1 .7  Calibration curve o f pHluorin-TeNT He in  v itro
The in vitro calibration curve o f pHluorin-TeNT He was generated by plotting 
the ratios o f the emission intensity at 405 nm and the intensity given at 488 nm 
R(405/488) for each pH (Fig. 3.5B, black dashed lines). Our chosen excitation 
wavelengths did not correlate with the emission peaks shown in Figure 3.5A, as we 
were bound to use the filters 405 nm and 488 nm for the ratiometric imaging for low- 
light microscopy. However, the single ratiometric intensities R(405/488) for each pH 
were clearly separated from each other. The calibration curve displays a sigmoid 
shape, the trend line is described as: y=-0.0144x3+0.1948x2-0.5117x+1.0431 
(R2=0.999). This curve is similar to the one reported by Miesenbock.
3.1.1.8 pHluorin-TeNT He binds specifically to motor neurons
It was essential to confirm that the novel GFP-TeNT He fusion protein had the 
ability to recognise the same receptor(s) as TeNT. Previous work has demonstrated 
that TeNT He binds to the same complex as TeNT in purified motor neurons and
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spinal cord cells o f mice (Lalli et al., 1999). Therefore, we assessed the binding of 
pHluorin-TeNT He to purified dissociated rat motor neurons. Rat motor neurons 
were cooled to 4°C to prevent endo- and exocytosis, and then the purified neurons 
were incubated with 40 nM pHluorin-TeNT He in Hanks' buffer for 20 min. As 
shown in Figure 3.6A, pHluorin-TeNT He binds to the rat motor neuron surface, 
displaying a distribution similar to TeNT and TeNT He in mouse spinal cord cells 
(Lalli et al., 1999). A punctate staining pattern was clearly visible along the motor 
neuron processes and the soma. Staining was abolished by pre-incubation o f motor 
neurons with a 100-fold excess o f unlabelled TeNT He, indicating binding specificity 
(Fig 3.6B).
3.1.1.9 Calibration curve o f pHluorin- TeNT He in  v ivo
Because we planned to use pHluorin-TeNT He in dissociated cultures o f E14 
rat spinal cord cells, it was important to establish a pH-calibration curve in this 
system (Fig. 3.7). Motor neurons were pre-treated with 40 nM pHluorin-TeNT He at 
37°C for 30 min, washed with DMEMe  medium and then incubated with buffers 
adjusted to the indicated pH values in Figure 3.7. Subsequently, the ionophores 
nigericin (10 pg/ml) and monensin (10 pg/ml) were applied to the cells. Nigericin 
resembles monensin in catalysing the electroneutral exchange o f an alkaline metal 
for H+-ions (antiport). Monensin is more susceptible to Na+-ions, whereas nigericin 
prefers K+-ions. Nigericin allows neutral K+/H+-ion exchange across membranes and 
does not affect membrane potential. However, at high K+-ion concentrations, 
nigericin may catalyse K+-ion uniport thus explaining its uncoupling effects on 
mitochondrial oxidative phosphorylation (Eisenman et al., 1973). Upon ionophore 
treatment, all cellular compartments have been observed to re-equilibrate to the pH
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Figure 3.6: Binding-competition experiment of pHluorin-TeNT Hc
A) Rat motor neurons were washed and incubated with 40 nM pHluorin-TeNT Hc in 
Hanks’ buffer for 20 min at 4°C, then washed, fixed and imaged by confocal micros­
copy. Shown is a single focal plane o f a motor neuron with bound TeNT Hc -pHluorin. 
Scale bar, 5 pm. B) Rat motor neurons were pre-incubated with a 100-fold excess of  
unlabelled TeNT Hc in Hanks’ buffer for 15 min at 4°C before adding 40 nM 
pHluorin-TeNT Hc for 20 min at 4°C. Unlabelled TeNT Hc engaged all TeNT bind­
ing sites and therefore, pHluorin-TeNT Hc could not access the binding sites. Scale 
bar, 5 pm.
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F ig u re  3 .7 : In vivo c a l ib ra t io n  c u rv e  o f  p H lu o r in -T e N T  H c
Motor neurons were incubated with 40 nM pHluorin-TeNT Hc in neurobasal medium 
for 30 min at 37°C. The medium was then exchanged with buffers at the indicated pH 
values prior to the addition o f monensin and nigericin. Ratiometric images were 
taken for every pH and processed as described. 405/488 ratios (R405/488±S.E.M.) o f  
pHluorin-TeNT Hc compartments (n=24-52) were averaged for each pH. The result­
ing curve is best described by the trend line y=-0.0006x3+0.0088x2-0.0159x+0.1163, 
R2=0.999.
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of the external medium (Awaji et al., 2001). After 20 min ratiometric images were 
taken. The samples were exposed to the 488 nm excitation wavelength, immediately 
followed by image acquisition using the 405 nm excitation. Several ratiometric 
images were collected for each pH and then processed to generate a cellular 
calibration curve for pHluorin-TeNT He. The 405/488 ratios for each pH were 
averaged from randomly chosen pHluorin-TeNT He positive organelles in axons and 
somas (n=24 to 52). The background intensities were subtracted from images before 
building the ratio. This calibration curve also shows a sigmoid shape and the trend 
line is described as: y=-0.0006x3+0.0088x2-0.0159x+0.1163 (R2=0.999). The overall 
shape o f the in vitro and in vivo curve is similar, only the ratio values are different. 
The linear relationship between R(405/488) and pH allows us to use this curve to 
infer the pH in pHluorin-TeNT He compartments.
3.1.1.10 Ratiometric imaging o f  TeNT H e containing organelles
To investigate the pH o f TeNT He containing organelles, we incubated primary 
rat motor neurons with 40 nM pHluorin-TeNT He at 37°C for 30 min. The cells were 
then washed and after 20 min, low-light time-lapse image capture started in the 488 
nm channel followed by the 405 nm channel. From these two time-series, ratiometric 
images R(405/488) were obtained (Fig. 3.8A, see also videos 3.1a-c). The progress 
of a retrograde pHluorin-TeNT He vesicle is indicated by arrowheads, whereas a 
stationary compartment is marked with asterisks.
The motor neuron membrane was in general faintly stained. Only at neurite 
contacts and synaptic sites was brighter staining observed. The pHluorin-TeNT He 
uptake in motor neuron somas is a fast process (see Fig. 3.26), however, moving
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Figure 3.8: pHluorin-TeNT Hc is retrogradely transported along axons in motor 
neurons.
A) Motor neurons were incubated with 40 nM pHluorin-TeNT Hc for 30 min at 37°C, 
washed, and imaged by low-light microscopy. Two representative 488- and 405-nm 
time series o f a motor neuron axon are shown. 405-nm frames have been inverted to 
improve their contrast. The cell body is located out o f view at the bottom o f the 
image. Intervals between single frames are 5 s. A retrograde carrier (arrowheads) and 
a stationary compartment (asterisks) are indicated. The single frame image size is 2.6 
pm x 14.6 pm. See also Videos 3.1a-c. Scale bar, 2 pm. B) The pH of pHluorin- 
TeNT Hc carriers remains constant during transport. The 405/488 ratios o f a repre­
sentative pHluorin-TeNT Hc positive round vesicle and tubule were measured every 
5 s, converted to pH (right axis) and plotted as a function of time.
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organelles could only be detected from 45 min after the initial pHluorin-TeNT He 
application onwards.
3.1.2 Kinetic behaviour of retrograde transported pHluorin-TeNT Hc 
carriers
TeNT and TeNT He have been shown to undergo axonal retrograde transport 
with a similar speed range both in vivo (0.8-3.6 pm/s) (Stockel et al., 1975), and in 
vitro (0.2-3.6 pm/s) (Lalli et al., 2003; Lalli and Schiavo, 2002). To investigate 
whether pHluorin-TeNT He carriers are transported with the same rate as the TeNT 
compartments, we determined their speed distribution profile. Both the average 
speed and the overall curve shape observed for pHluorin-TeNT He carriers fit well 
with the previously reported data (Lalli et al., 2003; Lalli and Schiavo, 2002). In 
particular, the average speed observed for tubules (n=34, 334 movements) was 1.18 
pm/s (±0.29, S.E.M.) whereas round vesicles (n=33, 402 movements) had an average 
speed o f 0.83 pm/s (±0.25, S.E.M.). During our measurements we also observed 
carriers with a pearl chain-like morphology, termed 'trains' (Fig. 3.9, Video 3.2). 
Trains are rare events, corresponding to less than 5% of the total o f carrier numbers 
(n=3, 78 movements). Their speed profile is shifted to lower values compared to the 
one observed for tubular structures and round vesicles with an average speed o f 0.59 
pm/s (±0.27 S.E.M.) (Fig. 3.10). These results indicate that this new fusion protein is 
a reliable probe to follow axonal retrograde transport in motor neurons.
So far, not much is known about the morphology of the train-carrier type. They 
might be round vesicles in the process o f budding from an original tubule and still 
connected via a membrane or tethering factors. Alternatively, they could be vesicles
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Figure 3.9: Pearl chain-like carriers are retrogradely transported along axons
A pHluorin-TeNT Hc positive pearl-chain like carrier, indicated by the arrowhead, is 
moving in a retrograde fashion along a motor neuron axon. The soma is located out 
o f view at the bottom o f the image. The frames o f the 488 nm time series o f a time- 
lapse low-light movie have been inverted to improve contrast. Intervals between sin­
gle frames are 5 s. The single frame size is 8.1 pm x 34.1 pm. See also Video 3.2.
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Figure 3.10: Quantitative kinetic analysis of pHluorin-TeNT Hc carriers.
A) The distribution o f single speed values observed for tubules (n=34, blue bars), 
vesicles (n=33, red bars) and “trains” (n=3, yellow bars; carriers o f a pearl chain-like 
morphology) from six independent experiments is shown. Retrograde movement is 
conventionally shown as positive. Single movements for the three carriers (tubules, 
333; vesicles, 402; trains, 78) were analysed and are represented as relative frequen­
cies. B ) As well as tubules and vesicles, pearl chain-like carriers display a neutral pH 
during transport. The relative frequency o f single movements of all three carrier 
types is plotted against their pH.
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traveling together with the same speed using the same transport machinery. Until 
now, trains have only been seen during time-lapse imaging of living motor neurons 
but not in fixed samples by immunofluorescence or electron microscopy (Lalli et al., 
2003; Dr. K. Deinhardt, personal communications). This might be due to the 
transient nature of these carriers or poor preservation upon sample fixation.
3.1.3 pH dynamics of TeNT Hc carriers
Following internalisation, TeNT is transported along the motor neuron axon 
towards the soma, released into the extracellular medium and enters inhibitoy 
intemeurons, where acidic pH triggers a conformational change in TeNT, allowing 
the active subunit to translocate through the endosomal membrane into the cytosol 
(Montecucco et al., 1994; Williamson and Neale, 1994). To reach the intemeuron in 
a fully functional condition, TeNT has to be protected during its passage through the 
motor neuron.
3.1.3.1 p H  o f  pHluorin-TeNT H e carriers
To follow the pH dynamics o f TeNT Hc-containing carriers, we monitored the 
R(405/488) emission ratio in a population of axonal carriers during transport in 
living motor neurons. As shown in Figure 3.8B, the pH of vesicles and tubules 
remained relatively constant during transport with only small pH variations. Based 
on this finding, we then measured the pH of these organelles by ratiometric imaging 
only in the first frame of the videos, thus avoiding possible artefacts due to 
phototoxicity and photobleaching. To unravel a possible correlation between 
intraluminal pH and the average speed of axonal pHluorin-TeNT He compartments, 
the velocity of the single movements (n=735; 67 carriers) o f round vesicles and
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tubules only was plotted against their corresponding pH (Fig. 3.11 A). The large 
majority o f moving organelles are neutral, their pH falling in the 7.0-7.5 (42% o f the 
total), 7.5-8.0 (26% of the total) or >8.0 (18% o f the total) range. This neutral 
population o f axonal carriers presented a speed distribution profile overlapping with 
that observed previously (compare Fig. 3 .11A with Fig. 3.10) (Lalli et al., 2003; Lalli 
and Schiavo, 2002). Only a few pHluorin-TeNT Hc-positive compartments displayed 
a pH below 7.0 (14% o f the total), whereas, no moving carriers having an acidic pH 
(^ 6.0) were detected. The pearl chain like carriers also displayed a neutral pH during 
transport (Fig. 3.10B) but as a result o f their low frequency (n=3) they have not been 
included in the pH-speed correlation profile.
In sharp contrast, stationary pHluorin-TeNT He positive organelles in somas 
and axons displayed a wide range o f pHs, from acidic to neutral (Fig. 3.1 IB). This 
result was confirmed by the partial colocalisation of these stationary compartments 
in the soma and axons with Lysotracker Red DND-99 using time-lapse confocal 
microscopy (Fig. 3.12; Video 3.3a,b). The video also shows that there are more 
Lysotracker than TeNT He organelles in the soma. However, moving organelles are 
only single positive for either Lysotracker or TeNT He. According to the 
manufacturer's information, Lysotracker is an acidotrophic dye, which accumulates 
irreversibly in acidic compartments and is generally not reversed by treatment o f  
cells with basic cell-permeant compounds. Therefore, we cannot conclude that 
Lysotracker positive compartments are still acidic because organelles will still 
display a positive signal even when they regained neutral pH.
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Figure 3.11: Moving TeNT Hc carriers display an overall neutral pH
A) Shown is the speed and frequency o f single movements (n=736) o f pHluorin- 
TeNT Hc carriers and their corresponding pH values. Neutral carriers (pH>=7.0) 
account for the large majority o f the total. B) Comparison between the pH distribu­
tion o f stationary organelles and axonal retrograde carriers containing pHluorin- 
TeNT Hc . The stationary organelles (white bars) include compartments in both axons 
and soma (n=171), whereas the carriers (black bars) include axonal round vesicles 
and tubules (n=67).
TeNT Hr -Alexa488 Lysotracker m erge
Figure 3.12: TeNT Hc enters acidic compartments in a motor neuron soma.
TeNT Hc -Alexa488 and Lysotracker Red DND-99 display a partial co-localisation in 
stationary organelles in a motor neuron soma. Motor neurons were incubated with 40 
nM TeNT Hc-Alexa488 and 100 nM Lysotracker Red DND-99 for 30 min at 37°C, 
washed and imaged without fixation by confocal microscopy. Panels show single 
frames (TeNT Hc in green, Lysotracker Red DND-99 in red) and the merged image 
from a dual colour confocal movie. See also Video 3.3. The inset displays a high 
magnification of the indicated area. Scale bar, 10 pm.
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3.1.3.2 Real time measurement o f organelle acidification
During time-lapse low-light microscopy, we observed organelle acidification in the 
cell body in real time, although with an extreme low frequency (n=l). Figure 3.13 
shows the single frame time series o f the 488 nm channel movie o f a motor neuron 
soma (see also videos 3.4a-c). The fluorescent signal o f the frames has been inverted 
to improve their contrast. An intensity change occurs in the motor neuron soma in 
the red encircled area, which is here visible from 35 s onwards. In contrast, other 
pHluorin-TeNT He positive compartments in the soma slightly lost intensity, 
presumably due to photobleaching (green circle). We have quantified the decrease in 
the R(405/488) ratio o f the red encircled organelle in Figure 3.14. Prior to building 
the ratio, intensities o f a region containing no pHluorin-TeNT He signal in the cell 
body were subtracted from both the 488 and 405 nm channels. The rapid change in 
the R(405/488) ratio likely reflects the acidification o f a stationary organelle from 
pH 7.5 to between pH 5.0-5.5 and was completed after 20 s. We suspect that we were 
unable to monitor more such events due to rapid acidification o f pHluorin-TeNT He 
organelles. The paucity o f related experimental data did not allow us to determine the 
kinetics o f the acidification process. In this regard the lack o f linearity seen in Figure 
3.14 may be due to the background noise o f the imaging. Given the absence o f  
vATPase from TeNT containing organelles (see below), the acidification can be 
achieved by fusion with a late endosome or lysosome. However, the determinants of 
this putative fusion event are currently unknown.
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Figure 3.13: Real-tim e m easurem ent of 
organelle acidification
Motor neurons have been incubated with 40 
nM  p H lu o rin -T eN T  H^, w a sh e d  and  
imaged by time-lapse low-light microscopy. 
The 488 nm time series is shown (see also 
videos 3.4a-c). The fluorescent signal o f the 
frames has been inverted to improve their 
contrast. An intensity change occurs during 
measurement in the red encircled area. This 
increase o f intensity in the 488 nm channel 
reflects the acidification o f  this stationary 
compartment in a m otor neuron soma. 
Other organelles positive for pHluorin- 
TeN T H c l o s t  in te n s ity  d u e  to  
photobleaching (green circle). The intervals 
between single frames are 5 s. The frame 
size is 37.4 pm x 28.3 pm.
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Figure 3.14: Real-time acidification of a stationary pHluorin-TeNT Hc organelle 
in a motor neuron soma
Motor neurons were incubated with 40 nM pHluorin-TeNT Hc for 30 min, washed 
and imaged. The ratiometric intensity change o f a single stationary pHluorin-TeNT 
Hc compartment in a motor neuron soma displays a rapid acidification o f this organ­
elle during 50 s. The ratio change indicates a pH change from 7.5 to 5.0/5.5.
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3.2 pH regulation of TeNT carriers is due to a differential 
targeting of the vacuolar (H*) A TPase
We have demonstrated that moving pHluorin-TeNT He retrograde carriers in 
motor neuron axons display a neutral pH, which is kept constant during transport. 
Stationary TeNT He organelles instead exhibit a wide range o f pH values, ranging 
form acidic to neutral. This distinct pH regulation might be due to a differential 
targeting o f the vacuolar (H+) ATPase (vATPase). Accordingly, inhibition o f the 
vATPase under conditions that completely abolish the intracellular accumulation of 
acidotrophic dyes does not affect axonal retrograde transport o f TeNT He. However, 
a functional vATPase, found on axonal endosomes containing TeNT He, is required 
for early steps o f TeNT He trafficking following endocytosis. Altogether, these 
findings indicate that the vATPase plays a specific role in early sorting events 
directing TeNT He to axonal carriers, but not in their subsequent progression along 
the retrograde transport route, which escapes acidification and targeting to 
degradative organelles.
3.2.1 The vA TPase is absent on TeNT He carriers
What is the cause o f the different pH distribution in moving and stationary 
pHluorin-TeNT He positive organelles in motor neurons? At least three formal 
explanations might account for this phenomenon: (i) the acidification machinery is 
excluded from transported organelles; (ii) its activity is specifically regulated via 
reversible disassembly; or (iii) the axonal retrograde carriers containing TeNT He 
rapidly dissipate the pH gradient due to a high permeability to protons.
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A major cellular complex involved in organelle acidification is the vATPase. 
vATPases are found on a variety o f intracellular compartments, including clathrin- 
coated vesicles, Golgi-derived vesicles, synaptic vesicles and secretory granules 
(Stevens and Forgac, 1997), and are responsible for the acidification of degradative 
organelles, such as lysosomes and phagosomes (Nelson, 2003; Stevens and Forgac, 
1997).
We tested the presence o f the vATPase on axonal and somatic organelles 
containing TeNT He using antibodies against the subunits B and E in the Vi domain 
o f the vATPase and the subunit a in the Vo domain (Fig. 3.15A). These antibodies 
exclusively recognise peptides o f the predicted molecular weight in rat brain extracts 
(Fig. 3.15B). Immunofluorescence microscopy reveals that vATPase and TeNT Hc- 
positive compartments in axons (Fig. 3.16A) and soma (Fig. 3.16B) differed in 
morphology and rarely colocalise (see also Fig. 3.26B), suggesting that the vATPase 
is excluded from TeNT He carriers. Colocalisation o f vATPase and TeNT organelles 
may reflect the stationary subset o f TeNT positive organelles, which can be acidified 
(Figs. 3.16 and 3.26). Moreover, vATPase partially colocalises with the acidic 
granule marker DAMP at early time-points o f internalisation (^ 2  min) (Fig. 3.17). 
40% to 50% of vATPase containing structures are also DAMP positive (n=6 ). As 
expected, vATPase organelles are more abundant than acidic granules, owing to the 
fact that this enzyme is also involved in the regulation o f membrane potential.
Vesicular uptake o f neurotransmitters requires both a neurotransmitter 
transporter and a vATPase (Cidon and Sihra, 1989; Floor et al., 1990). Synaptic 
vesicle re-loading is an H+-dependent process that depends on the proton gradient 
maintained by vATPases located in their membrane. Biochemical studies using
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Figure 3.15: The structure of vATPase and its subunit mapping by specific anti­
bodies
A) Schematic structure o f vATPases (adapted from Inoue and Forgac, 2005). The 
antibodies used for the Western blot analysis and immunofluorescence experiments 
were raised against the subunits B and E o f the Vj domain and the a subunit o f the VQ 
domain. B) The antibodies against vATPase subunits recognised single bands (a-31 
kDa, a-60 kDa and a -1 16 kDa) and a doublet (a-75 kDa) at their expected molecular 
weights in unboiled rat brain extracts.
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Figure 3.16: The vATPase is excluded from axonal retrograde carriers contain­
ing TeNT Hc -Alexa488
Motor neurons were Fixed after 45 min incubation with 20 nM TeNT Hc-Alexa488 
and probed with the different vATPase antibodies by confocal microscopy. Immuno­
fluorescence revealed that vATPase and TeNT Hc compartments were morphologi­
cally very different both in axons (A) and in soma (B). A very limited overlapping of  
the two staining patterns was seen, suggesting that the vATPase is not present on 
TeNT Hc carriers. Scale bars, 5pm.
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Figure 3.17: vATPase partially localises with acidic granules
A) As determined by confocal microscopy, DAMP (in green) shows a partial overlap 
with a -1 16 kDa vATPase-positive compartments (in red) in a motor neuron soma. 
Scale bar, 5 pm. B) Relative colocalisation between the vATPase (stained with an 
an tibody  ag a in st the  116 kD a su b u n it) and  DAM P (n= 8) a t ea rly  s tages o f  
internalisation (t=2 min).
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synaptic vesicle extracts have suggested that vATPases are involved in membrane 
fusion events (Peters et al., 2001) and could therefore play a role in neurotransmitter 
release, but direct immmunofluorescence evidence supporting this is lacking. We 
have found that the synaptic vesicle protein VAMP1 partially colocalises with the 
vATPase subunit E at synapse-like structures in motor neuron axons (Fig. 3.18), 
supporting the proposed involvement o f vATPases in membrane fusion.
3.2.2 Inhibition of the vA TPase does not affect axonal transport
3.2.2.1 Con A and B afA l block acidification o f  endocytic organelles
Althought our immunocytochemical data suggests that the vATPase is not 
required for axonal TeNT transport, vATPase may, in fact, simply reside on these 
vesicles at undetectable levels. To address this possibility and exclude a role for the 
vATPase activity in axonal TeNT transport, we specifically blocked its catalytic 
function using the macrolide antibiotics concanamycin A (ConA) and bafilomycin 
A l (BafAl). Both drugs bind with high affinity to the subunit c (see Fig. 3.15A) o f 
the vATPase Vo domain (ICso=10 nM for ConA and 0.5 nM for BafAl) (Bowman et 
al., 2004; Mattsson and Keeling, 1996). To test if  these drugs effectively block the 
acidification o f intracellular organelles in motor neurons at these concentrations, we 
pre-treated cultures with ConA and BafAl for 15 and 10 min, respectively and 
followed the accumulation of the acidotrophic drug Fysotracker Red DND-99. As 
shown in Figure 3.19, Lysotracker accumulation is undetectable compared to the 
DMSO-treated control sample, demonstrating that vATPase activity was inhibited by 
both ConA and B afA l.
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Figure 3.18: vATPase partially localises with synaptic vesicle markers
Confocal microscopy reveals that the synaptic vesicle protein VAMP1 (in green) par­
tially localises with the a-75 kD vATPase (in red) at synapse-like structures in motor 
neuron axons. Scale bar, 5 pm.
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Figure 3.19: ConA and BafAl inhibit acidification
DIC (left) and Lysotracker Red DND-99 staining (right) are shown for control, 
ConA-treated and BafAl-treated motor neurons. Motor neurons were pre-incubated 
with vehicle (DMSO) or 10 nM ConA (15 min) or 0.5 nM BafAl (10 min) prior to 
addition o f 50 nM Lysotracker. After 15 min incubation, cells were washed and 
imaged by confocal microscopy without fixation. Scale bar, 20 pm.
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3.2.2.2 TeNT transport is not altered by ConA and B afA l
Our immunofluorescence data suggests that vATPases are excluded from 
TeNT carrying organelles. One would predict, therefore, that vATPase inhibition 
would have no effect on TeNT transport. Motor neurons were incubated in complete 
medium containg TeNT Hc-Alexa488 and then imaged by low-light microscopy as 
described in Figure 3.20A. Once TeNT Hc-Alexa488 transport was detected, usually 
45 min after the initial TeNT Hc-Alexa488 application, ConA and BafAl were 
added to the cultures. Images were collected 5, 15 and 30 min after the addition of 
vATPase inhibitors and the speed profile o f TeNT Hc-Alexa488 carriers was 
determined. Direct comparison o f the speed distribution profile of TeNT Hc- 
Alexa488 He carriers in untreated motor neurons (Fig. 3.20; solid line) with those of 
treated motor neurons at different time points (Fig. 3.20; dotted lines) indicate that 
neither o f the drugs alters axonal retrograde transport (see also Videos 3.5a-e and 
Fig. 3.21). TeNT He transport was also observed after longer incubation with ConA 
(>90 min). We noticed a slight reduction in speed values and a decrease in carrier 
frequency at later time points (Fig. 3.20; empty triangles versus open circles). We 
attribute these minor variations to the repetitive, long term imaging of the same axon, 
since untreated motor neurons showed the same overall alterations o f TeNT Hc- 
Alexa488 transport (Fig. 3.22).
3.2.3 vA TPases play a role in TeNT sorting
3.2.3.1 A functional vATPase is not required fo r  TeNT internalisation
Various endocytic properties are independent o f vATPase functions, such as 
the rate o f transferrin receptor internalisation and the formation of multivesicular
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Figure 3.20: ConA and BafAl treatment does not alter axonal TeNT Hc trans­
port
A) Time scheme of the experiment. Motor neurons were incubated with 40 nM TeNT 
Hc -Alexa488, washed and imaged by low-light time-lapse microscopy (filled circles). 
Retrograde transport in the same axon was measured at 5 min (empty triangles), 15 
min (empty squares) and 30 min (empty circles) after application of 10 nM ConA (B) 
or 0.5 nM BafAl (C). The number of single movements quantified for each condition 
is indicated in the right hand tables.
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Figure 3.21: Time series of TeNT Hc -Alexa488 carriers in ConA-treated motor 
neurons
Cultured motor neurons were incubated with 40 nM TeNT Hc -Alexa488 for 30 min 
at 37°C, washed and then imaged by low-light time-lapse microscopy. ConA (10 nM) 
was added to the samples only after axonal transport was detected. Representative 
time series o f moving TeNT Hc -Alexa488 carriers (arrowheads) and a stationary 
organelle (asterisk), before and 5, 15 and 30 min after ConA treatment are shown in 
an axon. The motor neuron soma is located below the bottom o f the frames. Frame 
size is 3.12 pm x 16.9 pm and intervals between single frames are 5 s. Scale bar, 2 
pm.
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Phototoxicity during transport studies. Retrograde TeNT Hc -Alexa488 transport was 
measured in the same axon at the time points 5 min (full circles), 15 min (empty 
squares) and 30 min (empty circles) as described in Figure 3.20A. In this experiment 
no vATPase inhibitors were added to the cells. With progressing imaging time carri­
ers are shifted towards lower speed values.
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bodies (Johnson et al., 1993; van Deurs et al., 1996). However, functional vATPases 
seem to be important for transferrin receptor extemalisation (Johnson et al., 1993) 
and late fusion step(s) along the endocytic pathway (van Deurs et al., 1996).
To determine if vATPases play a role in TeNT uptake, we tested if  blocking its 
activity with 0.5 nM BafAl abolished TeNT internalisation. In one case, motor 
neurons were incubated with VSV-G tagged TeNT He for 30 min, as shown in the 
time scheme of the experiment (Fig. 3.23). After 45 min the cells were fixed and the 
surface bound TeNT He was detected using an a-rabbit VSV-G antibody (green). 
The motor neurons were then permeabilised and internalised TeNT He was detected 
using an a-mouse VSV-G antibody (red). This sequential staining experiment in 
absence and presence o f permeabilisation revealed that a pool o f TeNT He is 
internalised under the conditions o f BafAl pretreatment. The second experiment 
showed that BafAl did not impair the entry o f biotinylated TeNT He into motor 
neurons (Fig. 3.24). Following a 15 min treatment o f 0.5 nM BafAl, cells were 
incubated with TeNT He labelled with disulfide-linked biotin for 30 min, washed 
and incubated with a membrane-impermeable reducing agent (sodium 2 -mercapto- 
ethanesulfonate; MESNA) on ice. This treatment is effective in cleaving o ff the 
biotin from surface bound TeNT He (Deinhardt, 2005). Internalised TeNT He was 
detected using streptavidin-Alexa488. For the control, the motor neurons were 
incubated with TeNT Hc-biotin on ice for 20 min prior to MESNA treatment as 
described in the time scale. At 4°C the process o f internalisation is stopped and the 
toxin is not taken up into cells. All surface-bound biotin is cleaved o ff and no 
streptavidin-Alexa488 signal was detected. These findings strongly suggest that 
TeNT entry into motor neurons does not require a functional vATPase.
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Figure 3.23: BafAl does not inhibit VSV-G-TeNT Hc internalisation
Motor neurons were treated with 0.5 nM BafAl for 15 min at 37°C, followed by 30 
min incubation with VSV-G-Kin-TeNT Hc . Cells were fixed and surface-bound 
TeNT Hc was detected using an a-rabbit VSV-G antibody (in green). Motor neurons 
were then permeabilised and internalised TeNT Hc was detected using an a-m ouse 
VSV-G antibody (in red) and imaged with confocal microscopy. A scheme o f the 
experiment is shown on top. Scale bar, 5 pm.
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Figure 3.24: BafAl does not inhibit TeNT Hc -biotin internalisation
After BafAl treatment (0.5 nM), cells were incubated with TeNT Hc labelled with 
disulfide-linked biotin at 37°C for 30 min, washed and incubated with a membrane 
impermeable reducing agent (MESNA) on ice. Internalised TeNT was detected 
using Streptavidin-Alexa488. For the control, motor neurons were incubated with 
TeNT Hc -biotin on ice for 20 min prior to MESNA treatment. Confocal microscopy 
and DIC images are shown. Time-scale o f the experiment is on top. Scale bar, 10 pm.
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3.2.3.2 The vA TPase is involved in initial TeNT sorting
Our experiments revealed that neither TeNT uptake into motor neurons nor its 
axonal transport is depending upon a functional vATPase. Similar results were 
obtained in rat hippocampal neurons, where an inhibited vATPase did not block 
TeNT internalisation, but entrapped TeNT in small endocytic compartments, unable 
to cleave VAMP (Matteoli et al., 1996). To test whether the vATPase is involved in 
the regulation o f TeNT He downstream traffic events, motor neurons were incubated 
for 15 min with BafAl and ConA before adding TeNT Hc-Alexa488, to block the 
catalytic vATPase function (Fig. 3.25A). After washing the motor neurons with 
DMEMe , imaging started at t=0 min. Epifluorescence microscopy revealed only a 
faint membrane staining o f motor neuron axons at t=30 min (Fig. 3.25B). Moreover, 
kymographs (Fig. 3.25B) show a complete absence o f both, progressing or stationary 
TeNT Hc-Alexa488 containing compartments. Taken together, these data indicate 
that TeNT He is not sorted to the retrograde transport route in absence o f a functional 
vATPase. In contrast, kymographs o f motor neurons treated in absence o f ConA or 
BafAl and imaged at t=30 min (Fig. 3.20) are shown in Figure 3.25C for 
comparison. Several progressing carriers are visible (arrow-heads), together with 
stationary compartments (asterisks).
For a better understanding o f the role o f vATPases in TeNT uptake into 
neurons, we performed colocalisation experiments at early time points o f  
internalisation (t=2 min). TeNT Hc-Alexa488 incubation was stopped after 2 min, 
cells were fixed, permeabilised and probed for the vATPase subunit a, which is 
membrane bound. We observed a significant overlap between TeNT positive 
compartments and vATPase containing organelles at early stages o f uptake (t=2
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A) Schematic time-scale o f the experiment. Motor neurons were treated with 10 nM 
ConA or 0.5 nM BafAl and then incubated with 40 nM TeNT Hc -Alexa488, washed 
and imaged by low-light time-lapse microscopy. B) Epifluorescence o f motor neuron 
axons at t=30 min of imaging. The corresponding kymographs are shown below. C) 
Kymographs of motor neuron axons treated as described in Figure 3.20 (t=30 min). 
Arrowheads indicate retrograde TeNT Hc -Alexa488 carriers, whereas asterisks mark 
stationary organelles. In Figures 3.23B and 3.23C the motor neuron soma is located 
out o f view on the right. Vertical scale bar, 40 s, horizontal scale bar, 5 pm.
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min) (Fig. 3.26A). This represents a striking difference with the results obtained at 
late time points (t=45 min), when this colocalisation was very limited (Fig. 3.26B). 
These findings indicate that a functional vATPase is not required for TeNT He 
endocytosis or transport but plays a specific role in an early sorting step(s) targeting 
TeNT He to axonal transport carriers.
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Figure 3.26: Relative colocalisation of vATPase with TeNT
A) At early time points o f TeNT Hc -Alexa488 internalisation (t=2 min), a partial 
overlap between TeNT Hc -Alexa488 (in green) and vATPase (116 kDa subunit; in 
red) can be detected using confocal microscopy. Scale bar, 5 pm. B) Relative 
colocalisation between the vATPase, stained with an antibody against the 116 kDa 
subunit, and TeNT Hc at early (t=2 min) and late (t=45 min) internalisation time- 
points in axons and soma (n=6  to 8 ).
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3.3 A mutation in dynein rescues axonal transport defects 
and extends the life span o f ALS mice
The novel regulatory role for vATPases in TeNT sorting event(s) linked to 
retrograde transport adds to the numerous functions o f this protein complex, which 
include vacuolar fusion, lysosomal maturation and reloading of synaptic vesicles 
with neurotransmitters. Interestingly, hydrogen peroxide inhibits the vATPase 
localised to synaptic vesicles, which leads to a disturbed trafficking o f  
neurotransmitters. Increased levels o f reactive oxygen radicals have been detected in 
mice overexpressing human mutant Cu/Zn superoxide dismutase (S0D 1G93A) found 
in patients with familial amyotrophic lateral sclerosis (FALS). These mice have been 
shown to develop motor neuron degeneration and muscle paralysis as observed in 
ALS patients. Evidence suggests that defects in axonal transport play an important 
role in neurodegeneration. In a collaborative project, we show that retrograde axonal 
transport defects are already present in motor neurons o f S0D 1G93A mice during 
embryonic development. Surprisingly, crossing S0D 1G93A mice with mice having a 
single point mutation in the dynein motor complex (Loa) delays disease progression 
and significantly increases life span o f the double-heterozygote compared to 
SOD1G93a mice. Moreover, we observed a complete recovery in axonal transport 
deficits in motor neurons o f Loa/SO DlG93A mice, which might be responsible for 
amelioration o f the symptoms. We propose that impaired axonal transport is a prime 
cause o f neuronal death in neurodegenerative disorders such as ALS.
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The studies on the functional interaction between mutations in cytoplasmic 
dynein and in SOD1 were a collaborative work between the Sobell Department o f  
Motor Neuroscience and Movement Disorders (Dairin Kieran and Linda 
Greensmith), Sobell Department o f Neurodegenerative Disease - Institute o f  
Neurology (Elizabeth M. C. Fisher), Department o f Biochemistry - University o f  
Sussex (Majid Hafezparast), Neuroscience Centre - Queen Mary University o f  
London (Joanne Martin), and Molecular Neuropathobiology Laboratory - Cancer 
Research UK London Research Institute (Stephanie Bohnert and Giampietro 
Schiavo) (Kieran et al., 2005).
3.3.1 Expression o f the human S0D1G93A transgene
ALS is a fatal neurodegenerative disease characterised by a progressive motor 
neuron degeneration (Rowland and Shneider, 2001). Mutations in SOD1 are 
responsible for 20% o f FALS (Rosen, 1993) and transgenic mice overexpressing 
SOD1g93a develop an ALS-like phenotype (Gurney et al., 1994; Wong et al., 1995), 
which is presumably caused by disruptions in axonal transport (Williamson and 
Cleveland, 1999). Mice with a mutation in the dynein heavy chain (Dnchcl mutants 
termed Legs at odd angles mice; Loa) display a defect in axonal transport and motor 
neuron survival (Hafezparast et al., 2003). Furthermore, mutations in dynactin, a 
motor protein involved in dynein-mediated axonal transport have been identified in 
families with progressive forms o f ALS (Munch et al., 2004; Puls et al., 2003). To 
investigate in more detail the causes o f neuronal death in neurodegenerative 
disorders, we examined whether the interactions between mutant SOD1 and the 
dynein mutation would affect disease progression in double-heterozygote 
(Loa/SODlG,3A) mice.
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Loa  heterozygote female mice (n=12) were crossed with S 0D 1G93A males 
(n=10) to produce four genetically distinct groups o f littermates: wild type, Loa 
heterozygotes, SOD1G93a hemizygotes and Zoa/SO DlG93A double heterozygotes. All 
mice were identified by genotyping for mutations in the D nchcl gene (Loa  mutation) 
and the human SOD1 transgene (Kieran et al., 2005). The genotyping was performed 
at 21 days o f age and was repeated in adults after 120 days. The heritability o f the 
mutant SOD1 transgene from the Z,oa/SODlG93A double-heterozygous animals was 
examined by breeding Loa/+ females with Loo/SOD 1093A males. SOD 1093A mice 
from this breeding had the same phenotype as S 0D 1G93A mice from the regular FI 
(C57BL/6xSJL) hybrid background (Achilli et al., 2005; Kieran et al., 2005).
However, changes in the genetic background due to the breeding protocol 
might affect the expression levels o f the SOD 1093A transgene. Spinal cords from each 
genetic group were processed for Western blot analysis probing the SOD1 protein 
with NCL-SOD1 antibody (Novocastra) (Kieran et al., 2005). Human SOD1, which 
migrates in SDS-PAGE at a higher molecular weight than mouse SOD1, was only 
present in spinal cords o f SOD 1093A and Loa/SODlG93A mice, and not in wild type or 
Loa/+ littermates, as it was expected by their genotype (Fig. 3.27). The expression 
level o f mutant SOD1 in each group o f SOD 1093A mice was the same and was not 
reduced in Loa/SODlG93A mice.
3.3.2 Life span and weight loss o f mice expressing the human 
S0D1G93A transgene
As previously reported, Loa/+ mice had a normal life span (Hafezparast et al., 
2003), whereas S0D 1G93A mice had a significantly reduced life span o f only 125
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A representative Western blot o f human SOD1 using brain tissue. NCL-SOD1 was 
used to detect mouse/human SOD1. The expression levels o f mutant SOD1 protein 
was not reduced in Loa/SO DlG93A mice. This experiment was carried out by Dr. 
Majid Hafezparast.
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days (±2.5 S.E.M., n=20). Therefore, we examined if  the mutation in cytoplasmic 
dynein, inherited from Loa  mice, altered the life span o f S0D 1G93A mice. The disease 
end-stage was defined as loss o f the righting reflex and decrease o f 2 0% of body 
weight (Kieran et al., 2005). Surprisingly, the Lotf/SODlG93A mice lived for 160 days 
(±3.1 S.E.M., n=18), which reflects a 28% increase in life span (p;s0.001) compared 
to the S0D 1G93A mice (Figure 3.28A). Loa/SODlG93A mice also have a significant 
delay in the loss o f body weight compared to their S0D 1G93A littermates (Fig. 
3.28B). The differences in disease progression are also reflected in their pathological 
phenotype. At 120 days o f age S 0D 1G93A mice move slowly, and they do not show 
the toe-spreading reflex when suspended by the tail, which indicates that the 
hindlimb muscles are poorly innervated (Video 3.6a). In contrast, Loa/SODlG93A 
mice are much more active and move freely compared to their S0D 1G93A littermates 
(Video 3.6b). They show the characteristic "Legs at odd angles" {Loa) reflex, the 
hindlimbs are pulled in at an unusual angle when lifted by their tails. The delayed 
disease progression and the extended life span o f Loa/SODlG93A mice were 
unexpected results.
3.3.3 Muscle force of littermates
SOD1G93a mice lack the characteristic toe-spreading reflex and are hindered in 
their movement compared to their Loa/SODlG93A littermates (Videos 3.6a,b). We 
therefore examined in vivo the physiological properties o f the extensor digitorum 
longus (EDL), an ankle flexor muscle. EDL muscle contractions were elicited by 
stimulating the sciatic nerve and muscle force was assessed using increasing 
frequencies o f stimuli. At 120 days the EDL muscles o f Loa/+ mice produced a
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A) Increased life span o f  Z,o<2/S O D 1G93a m ice (green squares) compared to 
SOD1G93a mice (black triangles; n=18 to 20). Loa/SODlG93A mice lived on average 
35 days longer than S0D 1G93A mice. Loa/+ mice display a normal life span. B) 
Loa/SO D lG93A mice display a delayed loss o f  body weight compared to m ice 
expressing SOD1G93a (n= 18-20) (g=gram). These experiments were carried out by 
Dr. Dairin Kieran.
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normal force, but in S0D 1G93A mice they were drastically weaker (p^O.05) (Fig. 
3.29). Unexpectedly, the muscles in Loa/SOD 1G93A mice were as strong as in wild 
type mice (p=0.213). Furthermore, changes in the contractile characteristics o f EDL 
muscles that occur during disease progression in S0D 1G93A mice do not occur in 
Lo<2/SO D1G93a mice at this age (Kieran and Greensmith, 2004). The EDL muscle is 
under normal conditions a fast contracting muscle that fatigues rapidly when 
repeatedly stimulated. The traces o f EDL muscles illustrate the fatigue pattern o f the 
muscle in response to sustained contraction from which a fatigue index (F.I.) can be 
calculated (Burke et al., 1973; Burke et al., 1971). The F.I. describes the rate o f 
tiredness o f the EDL muscle by subtracting the stimulated tetanic tension from the 
initial tetanic tension over the muscle's initial tetanic tension. A F.I. approaching 1.0 
indicates that a muscle is very fatigable. The fatigue traces change drastically in 
SOD1G93a mice (Fig. 3.29B, Table 3.1), and by 120 days the muscle is slow and 
fatigue resistant (Kieran et al., 2005).
Table 3.1: Contractile and fatigue characteristics of EDL muscles
genotype n TTP [ms] !4 RT [ms] F.I.
Wild type 10 25.1±3.0 25.8±2.4 0.85±0.03
Loa/+ 10 31.2±2.3 32.4±3.9 0.82±0.04
SOD1G93a 12 44.5±3.8 86.5±6.0 0.41±0.06
Loa/SOD1G93a 10 27.8±1.0 30.0±3.8 0.72±0.04
Table 3.1 shows the time taken to reach the maximum twitch force (time to peak, 
TTP) the half-relaxation time ( lA  RT), and the fatigue index (F.I.) o f EDL muscles of 
mice from each cohort o f littermates at 120 days o f age. Values are ±S.E.M.
These changes are reflected in the histochemical properties o f the muscle 
fibres. There is an increase o f oxidative capacity in S0D 1G93A muscle fibres, which
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A) Maximum force generated by EDL muscles (n=10-12) in each group at 120 days 
of age (g=grams). EDL muscles o f  Loa/+ mice produce a normal force at 120 days, 
but S0D 1G93A mice are significantly weaker. In Lo<2/SOD1G93a mice, EDL muscles 
are as strong as in wild type. Error bars=SEM. Fatigue traces from EDL muscles o f
B) wild type, C) Loa/+, D) SOD 1093A and E) Loa/SODlG93A mice at 120 days o f  
age (bar=30 s). EDL muscles from each genotype have been repeatedly stimulated to 
generate their characteristic fatigue pattern. For S0D 1G93A mice, EDL is a slow, 
fatigue resistant muscle at 120 days. These experiments were performed by Dr. 
Dairin Kieran.
wild type
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stain darkly for the oxidative enzyme succinate dehydrogenase (data not shown). In 
contrast, Z,otf/SODlG93A mice retain the normal contractile and fatigue characteristics 
with no change in muscle fibre phenotype.
3.3.4 Motor unit numbers
The improved muscle function in Z,oa/SODlG93A mice compared to their 
SOD1G93a littermates is reflected in an increased number o f motor units, which is a 
motor neuron and all the muscle fibres it innervates and stimulates. To determine the 
number o f functional motor units in each EDL muscle, stimuli o f increasing intensity 
were applied to the sciatic nerve. This resulted in stepwise increments in twitch 
tension due to successive recruitment o f motor neurons (Kieran et al., 2005). Motor 
unit traces from representative samples for each genotype and the mean motor unit 
number are shown in Figure 3.30. In wild type mice EDL muscles were innervated 
with 28 motor units (±0.6 S.E.M., n=6), which is the same number as in Loa/+ mice 
(27±0.7 S.E.M., n=6 ). The number o f motor units in the S0D 1G93A EDL muscles was 
drastically reduced to only 11 (±0.9 S.E.M., n=6 ), but Lotf/SODlG93A mice showed a 
significant increase in motor unit numbers to 27 (±1.1 S.E.M., n=6 ), practically the 
same number as in wild type and Loal+ littermates at 120 days of age.
3.3.5 Motor neuron numbers
Because motor unit numbers were substantially lower in EDL muscles of  
SOD1G93a mice we asked if this reflects reduced motor neuron numbers in spinal 
cords. To address this point, spinal cord cross sections underwent Nissl staining, 
which detects cytoplasmic ribonucleoproteins (Kieran et al., 2005). Nissl-stained 
spinal cord cross sections showed an important increase in motor neuron numbers in
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Figure 3.30: Motor unit numbers
A) Representative examples o f motor unit traces from EDL muscles (n= 10) in wild 
type, Loa/+, S 0D 1G93A, and Loa/SO DlG93A mice and B) their average motor unit 
number at 120 days o f age. In SOD1G93a mice only 11 (±0.9, n=6 ) motor units were 
present, but Loa/SODlG93A mice have the same number o f motor units as wild type 
and Loa/+ mice. Error bars=S.E.M. These experiments were performed by Dr. Dairin 
Kieran.
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Loa!SOD1G93a mice compared to their 120 day old SOD 1093A littermates (Fig. 
3.31A). In SOD1G93a mice only 242 (±9.6 S.E.M., n=8) motor neurons o f the 
examined segment o f the sciatic motor pool were counted, compared to 608 (±12.7 
S.E.M., n=8) in wild type mice. The Z,otf/SODlG93A segment o f the sciatic motor 
pool showed increased motor neuron numbers o f 560 (±15 S.E.M., n=8 , psO.OOl) in 
total (Fig. 3.3 IB). There was no loss o f motor neurons in Loa/+ at this stage.
3.3.6 Defects in retrograde axonal transport
Since the dynein mutation results in defects in retrograde axonal transport in 
motor neurons o f Loa/Loa embryos (Hafezparast et al., 2003), the present results 
suggest that the onset and progression o f disease in Z,oa/SODlG93A mice may be 
delayed by disruption o f retrograde axonal transport. To examine whether retrograde 
axonal transport was altered in motor neurons o f Loa/SODlG93A mice, primary motor 
neuron cultures from spinal cords o f E l3 littermate embryos o f all four genotypes 
were prepared and analysed using the in vitro retrograde transport assay based on 
TeNT Hc-Alexa (Bohnert and Schiavo, 2005; Hafezparast et al., 2003; Lalli and 
Schiavo, 2002; Lalli et al., 2003). We incubated motor neurons with TeNT Hc- 
Alexa488 and the transport o f the TeNT He carriers was monitored in real time using 
low-light microscopy as shown in the kymographs o f Figure 3.32 and in the 
corresponding Videos 3.7a-h. During the total observation time, S 0D 1G93A motor 
neurons displayed slower and fewer TeNT He carriers compared to wild type, Loa/+ 
and Z,otf/SODlG93A motor neurons (Table 3.2).
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Cross sections o f  spinal cord showing motor neurons in the sciatic motor pools 
(dotted areas, magnified in insets) from A) wild type, B) Loa/+, C) S0D 1G93A, and 
D) Lotf/SO D lG93A littermates at 120 d o f  age (n=8 ). M ice were fixed  using  
transcardial perfusion with 4% PFA, and serial 20 pm transverse sections o f the spi­
nal cord were stained with gallocyanin, a Nissl stain. Scale bar, 400 pm (main 
panels); 200 pm (insets). E) Mean motor neuron number at 120 d o f age. The number 
o f  Nissl-stained neurons in the sciatic motor pool o f  every third section (n=60) 
between the lumbar levels L2 and L5 o f  the spinal cord were counted. Error 
bars=S.E.M. These experiments were carried out by Dr. Dairin Kieran.
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Figure 3.32: Kymographs of TeNT Hc-Alexa488 transport
The panels show kymographs of TeNT Hc-Alexa488 carrier traces in motor neuron axons 
from wild type. Ix)ci/+, SODl(W3A and Aoa/SODl(i9M primary cultures. The width of 
kymographs corresponds to 65 pm of axon length and the height represents 200 stagged 
frames (t= 1.000 s) of the corresponding movies. The relative abundance of stationary and 
oscillating TeNT Hc carriers is not related to their genoty pe. See also Videos 3.7a-h. 
Horizontal scale bar. 20 pm; vertival scale bar. 20 s.
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Table 3.2: Kinetic parameters of TeNT He carriers in motor neurons
Embryos Single
Movements
Carriers Observation 
time [si
Frequency
[carriers/sl
wild type 3 1488 144 6720 0.0214
Loa/+ 3 1040 111 6594 0.0168
SOD 1093 A 4 1630 M l 8721 0.0146
Loa! SO D lG9jA 2 1163 144 5457 0.0264
Table 3.2 shows the number of wild type, Loa/+, S0D 1G93A, and Z,otf/SODlG93A El 3 
embryos used for the single-embryo motor neuron cultures, their corresponding 
TeNT He carriers, and single movements during the total observation. The carrier 
frequency is calculated as the ratio o f carriers over time.
In the representative kymographs, SO D lG93A-derived TeNT He carriers also 
show a higher frequency of pauses and anterograde phases. Surprisingly, the 
frequency o f TeNT Hc-carriers in Z,oa/SODlG93A motor neurons is even higher than 
the one found in wild type. This can easily be seen in the increased number o f  
diagonal trajectories in the Loa/SODlG93A kymograph compared to the kymographs 
of the other genotypes. The corresponding displacement graphs derived from wild 
type, Loa/+ , SOD 1093A and Z,o<2/SO D lG93A motor neurons further confirmed 
differences in the dynamics o f TeNT He carriers in S0D 1G93A and Loa/SO DlG93A 
(Fig. 3.33). The number o f carrier traces o f Z,ofl/SODlG93A over 1,000 s o f  
observation was considerably higher than those for the remaining three genotypes. 
The steepness o f the curves in the graphs on the right hand side o f Figure 3.33 is an 
indicator o f carrier speed, which was the highest for retrograde carriers in 
Z,ofl/SODlG93A motor neurons.
These differences were quantified by analyzing the speed distribution profiles 
shown in Figure 3.34, which were obtained from 144 carriers (1488 single 
movements) from three wild type embryos, 111 carriers (n=1040) from three Loa/+
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Figure 3.33: Kinetic analysis of retrograde axonal transport
Displacement graphs o f TeNT He carriers from the corresponding carrier tracks o f  
kymographs shown in Figure 3.32. Graphs were derived from movies o f 200 frames 
over a time period o f 1,000 s. Displacement o f 20 carriers with 202 single 
movements in wild type axons, 17 carriers with 206 single movements in Loa/+ 
axons, 26 carriers with 331 single movements in S0D 1G93A, and 50 carriers with 372 
single movements in Loo/SOD 1G93A are shown. For the panels on the right, the start 
of tracking for each carrier was set to time=0 .
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Figure 3.34: Speed distribution profile of TeNT Hc -Alexa488 carriers
Single movements, which are described by their displacement between two 
consecutive frames, have been plotted against their frequency. Retrograde transport 
is conventionally shown as positive, anterograde as negative and pauses during 
movement are grouped at 0 pm/s. Error bars=S.E.M. A) Speed profiles of axonal 
TeNT Hc -Alexa488 compartments from wild type and Loa/+ E l3 motor neurons are 
similar. B) The speed profile of TeNT Hc -Alexa488 carriers from SO Dl09^  motor 
neurons is shifted towards lower values and shows an increased rate o f carrier 
pauses. In /.oa/SO Dl0^  motor neurons deficits in TeNT Hc -Alexa488 carrier 
tranport are rescued. The frequency o f pauses is reduced and single movement speed 
increased on average.
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embryos, 127 carriers (n=1630) from four S0D 1G93A embryos, and 144 carriers 
(n=1163) from two Loa/SOD 1G93A embryos (see Table 3.2). The vast majority of 
movements o f TeNT He carriers are retrograde and are conventionally shown as 
positive x-axis values. Periods o f anterograde movement are displayed as negative x- 
axis values. Surprisingly, even at E l3, a relatively early stage o f embryonic 
development, kinetic analysis o f the axonal retrograde compartment revealed that 
motor neurons derived from S 0D 1G93A littermates already displayed an impairment 
of retrograde transport, emphasising the role that disruptions in axonal transport may 
play in ALS pathogenesis (Fig. 3.34B, black curve). In particular, S0D 1G93A carriers 
are characterised by an increased frequency o f pauses and oscillatory movements, as 
shown by an increased rate o f events in the speed range o f -0 .2/0.2  pm/s, and by a 
shift in their speed profile towards lower values (Fig. 3.35, S0D 1G93A, black line 
versus wild type, red line). Loa/+ motor neurons displayed a speed profile very 
similar to that seen in wild type mice (Fig. 3.34A, blue line versus red line; see also 
Fig. 3.35) suggesting that two copies o f a mutated dynein heavy chain are required to 
observe the dramatic alteration in retrograde transport previously detected in 
Loa/Loa homozygous mice (Hafezparast et al., 2003). Surprisingly, the deficit in 
carrier frequency and retrograde transport observed in S0D 1G93A motor neurons is 
completely rescued in Loa/SOD 1093A cells in which we observed a decrease in the 
frequency o f pauses and a shift in the speed profile towards higher values. (Fig. 
3.34B, Loo/SOD1G93a, green line versus S0D 1G93A, black line; see also Fig. 3.35). 
This recovery went beyond expectations; the frequency and speed o f the carriers 
exceeded on average those observed in wild type motor neurons (Fig. 3.35).
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Figure 3.35: Combined speed distribution profile of TeNT Hc -carriers
Speed profile of axonal TeNT Hc -compartments from wild type, Loa/+, S 0D 1G93A 
and Loa/SOD1G93a E13 embryos. The frequency and speed of Hc -Alexa488 carriers 
in Loa/SODlG93A motor neurons are on average higher than in wild type. Single 
movements of TeNT Hc -Alexa488 carriers, which are described by their progress 
between two consecutive frames, have been plotted against their frequency. 
Retrograde transport is conventionally shown as positive, anterograde as negative 
and pauses during movement are grouped at 0 pm/s. Error bars=S.E.M.
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3.4 Compartmented motor neuron cultures
Our observations on TeNT uptake and transport in cultured motor neurons 
suggest at least two different sites o f toxin internalisation, the axonal synapse and the 
somatodendritic compartment. TeNT transport in axons o f dissociated cultures was 
only detectable after 45 min o f toxin internalisation. However, TeNT accumulation 
in the soma could be seen at early stages o f internalisation. To investigate the 
different sites o f toxin uptake, we chose to use Campenot cultures, a technique to 
spacially separate the growth o f neuronal somas and processes in different 
compartments on a culture dish. We have obtained data confirming that primary 
motor neurons can be differentiated in this system. However, it proved difficult to 
optimise this technique for motor neurons and obtain reliable compartmented 
cultures with high frequency of barrier crossing. Therefore, we concluded that other, 
more reliable methods should be used to address questions regarding motor neuron 
physiology, such as axonal transport and neuronal regeneration.
3.4.1 Compartmented neuronal culture assembly
Compartmented neuronal cultures were developed by Prof. Robert B. 
Campenot (Campenot, 1977) to investigate the formation and maintenance o f  
neuronal projections. He showed that in sympathetic neurons the growth o f neurites 
depends upon nerve growth factor in their local environment. Since then, several 
groups successfully used this culture system, for example to study neuronal 
regeneration (Schwab and Thoenen, 1985) or the mechanism of retrograde GDNF- 
signalling in sympathetic neurons (Coulpier and Ibanez, 2004). So far the 
compartmented system has been used for sensory and superior cervical ganglia
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neurons, however, motor neurons have not been cultured successfully in this system 
(Taylor et al., 2005). As it was absolutely crucial for us to grow motor neuron somas 
and their processes separately, we approached Prof. Campenot to help us with the 
setup o f the cultures.
3.4.1.1 Culture o f superior cervical ganglia
In Prof. Campenot's lab the training was first focused on the dissection o f  
superior cervical ganglia and their compartmented culture on plastic culture dishes, 
because numerous attempts using motor neurons failed so far. The dissection and 
culture o f  the superior cervical ganglia were performed as described in materials and 
methods. A crucial step in this procedure is the assembly o f the Campenot chamber. 
Figure 2.2 describes step by step the construction o f this culture system. Using a 
pinrake, scratches were applied to the collagen coating on the culture dishes to direct 
the axonal growth into the side compartments. It was very important to wet the 
collagen at the scratched area before the Teflon chamber was applied. This resulted 
in a film o f medium, which allowed the processes to cross the silicone-grease barrier. 
To attract growth to the side compartments, a medium gradient was established, each 
that the side compartments contained five times more NGF than the middle 
compartments.
Two days after ~5,000 superior cervical ganglia were plated in the central 
compartment o f the Campenot chambers, axons started to appear under the silicone 
border and in the side compartments. The dendrites o f superior cervical ganglia are 
very short (only a few micrometers) compared to their axons, therefore, axons alone 
were able to cross the silicone barrier. After seven days the cultures were ready to be 
used for experiments. In Figure 3.36 the superior cervical ganglia on plastic dishes
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Figure 3.36: Superior Cervical Ganglia in Campenot chambers
Superior cervical ganglia (eight days in culture on plastic dishes) have been stained 
with FM1-43. The cultures were imaged with low-light microscopy. The letters in the 
figures correspond to the locations in the inset. The dashed lines indicate the silicone 
borders. A), B) Axons grow in a parallel fashion from the center compartment along 
the scratches into the side chamber. The axons tend to bundle. C) At the end o f the 
scratches, axonal growth loses directionality. D) The axons can only pass the silicone 
barrier as long as the substratum has been wetted before chamber assembly. At the 
end of scratches the collagen coating was dry at the time o f chamber assembly and 
neurites cannot cross the grease barrier. Scale bar, 100 pm.
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were incubated with FM1-43, a dye extensively used in synaptic vesicle recycling, 
for 3 h at 37°C and imaged using low-light microscopy (Betz and Bewick, 1992; 
Vanden Berghe and Klingauf, 2006). Under these experimental conditions FM1-43 
artificially stains the plasma membrane, thus improving the contrast o f the axons. 
The axons tended to bundle after they crossed the silicone barrier towards the side 
compartments.
It was absolutely necessary to scratch the collagen coating prior to chamber 
assembly because the scratches give the axons their growth direction. In Figure 
3.36C the axons lose their direction ability once they reach the end o f the scratches. 
The higher concentration o f growth factor in the side compartments only increases 
axon branching, but it does not affect the length o f axons (Prof. R. Campenot, 
personal communications).
3.4.1.2 Culture o f motor neurons in compartmented chambers on plastic dishes
Since the compartmented superior cervical ganglia culture was successful, we 
started to culture primary motor neurons from E14 rat embryos in Campenot 
chambers. The dissection was performed as described in Materials and Methods. We 
found that motor neurons did not survive in the supplemented L-15 medium for the 
superior cervical ganglia culture. We, therefore, replaced the horse serum in the 
complete medium with rat serum for the compartmented motor neuron culture and 
supplemented it with methylcellulose to a final concentration o f 0 .8%. 
Methylcellulose has been used to immobilize large neurons and it acts as a matrix for 
neuronal growth (Dagan and Levitan, 1981; Koike and Pfeiffer, 1979).
Motor neurons are much smaller than superior cervical ganglia neurons and the 
density o f plated neurons needed to be high so that the cells could form aggregates
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on the scratched area in the central compartment (as described later in Figure 3.39). 
If less than 6,000 motor neurons were plated, aggregates could not form and the 
processes did not cross the silicon barrier towards the side compartments. Therefore, 
motor neurons were plated at a density o f 10,000 per middle compartment. The 
earliest event in silicone barrier crossing was detected after 5 days in culture. After 8 
days, the motor neuron processes reached the same length as superior cervical 
ganglia axons. In Figure 3.37 the motor neuron processes have been cultured for the 
same amount o f time as the superior cervical ganglia in Figure 3.36. Even though the 
number o f motor neurons plated was double than that o f superior cervical ganglia, 
the number o f  processes crossing the barrier was much lower in this case. However, 
this represents proof o f principle that motor neurons are able to cross the silicone 
barrier and can be differentiated in compartmented chambers. This experiment has 
been repeated in our laboratory in London (Fig. 3.38) and the result was similar.
3.4.1.3 Compartmented motor neuron cultures on glass
We planned to use the Campenot system for live cell imaging and therefore we 
needed to switch from plastic to glass bottom culture dishes. This approach turned 
out to be more challenging than we expected.
For the experiments we used WillCo dishes with a glass bottom ( 0  30 mm), 
which were big enough to hold the Teflon dividers. We found that the optimal 
coating was collagen, however, a sequential polyomithin and laminin coating worked 
as well. Once the coating was completely dried, scratches were applied to the coating 
under a stereomicroscope using a pinrake. The metal pins did no damage to the glass; 
they only scraped the coating. Applying the medium drop to wet the coating at the 
scratched region was more difficult than on plastic because it easily ran out o f the
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Figure 3.37: Motor neurons in Campenot chambers
Motor neurons (eight days in culture on a plastic dish) have been stained with FM1- 
43. The cultures were imaged with low-light microscopy. The area o f imaging corre­
sponds to the boxed region o f the inset and shows a field where processes emerge 
from the Teflon divider in the side chamber. The growth o f processes from the middle 
compartment is directed by the scratches in the substratum towards the side compart­
ment. The number o f processes is very low compared to Figure 3.36. Scale bar, 100 
pm.
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Figure 3.38: Motor neurons in Campenot chambers on plastic dishes
We have been able to reproduce the results obtained Campenot’s laboratory. Motor 
neurons 10 days in culture are shown. Only few processes were able to cross the sili­
cone barrier. Scale bar, 100 pm.
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scratched area rendering the dish useless. The motor neurons were plated at higher 
density (20,000/dish) than on plastic dishes (10,000/dish). After two days in culture 
motor neurons start to aggregate (Fig. 3.39A). Huge bundles of processes originated 
from these cell aggregates and grow towards the side chambers, invading the silicon 
barriers indicated by arrows (Fig. 3.39C,D).
The first neurites o f motor neurons emerge into the side compartments after 
seven days, two days later than on plastic dishes. The cell clumps in the middle 
compartments changed even further over time (Fig, 3.40A). After nine days, cell 
clusters grow more or less parallel along the scratched coating and their processes 
bundle directly towards the side compartments. In the side chambers motor neuron 
processes grow on the collagen coating in a parallel fashion (Fig. 3.40B,C). Some 
bundles were able to split and managed to cross the 20  jim wide scratched, uncoated 
glass bottom (encircled areas). A part o f the neurites in the bundle remained on the 
collagen stretch and another part crossed to the neighbour collagen area. Normally, 
motor neurons do not grow on uncoated, unpolarised glass surfaces. Under the 
experimental conditions, motor neuron processes might have been attracted by 
neurites growing on neighbouring collagen stretches to form networks as shown in 
Figure 3.41. In the case o f superior cervical ganglia, we did not observe axons or 
axon bundles crossing scratches. Furthermore, superior cervical ganglia neurons 
mainly formed axon bundles and network formation was mainly visible at the end of  
scratches (Fig. 3.36C).
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Figure 3.39: Motor neurons in center compartment of Teflon dividers
A) 20,000 motor neurons have been plated in the middle chamber. Aggregates started 
to form after two days in culture. B) Motor neurons in culture for eight days. The cell 
aggregates in Figure 3.40A merged over time to form bigger cell accumulations. C), 
D) The insets show enlarged areas from Figure 3.39B. Originating from the cell 
clumps are huge bundles o f processes, which grow towards the side chambers, invad­
ing the silicon barriers as indicated by arrows. Scale bar, 200 jim.
Figure 3.40: Motor neurons in Campenot chambers on glass dishes
A) Motor neurons, nine days in culture. Cell clusters form along the scratched colla­
gen coating and their processes are directed towards the side compartments. B) In the 
side chambers motor neuron processes grow on the coating, forcing them into a 
mainly parallel growth pattern. C) Some bundles manage to cross the uncoated glass 
area (encircled areas), although at low frequency. Scale bars, 100 pm.
Figure 3.41: Motor neurons develop networks in Campenot chambers
After nine days in culture, motor neuron processes were bundled (A) but were also 
able to develop extended networks (B). Scale bar, 20 pm.
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3.4.2 Campenot chambers form sealed compartments
Before using the Campenot chambers for transport studies, it was necessary to 
prove that there was no medium leakage occurring between the different 
compartments. Therefore, motor neuron cultures with processes crossing the silicone 
barrier were incubated with a radioactive cell impermeable tracer 0.5-1 pC [32p]yATP 
in one o f their side compartments as shown in Figure 3.42. Following incubation at 
either 37°C or 4°C for 1 h, samples o f the culture media from the side and middle 
compartments were taken and compared. The radioactive counts o f the middle 
compartments and the untreated side compartment were the same as the background 
measurement, indicating that no medium exchange between the adjacent 
compartments occurs, even though processes crossed the grease barrier (Table 3.3).
3.4.3 Sites ofTeNT uptake
In vivo, axons are surrounded by a myelin sheet produced by Schwann cells 
and TeNT internalisation exclusively occurs at the neuromuscular junction and at the 
node o f Ranvier (Roux et al., 2005), where TeNT can access the motor neuron 
membrane. In contrast, differentiated motor neurons in culture can also internalise 
toxin at the axonal synapse and the somatodendritic compartment. TeNT axonal 
transport in motor neuron is generally only detectable 45 min after the initial TeNT 
application, but somatic TeNT accumulations are detectable earlier. The Campenot 
chamber represents an ideal model to address the different kinetics for TeNT uptake 
and transport at axons and somas.
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Figure 3.42: Medium exchange is not detectable in Campenot chambers
Campenot chambers with motor neuron processes crossing the silicone barrier into 
the side compartments have not shown medium leakage between different compart­
ments. 0.5-1 pC [32plyATP has been added to the side compartment labelled with ( 1) 
and the chamber was incubated at 4°C or at 37°C for 1 h. Then samples o f both side 
compartments (1 and 2) and the central compartment (3) were analysed for radioac­
tivity.
Table 3.3: Test for medium exchange in Campenot chambers using I32PlyATP
Sample
area
cpm (counts 
per minute)
background 26
© 4°C side plus 0.5-1 pC l32plA T P 76541.5
© 4°C side compartment 23
© 4°C middle compartment 20
© 4°C side plus 0.5-1 pC l32p|-*ATP 165076.9
© 4°C side compartment 15
© 4°C middle compartment 24.01
© 37°C side plus 0.5-1 pC [32ply\T P 216689.1
© 37°C side compartment 29.02
© 37°C middle compartment 20.01
The radioactive counts in the different compartments o f Campenot chambers follow­
ing a one hour incubation of 0.5-1 pC [32pfyATP is shown. During the experiment no 
medium leakage could be detected.
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Two Campenot chambers were incubated with 40 nM TeNT Hc-Alexa488 in the 
central compartment and 40 nM TeNT Hc-Alexa555 in one o f the side chambers so 
as to simultaneously observe and compare trafficking originating from both, soma 
and axons. The labelled toxins were present in the medium throughout the course o f  
live cell imaging. TeNT Hc-Alexa555 binds to motor neuron processes in the side 
compartment, where it is internalised and transported to the soma (Fig. 3.43). In the 
central compartment, only a few motor neuron soma show TeNT Hc-Alexa555 
accumulation. This might be due to the limited number o f processes crossing the 
silicone barrier. The real time imaging o f transported toxin carriers was not 
conclusive because the membrane staining o f the processes was very high and nearly 
all the processes were bundled, preventing the visualisation of individual carriers.
The vast majority o f motor neuron soma (87% o f the total) in the central 
compartment o f the Campenot chambers bind TeNT Hc-Alexa488. Surprisingly, 
nearly all soma positive for TeNT Hc-Alexa555 (12% of the total), which was 
applied to the side chamber, are negative for TeNT Hc-Alexa488. Only very few 
motor neuron cell bodies (1% o f the total) are double positive for TeNT Hc- 
Alexa555 and TeNT Hc-Alexa488. Cell bodies not labelled with TeNT were 
excluded from the analysis; these are most likely not motor neurons. We also noticed 
that the shape o f the motor neuron soma in the central chamber is very different from 
that in dissociated cultures as described earlier (see Fig. 3.6). Soma appear round and 
their processes were difficult to detect. This might be a result of their very high 
plating density compared to the neurons previously used for transport studies.
We tried to improve the quality o f the motor neurons in the compartmented 
cultures using different growth factors, including NGF and BDNF, altering their
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Figure 3.43: Transport o f TeNT Hc  
in compartmented cultures
Motor neurons in compartmented cham­
bers have been incubated with 40 nM 
TeNT Hc -Alexa555 (red) in one o f their 
side chambers and with 40 nM TeNT 
Hc -A lexa488 (green) in the central 
compartment. A) Motor neuron pro­
cesses are highly stained with TeNT 
Hc -A lexa555 , TeNT H p-A lexa488  
could not be detected. B), C) Motor 
neuron soma in the central chamber are 
positive for TeNT Hc -Alexa488. One 
soma is labelled with red TeNT Hc but 
not with green TeNT Hr . Scale bars, 5 
pm.
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concentrations and finally using conditioned medium, taken from 5 day old motor 
neuron cultures. However, these manipulations did not improve the yield o f neurite 
crossing (see Table 3.4).
Table 3.4: Medium combinations for motor neurons in Campenot chambers
Centre compartment Side compartment
CNTF
[ng/ml]
GDNF
[pg/ml]
NGF
[ng/ml]
BDNF
[ng/ml]
Cond.
med.
CNTF
[ng/ml]
GDNF
[pg/ml]
NGF
[ng/ml]
BDNF
[ng/ml]
Cond.
med.
1 0 1 0 0 - - - 1 0 1 0 0 - - -
1 0 1 0 0 - - Yes 1 0 1 0 0 - - Yes
1 0 1 0 0 1 0 0 - - 1 0 1 0 0 1 0 0 - -
1 0 1 0 0 1 0 0 - Yes 1 0 1 0 0 1 0 0 - Yes
1 0 1 0 0 - - - 1 0 1 0 0 - 1 -
1 0 1 0 0 - - - 50 500 - - -
1 0 1 0 0 - - Yes 50 500 - - Yes
1 0 1 0 0 1 0 0 - - 50 500 500 - -
1 0 1 0 0 1 0 0 - Yes 50 500 500 - Yes
1 0 1 0 0 - 1 - 50 500 - 1 0 -
1 0 1 0 0 - - - 1 0 0 1 , 0 0 0 - - -
Table 3.4 shows the different medium combinations for motor neuron culture in 
Campenot chambers for the middle and side compartments. The quality o f neurite 
outgrowth in all conditions was similar. Cond. med.= conditioned medium taken 
from 5 day old motor neuron cultures.
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4 Discussion
In this thesis, the axonal transport dynamics o f tetanus toxin in motor neurons 
were characterised. The pH o f axonal retrograde TeNT carriers is neutral, whereas 
stationary TeNT compartments display a wide range o f pHs. This differential pH 
distribution is most likely due to the lack o f a vATPase on the carrier membranes. In 
mice mimicking human ALS, transport defects o f axonal TeNT have been observed. 
Surprisingly, crossing these mice with mice, which have a transport defect due to a 
mutation in dynein, leads to a complete recovery o f axonal transport in motor 
neurons.
4.1 TeNT is transported in a neutral compartment along 
axons
4.1.1 GST-pHluorin is a faithful pH  reporter
Recently, chimeras o f pHluorin were used as pH probes in a variety o f  
biological systems. In neurons, pHluorin-based sensors were exploited to follow the 
presynaptic activity within neuronal networks (Yuste et al., 2000), to report synaptic 
vesicle fusion (Bozza et al., 2004), to assess the molecular identity o f  different 
synaptic compartments during synaptic vesicle recycling (Mitchell and Ryan, 2004) 
and to measure synaptic vesicle acidification at hippocampal nerve terminals (Atluri 
and Ryan, 2006). Furthermore, in a transgenic mouse expressing synaptopHluorin, 
which is a fusion protein o f VAMP2 and a pHluorin, synaptic vesicle recycling was 
studied (Li et al., 2005a). The excitation spectrum o f wild type GFP shows two peaks
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at 395 and 475 nm resulting from the protonated and deprotonated states o f the 
chromphore Y6 6 , which are essentially unaltered between pH 5.5 and 10. To create a 
pH sensor, GFP underwent several rounds o f  mutagenesis (Miesenbock et al., 1998). 
One class o f  pH-sensitive proteins was named Tatiometric pHluorin'. After 
expression in pGEX-2T and thrombin cleavage o f GST, ratiometric pHluorin was 
diluted in pH buffers, and the recorded spectrum showed a reversible excitation ratio 
change between pH 5.5 and 7.5 (Miesenbock et al., 1998) (Fig. 4.1). Subsequent to 
receiving the clone pGEX-2T-AF058694 encoding ratiometric pHluorin, the 
bacterially expressed protein was tested for its spectral properties. It was diluted in 
buffers ranging from pH 5.0 to 8.0 with the same chemical composition as used by 
Miesenbock. However, under our experimental conditions, the in vitro and ex vivo 
(data not shown) fluorescence spectrum o f ratiometric pHluorin did not correlate to 
the published data (Miesenbock et al., 1998) (compare Figs. 3.4 and 4.1). The ratios 
R(405/488) between 0.9 and 1.3 associated with more than one pH value between pH 
5.0 and 6.25. However, the optical properties o f GST-tagged pHluorin were similar 
to the originally reported fluorescence excitation spectrum o f ratiometric pHluorin 
(Miesenbock et al., 1998) (see Fig. 3.2). The in vitro calibration curve o f  GST- 
pHluorin revealed a unique ratio R(405/488) for each pH.
Why untagged pHluorin did not display similar spectral features to GST- 
pHluorin is not known. One possibility is that pHluorin is unstable under our 
experimental conditions and needs the 26 kDa GST tag for protein folding into the 
correct conformation. This would be in agreement with the findings o f Sacchetti and 
Alberti who reported that fusion o f GFP to various tags is able to enhance the folding 
o f GFP in eukaryotic systems (Sacchetti and Alberti, 1999). However, in their case
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folding ability was only increased when a streptavidin-binding peptide was added to 
wild type GFP and used as a carboxy-terminal tag for recombinant proteins. 
Randomly chosen carboxy-terminal tags did not improve GFP folding and amino 
terminal-tags decreased GFP folding efficiency (Sacchetti and Alberti, 1999). The 
GST-tag o f our fusion protein is located at the amino-terminus o f pHluorin and GST- 
pHluorin should therefore have a reduced folding ability. Other groups have 
demonstrated that protein folding is affected by temperature, the surrounding 
medium and the surface potential generated by hydrophobic and polar amino acids 
(Li et al., 2005b; Pace et al., 2004). However, the ratio o f hydrophobic and polar 
amino acids o f pHluorin and GST-pHluorin is similar, and all spectral protein 
measurements were performed under the same conditions (both at room temperature 
and in identical medium). Therefore, we were unable to draw any conclusions about 
the reasons for the dissimilar spectral behaviour o f ratiometric pHluorin isolated in 
two different laboratories.
The functionality o f GST-pHluorin as a pH probe was then tested in a cellular 
system. Since motor neurons are post-mitotic and non-migrating cells with only 
limited activity in fluid-phase uptake (macropinocytosis), the luminal pH o f late 
endosomes and lysosomes was monitored using macropinocytosis. High 
concentrations o f ratiometric GST-pHluorin were necessary in order to achieve a 
sufficient level o f macropinocytosis and to visualise the endosomes. This uptake is 
an efficient way o f a non-selective probe internalisation via phagocytosis (Swanson 
and Watts, 1995). Following GST-pHluorin incubation, immediate ratiometric 
imaging of motor neurons revealed a broad pH spectrum from neutral (pH 8.0) to 
acidic (pH 5.0). These values reflect the pH heterogeneity o f different organelles in
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the endocytic pathway. They are in agreement with a previous electron microscopy 
study, where gold-labelled BSA was localised to endosomes (pH 5.0-6.0) after 15 
min internalisation into NRK (normal rat kidney epithelial) cells and to dense core 
lysosomes (pH <5.0) after 30 min (Bright et al., 1997). In this regard, we allowed a 
chase o f 30 min in some samples to accumulate GST-pHluorin in late endosomes 
and lysosomes. Our data exposed mainly acidic GST-pHluorin structures after the 
chase, reflecting the probe's accumulation in late endosomes and lysosomes. Taken 
together, these results confirm that GST-pHluorin works as a faithful pH probe in 
motor neurons.
4.1.2 pHluorin-TeNT is internalised and directed to the retrograde 
axonal transport route
Previous work demonstrated that TeNT He is able to undergo axonal 
retrograde transport in vivo (Bizzini et al., 1977; Coen et al., 1997). These studies 
were mainly based on the accumulation o f TeNT He at the site o f nerve ligation after 
its intramuscular injection, followed by immunohistochemistry or autoradiography. 
In dissociated living motor neurons, retrograde transport o f TeNT He was visualised 
by labelling TeNT He fragments with fluorescent markers (Lalli and Schiavo, 2002). 
The in vivo injection o f a fusion protein between TeNT He and GFP revealed a rapid 
clustering o f GFP-TeNT He in nerve terminals at the neuromuscular junction and 
accumulation in various axonal compartments during retrograde trafficking (Roux et 
al., 2005).
Since acidic pH is crucial for the translocation o f the TeNT catalytic chain into 
the cytosol o f adjacent inhibitory intemeurons in vivo and hippocampal neurons in
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vitro after its passage through a motor neuron, a fusion protein o f ratiometric 
pHluorin and TeNT He was chosen as a non-invasive method to investigate the pH 
o f the fast axonal retrograde compartment in motor neurons. By inserting the 
ratiometric pHluorin in the pGEX-4T-3-VSV-G-Kin-Hc expression vector, we 
successfully expressed pHluorin-TeNT He as a soluble GST fusion protein.
First we tested if  the fusion protein pHluorin-TeNT He retained the 
characteristic ability o f TeNT He to specifically bind to motor neurons. So far 
several studies have shown that TeNT binds to gangliosides and a 15 kDa protein 
receptor (pl5) (Halpem and Neale, 1995; Herreros et al., 2000b; Schiavo et al., 
2000). At 4°C, a temperature that prevents endo- and exocytosis, the pre-incubation 
of motor neurons with unlabelled TeNT He resulted in the block o f pHluorin-TeNT 
He binding. The binding pattern o f  pHluorin-TeNT He to rat motor neurons was 
similar to the one observed for TeNT and TeNT He in mouse spinal cord cells (Lalli 
et al., 1999). This implies that pHluorin-TeNT He specifically binds to motor 
neurons in culture, and it is plausible that pHluorin-TeNT He binds to gangliosides 
and p i5, as was shown for TeNT He.
After TeNT binding and internalisation, the toxin is directed towards the 
retrograde transport pathway. The onset o f axonal transport o f TeNT He occurs 45 
min after incubation o f motor neurons in culture with the toxin (Lalli and Schiavo,
2002). The same internalisation kinetics were observed with pHluorin-TeNT He. The 
slow progression o f TeNT towards its transport compartment is consistent with the 
internalisation kinetics o f p75NTR complexes, which is also a slow process occurring 
within 42-50 min (Bronfman et al., 2003). A similar time-delay (45-60 min) was 
observed for the onset o f transport o f exogenously applied p75NTR antibody
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(Deinhardt, 2005). Therefore, TeNT most likely uses a similar route for uptake as 
p75NTR, which would be in agreement with the finding that TeNT carriers are 
partially shared by NGF and its low affinity receptor p75NTR (Lalli and Schiavo, 
2002).
4.1.3 Morphology and transport characteristics o f TeNT carriers
The speed ranges previously found for TeNT and TeNT He in vivo (0.8-3.6 
pm/s) and in vitro (0.2-3 .6  pm/s) are very similar to the velocity o f pHluorin-TeNT 
He carriers (0.2-3.4 pm/s), suggesting that this novel probe enters the same organelle 
used by TeNT for retrograde transport (Lalli et al., 2003; Lalli and Schiavo, 2002; 
Stockel et al., 1975). Additionally, the experimental data correlate well to the in vivo 
transport values for fast axonal transport (1-5 pm/s) (Goldstein and Yang, 2000).
TeNT He is transported in round vesicles and tubular structures along axons in 
dissociated motor neuron cultures (Lalli and Schiavo, 2002). Round transport 
vesicles were observed in dorsal root ganglia (Nakata et al., 1998), whereas long 
tubules were shown to mediate the transport o f newly synthesised proteins in 
hippocampal neurons (Kaether et al., 2000). Tubular membranous structures that 
move fast along microtubules were shown to mediate Simian Virus 40 delivery 
towards the smooth ER in CV-1 cells (Pelkmans et al., 2001). The transport studies 
on pHluorin-TeNT He carriers confirmed the existence o f vesicular and tubular 
transport organelles but also revealed a novel carrier type with a pearl chain-like 
morphology, termed 'trains'. The fastest pHluorin-TeNT He carriers are tubules, 
followed by vesicles and then trains. The average speed observed for the overall 
continuously moving tubules was 1.18 pm/s. Round vesicles instead display a rather 
discontinuous movement, which includes pauses and short periods o f anterograde
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movement, with an average speed o f 0.83 pm/s. Trains are the rarest and slowest 
group o f retrograde pHluorin-TeNT He carriers. They also display a discontinuous 
movement with an average velocity o f  0.59 pm/s. The unusual morphology o f trains 
might represent round vesicles travelling with similar speeds using the same 
transport machinery or a tubule in the process o f budding. This new carrier type was 
only observed during live-cell imaging; fixed cell samples for electron and confocal 
microscopy did not reveal pearl-chain like TeNT organelles (Lalli et al., 2003; Dr. K. 
Deinhardt, personal communications). This might be due to poor preservation o f  
those structures upon sample fixation.
So far, the molecular determinant(s) for the different pHluorin-TeNT He 
carrier speeds remain unknown. The diverse velocities for each carrier type might 
originate partly from their different shapes. A further reason for the speed differences 
could be that distinct molecular motors and motor densities reside on the organelle 
surface o f each TeNT carrier type. TeNT carriers are likely to use more than one 
motor protein for their transport. Myosin Va, kinesin (Lalli et al., 2003) and 
cytoplasmic dynein (Hafezparast et al., 2003) and scaffolding proteins are 
particularly important for TeNT transport (Deinhardt, 2005). Furthermore, the 
overexpression o f p50/dynamitin, which leads to a disruption o f the dynein-dynactin 
complex and therefore dynein-dependent transport (Echeverri et al., 1996), 
significantly reduced axonal TeNT transport speeds and the number o f fast single 
movements (Deinhardt, 2005). A similar shift towards lower TeNT transport values 
was observed in mice with a mutated dynein heavy chain (Hafezparast et al., 2003). 
Cytoplasmic dynein was also implicated in the long-range transport o f mitochondria 
along microtubules (Hollenbeck and Saxton, 2005). According to dynein being
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involved in fast axonal transport and long-range transport, tubular carriers might 
principally use the dynein motor for their progression. The lower transport speeds 
and the overall discontinuous movement o f vesicles and trains might be generated 
mainly by myosins, which are responsible for short-range movement in mitochondria 
(Hollenbeck and Saxton, 2005). So far myosin V has not been associated with 
mitochondria in neurons. However, Hollenbeck and Saxton suggested myosin V as a 
likely candidate for axonal mitochondria movement along actin filaments since in 
vitro movement o f myosin showed similar rates o f transport (Hollenbeck and Saxton, 
2005). In hippocampal neurons, the movement o f mitochondria was measured to be 
0.43-0.60 pm/s (Jimenez-Mateos et al., 2006) and the velocity o f mouse myosin V 
was calculated as 0.54 pm/s by relating its step size (0.036 pm) to the ADP release 
rate (15 s'1) (0.036 pm x 15 s 1=0.54 pm/s) (Toth et al., 2005). The calculated 
myosin V velocity (0.54 pm/s) and the average speed o f trains (0.59 pm/s) are 
similar and this would support a transport relationship between myosin V and trains. 
Myosin Va is also thought to securely drag its cargo through the ‘jungle’ o f cortical 
actin filaments using its long lever arm to swing from actin filament to actin filament 
(Schliwa and Woehlke, 2003). This swaying between actin branches might account 
for the rather discontinuous movement o f vesicles and trains. However, more work 
has to be done to understand the movement patterns o f the TeNT carrier types.
4.1.4 TeNT carriers have a neutral pH during transport
Following retrograde transport in motor neuron axons, TeNT is taken up by 
adjacent inhibitory neurons where an acidic pH triggers a conformational change o f  
TeNT, which allows its membrane insertion and the translocation of the L-chain into 
the cytosol, where it cleaves VAMP2 (Humeau et al., 2000). This phenomenon
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occurs in hippocampal neurons in vitro (Matteoli et al., 1996), and in spinal cord 
inhibitory intemeurons in vivo (Habermann and Dreyer, 1986; Schiavo et al., 2000). 
In artificial liposomes, the pH initiating the membrane insertion o f TeNT is about 5.0 
(Schiavo et al., 1990b), which is within the pH range o f the endosomal pathway. In 
this regard, TeNT must reach the intemeurons without displaying its catalytic 
function during the passage through motor neurons. Previous work showed that 
TeNT Hc-labelled organelles do not colocalise with organelles containing an acidic 
pH (Lalli and Schiavo, 2002). Double-colour time-lapse microscopy was performed 
in living motor neurons using TeNT Hc-Alexa488 and the acidotrophic membrane- 
permeable dye Lysotracker that stains acidic organelles and lysosomes. A striking 
lack of colocalisation between TeNT Hc-labelled endosomes and Lysotracker- 
stained organelles, which oscillated or moved along axons mainly in a retrograde 
fashion, was observed (Lalli and Schiavo, 2002). However, these findings did not 
allow any conclusions about the pH dynamics o f the retrograde TeNT transport 
compartment or its regulation in the axon and soma.
Since the in vivo calibration curve o f pHluorin-TeNT He in motor neurons 
produced a linear relationship between the ratio R(405/488) and pH, and according 
to previous studies, pHluorin-TeNT He was transported normally, the novel fusion 
protein pHluorin-TeNT He was used as a faithful pH reporter in motor neurons. 
Ratiometric imaging of endocytic carriers positive for pHluorin-TeNT He revealed 
their neutral pH, which was kept constant during axonal movement. These findings 
are in contrast with the pH dynamics described for classical endosomal pathways, 
which undergo a rapid acidification upon internalisation (Weisz, 2003). The entry o f  
TeNT in a neutral endocytic compartment has important mechanistic effects on the
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pathogenesis o f tetanus. By demonstrating that the fast axonal retrograde 
compartment in motor neurons displays a neutral pH, we provide an explanation for 
the entrapment o f TeNT in the lumen o f the retrograde carrier during axonal 
transport to the soma, a journey shared with neurotrophins and their receptors (Lalli 
and Schiavo, 2002). The lack o f acidification of the fast retrograde transport carriers 
might contribute to the low degradation capability o f this compartment, which 
ensures the integrity o f its endogenous and exogenous cargoes. This is in agreement 
with the long half-life of internalised TeNT in vivo (s  5 days in mouse sciatic nerve) 
(Habermann and Dreyer, 1986).
Several pathogens and virulence factors were shown to either transit or 
accumulate in non-acidic cellular compartments. This is the case for Shiga-like and 
Cholera toxin B subunits, which were extensively used as probes to uncover Golgi- 
dependent and independent pathways from the plasma membrane to the ER (Lencer 
et al., 1995; Schapiro et al., 1998). Chlamydia pneumoniae, an intracellular parasite, 
inhabits a non-acidic vacuole, which is distinct from late endosomes and lysosomes 
(Al-Younes et al., 1999). Also Chlamydia trachomatis replicates within an organelle 
o f neutral pH, which is detached from the endocytic pathway (Heinzen et al., 1996). 
Furthermore, after leaving the plasma membrane, Echovirus 1 and Simian Virus 40 
enter a non-acidic compartment, which lacks markers for endosomes, lysosomes, ER 
or Golgi (Pelkmans et al., 2004; Pelkmans et al., 2001; Pietiainen et al., 2004). Also 
the p75NTR complex accumulates after internalisation in vesicles that did not undergo 
acidification (Bronfman et al., 2003). We suggest that TeNT is using a similar route 
of internalisation to escape organelle acidification.
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4,1.5 Stationary TeNT compartments exhibit a wide range o f pH  
values
In contrast to the retrograde transport carriers, stationary TeNT Hc-positive 
compartments, which are located in the soma and neurites, have a much broader pH 
range, spanning from pH 5.0 to pH 7.5. This observation is in agreement with the 
reported trimodal frequency distribution o f the endocytic organelle pH in axon shafts 
o f sympathetic neurons (Overly and Hollenbeck, 1996). For the acidification o f the 
endocytic pathway, neutral pH values corresponded to endosomes, which have been 
internalised but not yet acidified, pH values o f 5.0-6.0 corresponded to early and late 
endosomes, a pH <5.0 to lysosomes (Mellman et al., 1986). These findings suggest 
that the machinery determining the intralumenal pH o f the axonal compartments is 
strictly regulated and that at least two main acidification steps occur.
During the pH measurements o f TeNT organelles in motor neurons, a single 
event o f stationary organelle acidification was monitored. The acidification process 
was rapid and complete after 20 s. This finding supports the existence o f a single 
acidification step for stationary TeNT He component. However, we were not able to 
distinguish if  this rapid acidification was due to a fusion event o f a pHluorin-TeNT 
He positive structure with a lysosome or if  this acidification was a result o f proton 
accumulation in the organelle via proton pumps. Because the axons o f cultured 
motor neurons lack a surrounding myelin sheet, the toxin is internalised not only at 
synapses but also at somatodendritic sites. The stationary acidic TeNT organelles 
might therefore be the consequence o f this different internalisation mechanism, 
which may follow the classical endocytic pathway.
221
Chapter 4.2: Discussion - Differential targeting o f  vATPase to TeNT organelles
Acidification o f TeNT in inhibitory intemeurons is necessary for its ability to 
cleave VAMP2 in vivo but is there any physiological relevance for acidic stationary 
TeNT compartments in motor neurons? To date there are no in vivo data available on 
stationary acidic TeNT compartments in motor neurons and we have to keep in mind 
that these observations might be an artefact o f the experimental conditions. However, 
it could be argued that the accumulation o f TeNT in acidic compartments in rat 
motor neurons will hinder TeNT from its long-range transport and block its final 
delivery to intemeurons, delaying VAMP2 cleavage.
4.2 Differential targeting of vATPase to TeNT organelles
Moving TeNT carriers display a neutral pH, which is in contrast to stationary 
TeNT organelles that exhibit a wide range o f pH values. But what is the mechanistic 
basis o f this differential pH regulation o f moving and stationary TeNT organelles? A 
likely possibility is that this pH control is due to the sorting o f the proton pump 
vATPase, which is responsible for organelle acidification, away from the transported 
TeNT compartment. Alternatively, pH might be controlled by the reversible 
disassembly o f the vATPase (Kane, 1995), which could be triggered by the presence 
of TeNT, or by dissipation o f the pH gradient via proton permeability. Acidification 
is essential for diverse cellular processes, such as protein targeting along the 
secretory pathway, recycling o f receptors to the plasma membrane, and protein 
degradation in the endomembrane lumen (Nelson and Harvey, 1999; Stevens and 
Forgac, 1997), and inhibition o f the vATPase activity perturbs some o f these 
functions (Schoonderwoert et al., 2000; van Weert et al., 1995).
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4.2.1 TeNT carriers lack a functional vATPase
vATPases are responsible for the synaptic vesicle reloading with 
neurotransmitters (Nelson, 1991) and the regulation o f synaptic vesicle docking to 
pre-synaptic membranes (Morel, 2003). Furthermore, the vATPase was located to 
nerve terminals and to the raft fraction o f synaptic plasma membrane and synaptic 
vesicles in rat brain (Morel et al., 2003; Yoshinaka et al., 2004). Lipid rafts were also 
identified as interaction sites for TeNT binding and internalisation into neurons 
(Herreros et al., 2001). Therefore, it was plausible to test for the presence o f the 
vATPase on internalised TeNT-positive organelles. Several antibodies against 
different subunits o f the vATPase peripheral and trans-membrane domains were 
used. In order to test if  the vATPase antibodies were functional in 
immunofluorescence experiments, we partially localised the vATPase to acidic 
granules and to the synaptic vesicle protein VAMP1, the mRNA o f which was found 
primarily in rat spinal cord (Rossetto et al., 1996). After 45 min incubation, when 
TeNT He was supposed to have reached the axonal transport route, our experiments 
revealed very little colocalisation between TeNT He and organelles positive for the 
different vATPase subunits. Furthermore, TeNT and vATPase positive organelles 
were morphologically very diverse. Therefore, the lack of acidification is either 
caused by the absence o f the vATPase from the retrograde TeNT carriers or a 
disassembled vATPase (Kane, 1995) that cannot be recognised by the antibodies 
because o f an epitope masking event, a conformational change or the absence o f a 
subunit.
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4.2.2 A functional vATPase is not required for TeNT transport
In contrast to moving TeNT organelles, the vATPase is likely to be present on 
stationary organelles, which can be acidified. Furthermore, an inducible, organelle- 
specific vATPase sorting was previously demonstrated for phagosomes containing 
Mycobacterium avium, which fail to acidify due to the exclusion o f vATPase from 
their delimiting membranes (Sturgill-Koszycki et al., 1994). To test for the presence 
of a sorting organelle where TeNT and vATPase are directed towards different 
compartments, we specifically inhibited the catalytic function of the vATPase. The 
antibiotics Bafilomycin A l and Concanamycin A bind with high affinity to the 
subunit c o f the vATPase, blocking proton pumping (Mattsson and Keeling, 1996) 
(Bowman et al., 2004). Both inhibitors were used at concentrations which abolished 
the accumulation o f the acidotrophic dye Lysotracker, which confirmed the arrest o f  
acidification o f endocytic organelles. The notion that vATPase activity is dispensable 
for fast retrograde TeNT transport in motor neurons was confirmed by the 
ineffectiveness o f vATPase inhibitors applied after the observed axonal TeNT 
transport. The shift towards lower transport speeds at later time points o f the 
measurement could be attributed to phototoxicity since untreated cells showed a 
similar transport behaviour after repetitive exposure to UV light. The finding that a 
functional vATPase is not necessary for TeNT transport is in agreement with 
previous results that some endocytic events, such as receptor internalisation and the 
formation and maturation o f multivesiclular endosomes, are not affected by the 
inhibition o f the vATPase (van Deurs et al., 1996). However, onward trafficking 
from endosomes to lysosomes and receptor extemalisation are absolutely dependent 
on functional vATPases (Johnson et al., 1993; Tawfeek and Abou-Samra, 2004). It
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was therefore necessary to investigate if  TeNT has similar features, being 
independent from the vATPase for internalisation but dependent on it for other 
trafficking processes.
4.2.3 The vATPase is involved in a sorting step directing TeNT 
towards retrograde axonal transport
Synaptic vesicle retrieval is responsible for the vast number o f endocytic 
procedures at presynaptic terminals (Murthy and De Camilli, 2003). Some studies 
have shown that nerve stimulation assists TeNT intoxication (Habermann et al., 
1980; Schmitt et al., 1981). Additionally, TeNT uptake was reported to be dependent 
on presynaptic activity in motor neurons in vivo (Miana-Mena et al., 2002) and small 
synaptic vesicle endocytosis in vitro (Matteoli et al., 1996). Furthermore, Matteoli et 
al. showed that TeNT internalisation via small synaptic vesicles into rat hippocampal 
neurons is independent o f a functional vATPase. However, TeNT was unable to 
translocate into the cytosol to cleave VAMP2 in Bafilomycin A l treated 
hippocampal neurons. They concluded that the acidification o f neuronal vesicles is 
indeed necessary for the membrane translocation o f the catalytic L-chain into the 
cytosol (Matteoli et al., 1996). However, it was described that in mouse phrenic 
nerve-diaphragms, neurotransmitter release was not essential for TeNT binding to 
the presynaptic membrane (Schmitt et al., 1981). Also BoNT/A intoxication o f the 
leg o f a mouse did not inhibit TeNT transport from the site o f intoxication to the 
spinal cord, which lead to the conclusion that neuronal uptake or transport o f TeNT 
to the spinal cord in vivo is independent o f intact nerve endings (Habermann and 
Erdmann, 1978). This is in agreement with the observation that retrograde transport
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of HRP is not impaired in silenced neuromuscular junctions (Kemplay and 
Cavanagh, 1983; Kristensson and Olsson, 1978). In motor neurons, it was shown that 
TeNT entry is independent o f synaptic vesicle recycling because only a limited 
overlap between VAMP2 and TeNT positive structures was detected, which was not 
enhanced upon stimulation o f synaptic vesicle recycling (Deinhardt, 2005). 
Additionally, pre-treatment o f motor neuron cultures with BoNT/A and /D did not 
impair TeNT endocytosis (Deinhardt, 2005). In conclusion, these findings suggest 
that TeNT uptake is independent o f synaptic vesicle endo- or exocytosis.
To test if  TeNT internalisation into rat motor neurons is also independent from 
a functional vATPase, as it was shown for rat hippocampal neurons (Matteoli et al., 
1996), cells were pre-treated with Concanamycin A or Bafilomycin A l to block 
proton pumping of the vATPase before TeNT was applied. Under these conditions, 
axonal TeNT transport was not observed. However, this observation did not allow us 
to draw any conclusions about the contribution o f the vATPase to the TeNT 
pathway. Since we were not able to distinguish between block o f TeNT 
internalisation and TeNT onward trafficking by an inhibited vATPase, this point was 
further addressed by performing two independent endocytosis assays. We either used 
a sequential staining o f VSV-G tagged TeNT in the absence and presence o f motor 
neuron permeabilisation, or biotinylated TeNT He. Both experiments revealed that 
the entry o f TeNT into motor neurons is not altered by inhibition o f the vATPase. 
Therefore, we tested for the involvement o f the vATPase in a sorting step allowing 
the entry o f TeNT into the retrograde transport carriers. To monitor the fate o f a 
stationary sorting endosome, motor neurons were incubated with TeNT Hc-Alexa488 
for 2 min to capture only the first step o f toxin endocytosis, fixed and then probed for
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the vATPase. At this time point a partial overlap between the internalised TeNT and 
vATPase was demonstrated (Fig. 3.26), supporting the idea o f an early stationary 
organelle containing the vATPase. Taken together, a functional vATPase is 
necessary for TeNT sorting towards the retrograde transport route but is dispensable 
for TeNT internalisation and transport. Our results are in agreement with Matteoli's 
on TeNT uptake in rat hippocampal neurons being independent from a functional 
vATPase (Matteoli et al., 1996). TeNT internalisation into motor neurons is also not 
compromised by a non-functional vATPase and TeNT is entrapped in endocytic 
organelles, which does not allow sorting to retrograde carriers.
Ultrastructural studies have shown that TeNT localises to coated pits in 
primary spinal cord cultures (Lalli et al., 2003; Parton et al., 1987) and was found in 
clathrin-coated vesicles in spinal cord neurons (Parton et al., 1987). Electron 
microscopy studies revealed that TeNT is internalised via a clathrin-dependent 
pathway in isolated motor neurons (Deinhardt, 2005). Furthermore, the vATPase was 
located on clathrin-coated vesicles (Stevens and Forgac, 1997). Clathrin coated 
vesicles and other early endocytic organelles, which may coincide with stationary 
TeNT He structures positive for the vATPase, might act as initial sorting stations 
where axonal carriers are formed and their contents are sorted for transport. In fact, 
mild acidic pHs might play a role in early steps of the endocytic pathway o f TeNT by 
inducing a partial conformational change, which, although not sufficient to trigger 
the insertion of the molecule in the inner core o f the lipid bilayer, might promote an 
enhanced interaction with the membrane surface and facilitate the initial sorting o f  
TeNT He. This new regulatory role o f the vATPase in TeNT sorting adds another 
task to the multiple functions of this protein complex.
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In conclusion, a functional vATPase is transiently required for the initial sorting of 
TeNT He to its retrograde transport route and it is then sorted away from the axonal 
carriers at later stages (Fig. 4.2). As a consequence, these retrograde organelles 
maintain a neutral luminal pH, which might protect the native conformation o f acid- 
labile cargo and stabilise receptor-ligand interactions. In particular, these conditions 
might allow the sustained interaction o f some neurotrophins such as nerve growth 
factor and its receptors, which have been found to enter TeNT He carriers (Lalli and 
Schiavo, 2002), providing further evidence for the long-range axonal neurotrophin 
signalling (Howe and Mobley, 2004). Future experiments will directly address the 
molecular composition o f these retrograde carriers and the activation status o f 
neurotrophin-receptor cargo complexes during transport.
4.3 Sites of TeNT uptake into motor neurons
The work on TeNT uptake and transport implies different mechanisms o f toxin 
uptake because axonal TeNT transport is only visible 45 min after the initial toxin 
application, but motor neuron soma show TeNT accumulation at very early 
incubation time points. To investigate if  there are indeed different uptake 
machineries for TeNT, it was necessary to spacially separate motor neuron somas 
from their processes. The Campenot chamber system allowed us to culture motor 
neuron soma apart from their processes, facilitating TeNT application to either the 
motor neuron processes or the soma.
After confirming that the Campenot chambers form sealed motor neuron 
cultures using a radioactive cell-impermeable tracer, the sites o f TeNT uptake were 
investigated by simultaneously applying different fluorescently labelled TeNT He to
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Figure 4.2: Initial sorting of TeNT to the retrograde transport route
TeNT binds to neuronal membranes via APRs and is internalised by a rapid (Dr. O. 
Berninghausen, personal comm uncations) clathrin-mediated endocytosis into 
vATPase positive compartments. In a stationary sorting compartment, the vATPase is 
most likely sorted away (or disassembled) to a recycling endosome and TeNT is 
directed towards the fast retrograde transport route. See text for details.
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the processes and to the soma. We found that the majority of motor neuron soma, 
which were plated into the middle compartment, bound and internalised the TeNT 
Hc-Alexa488 applied to this compartment. TeNT Hc-Alexa555 was applied to the 
motor neuron processes in the side compartment and only a few soma showed a 
positive signal for this probe. Rarely soma were double positive for both fluorescent 
probes (Fig. 3.43). The low number o f soma that acquired TeNT Hc-Alexa555 from 
the side compartments is likely to be the result of only a limited quantity o f processes 
having crossed the silicone barrier.
The finding that only very few soma showed a positive signal for distally and 
locally applied TeNT He was very surprising. Motor neurons might either internalise 
the toxin at the somatic site or over the processes and both ways could be able to 
exclude each other. Even though the toxin was applied simultaneously in both 
chambers, some soma might have bound TeNT earlier than their processes and vice 
versa, thereby triggering a signalling cascade only allowing internalisation at one 
site.
However, this phenomenon might also be caused by the culture o f motor 
neurons in the compartmented system. The motor neuron soma appear very round 
compared to the dissociated motor neuron cultures. This shape change is most likely 
caused by the high cell plating density in the central chamber and resembles their 
shape in neuronal tissue. Furthermore, we only plated crude prep cells, a substantial 
amount of which were fibroblasts, astrocytes and glial cells.
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4.4 Defects in axonal transport of ALS mice
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative 
condition characterised by motor neuron death (Rowland and Shneider, 2001). There 
is no source o f early onset models o f ALS available. Therefore, mice with an axonal 
transport defect caused by a mutation in dynein {Loa/+) were crossed with mutant 
SOD1 (SOD1G93a) mice mimicking ALS, to obtain a strain, which may present early 
symptoms and therefore be a novel tool to study ALS. Furthermore, this model 
would allow us to investigate if  interactions between mutant SOD1 and mutant 
dynein influence motor neuron disease progression.
4.4.1 Phenotypes o f wild type, Loa/+, S0D1G93A and Loa/SODlG93A 
mice
Loa/Loa mice die within 24 hours o f birth due to an inability to feed and move, 
and so were linked to motor neuron degeneration (Hafezparast et al., 2003). Mice 
overexpressing human mutant SOD1 showed a drastically decreased life span (Guo 
et al., 2003). Measurements o f life span and weight loss o f littermates obtained from 
crossing Loa heterozygotes with SOD 1093A mice revealed an unexpected extension 
o f life span and a delayed loss o f body weight for Lotf/SODlG93A mice compared to 
SOD1G93a mice. Furthermore, the EDL muscle force o f Loa/SODlG93A mice was as 
strong as in wild type mice but severely reduced in S0D 1G93A mice. The motor unit 
numbers and motor neuron survival were significantly lower in SOD1G93a mice, 
however, L W S 0D 1G93A mice showed no reduction in comparison to wild type and 
Loa/+ mice. All these phenotypic improvements for Loa/SODlG93A mice compared 
to wild type, Loa/+ and SOD 1093A were unexpected.
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4.4.2 Retrograde axonal transport defects
The positive effects on disease onset and progression in LoalS 0D 1G93A mice 
compared to S 0D 1G93A mice are most likely due to alterations in axonal transport. 
The axonal transport o f embryonal motor neurons in each distinct group o f genotypes 
was measured using the probe TeNT Hc-Alexa488. The TeNT carriers in S 0D 1G93A 
motor neurons were slower and had a lower abundance compared to wild type, Loa/+ 
and Z,o<3/SO D1G93a motor neurons. This demonstrates that transport defects are 
already manifested at an embryonal stage in motor neurons in a mouse model o f  
human ALS.
The observation that the transport characteristics o f TeNT are very similar in 
wild type and Loa/+ motor neurons suggests that two copies o f D nchcl are necessary 
to detect strong transport alterations as seen in Loa/Loa mice (Hafezparast et al.,
2003). This is in agreement with a previous report where cDHC+/' (cytoplasmic 
dynein heavy chain) mice displayed no noticeable irregularities (Harada et al., 1998). 
Surprisingly, in Lotf/SODlG93A mice the transport defects are rescued, displaying 
higher carrier frequencies and speeds beyond those observed for wild type and Loa/+ 
motor neurons. Therefore, these results show that axonal transport defects play a 
critical role in motor neuron degeneration in S 0D 1G93A mice. Moreover, 
compensating defects can have a distinct beneficial role for both life span and motor 
abilities. The unexpected improvement o f the Loa/SODlG93A mice life span might 
arise from a rescue o f the balance between anterograde and retrograde transport in 
double heterozygote motor neurons. Axonal transport defects have already 
previously been suggested to play a role in the pathogenisis o f ALS. Mice 
overexpressing S0D 1G93A have severe defects in fast anterograde transport at an
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early asymptomatic stage, before the loss o f neurons occurs (Warita et al., 1999). 
Our work allowed us to uncover for the first time a defect in retrograde transport at a 
pre-symptomatic stage.
Synaptic vesicle precursors, plasma membrane and mitochondria are cargoes 
o f fast anterograde transport, while endosomal vesicles, mitochondria and recycled 
proteins from the anterograde route are also recruited to the retrograde axonal traffic. 
Malfunction o f fast anterograde transport in motor neurons might therefore result in 
reduced action potential transmission and impaired neurotransmitter release as it was 
reported for mutations in the kinesin heavy chain gene (Gho et al., 1992). It was 
shown in an electromyographic study that S 0D 1G93A mice suffer from motor neuron 
dysfunction and a massive loss o f functional motor units from 47 days o f age 
onwards. The impairment o f motor neuron function started six weeks prior to the 
onset o f clinical symptoms and motor neuron loss. The neuromuscular deficits were 
attributed to the loss o f axonal integrity and not to motor neuron death (Kennel et al., 
1996). This correlates with our findings that embryonal transport defects in 
SOD1G93a are observed way before the symptoms of disease are manifested.
The amelioration o f disease in Loa!S0D 1G93A mice may result from the 
restoration o f axonal homeostasis in regards to the equilibrium between peripheral 
versus proximal cargo distribution or by reconstituting the axonal balance between 
positive and negative transport inputs. The modulation o f negative retrograde signals 
may be particularly important in S 0D 1G93A mice. In non-transgenic or wild type 
human SOD1 expressing control mice, axotomy led to axonal atrophy and loss o f a 
small number o f axons (Kong and Xu, 1999). However, axotomy in SOD 1093A mice
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reduced the extent o f axon degeneration at the end stage o f the disease, leading to an 
increase in the number o f  surviving motor axons (Kong and Xu, 1999).
Neurotrophins positively affect neuronal survival and differentiation by 
activating signalling cascades through the receptors Trk and p75NTR (Fig. 4.3). The 
activation o f p75NTR promotes cell death o f injured neurons but promotes migration, 
growth and survival in other cells (Kaplan and Miller, 2000). p75NTR is hypothesised 
to endorse target innervation by dropping the sensitivity o f axons to neurotrophin-3 
in target tissues (Kuruvilla et al., 2004). As discussed in Reichardt and Mobley, it is 
possible that NGF-dependent neurons increase expression o f p75NTR when 
innervating their NGF-rich target tissues and it was shown that p75NTR restrains 
activation o f TrkA by neurotrophin-3 without disturbing NGF activation o f TrkA 
(Reichardt and Mobley, 2004). NGF exists in two forms: unprocessed and mature. 
Mature growth factors are produced by proteolytic cleavage o f pro-neurotrophins by 
the serine protease plasmin and specific matrix metalloproteinases (MMPs). NGF 
preferentially binds to TrkA, promoting survival, whereas pro-NGF activates p75NTR 
(with minimal effects on TrkA) and triggers cell death (Lee et al., 2001). In the 
cerebrosinal fluid o f ALS patients, enhanced levels o f tissue inhibitors o f matrix 
MMPs (TIMPs) were found. It was therefore suggested that TIMPs play a potential 
role in neurodegenerative diseases, probably by inhibiting the production o f mature 
NGF (Lorenzl et al., 2003). However, several studies detected increased levels o f  
MMP in the spinal cord o f S 0D 1G93A expressing mice and early oral administation of 
the MMP inhibitor Ro 28-2653 enhanced their motor performance and extended the 
life span o f S0D 1G93A mice (Demestre et al., 2005; Lorenzl et al., 2003). 
Additionally, oxidative stress induced by hydrogen peroxide stimulates the
234
NGFpro*NGF
O C - ^ 5 ^  o
Q V j j l a a t v i ^ /  Q
O  ‘lrflYTsfe
% QO
cz>
target tissue
o  <=> o o
©
p75NTR
I I
survival/ survival 
proliferation 
cell death
©
Q  pro-NGF
• catalase/ glutathione peroxidase
O Q S O D 1
© < V
■  TIMPs
dathnn
0 2 + h2o 2
retrograde
transport
n e u r o -
l i l a m e n t s
C ^MMPs
Y  TrkA
Y  P75NTfl
V  dynein/ 
dynactin 
complex
Figure 4.3: SOD1 in wild type motor neurons
T arget t is s u e s  p ro d u c e  N G F to  a t t r a c t  in n e rv a tio n . P la sm in  and  m a tr ix  
metalloproteases (MMPs) cleave pro-NGF to produce mature NGF. Signalling cas­
cades via p75N1R and TrkA stimulate neuronal survival and outgrowth. Inhibitors of 
MMPs (TIMPs) regulate pro-NGF cleavage. SOD1 catalyses superoxide to oxygen 
and peroxide. Hydrogen peroxide is then processed to non-toxic by-products. See 
text for further details.
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production o f MMPs and alters the balance between MMPs and TIMPs (Hemmerlein 
et al., 2004; Lu and Wahl, 2005). It can therefore be speculated that the high level o f  
MMPs in ALS patients results from their block by TIMPs. The expression o f MMPs 
might be increased, trying to compensate for the lack o f mature NGF-availability. 
This in turn could lead to a higher abundance o f pro-NGF and consequently a higher 
activation of p75NTR-induced cell death (Fig. 4.4), explaining the motor neuron loss 
in SOD1G93a mice.
As discussed earlier, the vATPase plays an important role in various cellular 
processes. We have also shown that the vATPase is involved in the sorting o f TeNT 
to the retrograde transport route in motor neurons. vATPase activity is highly 
sensitive to hydrogen peroxide. This was suggested to reduce the uptake o f  
neurotransmitters, such as glutamate into synaptic vesicles, therefore down 
regulating neuroexocytosis during oxidative stress (Wang and Floor, 1998). 
Furthermore, hydrogen peroxide was shown to induce the aggregation of  
neurofilaments (Kim et al., 2004) and this in turn is thought to play an important role 
in ALS pathogenesis, generating a negative input on transport by clogging the motor 
neuron axon (strangulation) (Lobsiger et al., 2005). Hydrogen peroxide is a by­
product of the catalysis o f superoxide to water by SOD. Under normal conditions 
hydrogen peroxide is further processed by the glutathione peroxidase to water. It has 
been shown that immature murine neurons overexpressing glutathione peroxidase are 
protected from hydrogen peroxide toxicity (McLean et al., 2005). However, in 
anterior horn tissues from ALS patients, no detectable glutathione peroxide was 
found (Shaw et al., 1995a). This suggests that the neurons o f ALS patients are poorly 
protected against hydrogen peroxide toxicity. Our transport studies revealed that
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Figure 4.4: Effects of mutant SOD1 on motor neurons
Mutant SOD1 produces highly reactive hydroxyl radicals leading to peroxidation. 
This leads to oxidative damage by inhibition o f the vATPase resulting in an aberrant 
sorting o f organelles towards the retrograde transport pathway. Reloading o f synaptic 
vesicles is altered and therewith the neuroexocytosis. Furthermore, hydrogen perox­
ide blocks the catalytic activity o f plasmin and MMPs, producing higher levels of 
pro-NGF that triggers a death cascade. TIMPs levels are high, leading to a further 
inhibition of mature NGF production. Neurofilament aggregation is enhanced in the 
presence o f hydrogen peroxide. See text for further details.
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motor neurons o f S 0D 1G93A mice show slower retrograde transport speeds o f TeNT 
and lower carrier frequencies compared to wild type, Loa/+ and Loa/SO DlG93A 
motor neurons. A possible explanation for these results is that increased hydrogen 
peroxide levels caused by a malfunctioning SOD and glutathione peroxidase inhibit 
the vATPase and alter sorting o f our TeNT-probe to the retrograde transport route. 
This might result in fewer TeNT carriers in S 0D 1G93A motor neuron axons. The 
slower transport rates in SOD 1093A motor neurons can be attributed to an effect o f  
hydrogen peroxide on neurofilament aggregation. However, this would imply that in 
Loa/SOD  1G93A motor neurons the sorting defects o f TeNT and the number o f carriers 
of the retrograde transport route are rescued. This rescue could be attributed to the 
function of mutated dynein, directing the TeNT carriers to the retrograde transport 
route, bypassing the sorting organelle. Therefore, transport is unaffected by a 
malfunctioning vATPase. There is also a likelihood that the dynein mutation in 
Loa/+ motor neurons causes abnormal organelle transport, which might alter the 
interaction o f mutant SOD1 with organelles such as mitochondria and therewith 
delay cell death. This would be in agreement with previous findings where only 
mutant SOD1, but not wild type SOD1, is recruited to spinal cord mitochondria of 
affected tissues, which would account for the basis for selective toxicity in ALS (Liu 
et al., 2004). Moreover, mutant SOD1 can bind to mitochondria and form aggregates 
that entrap the anti-apoptotic protein Bcl-2 and therefore may deplete motor neurons 
from this protein (Pasinelli et al., 2004).
So far, the molecular processes responsible for the disease are mainly unknown 
and the molecular mechanism by which dynein induces amelioration in 
Loa/SOD 1G93A mice is still under investigation. However, it is apparent that the
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specific impairment o f the neuronal function o f  cytoplasmic dynein rescues the 
defect observed in SOD1G93a mice and produces a complete recovery o f the axonal 
transport defects o f TeNT. This in turn may be responsible for the dramatic delay in 
disease progression and extension in life span observed in Z,o^/SOD1G93a mice.
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4.5 Future outlook
This study concentrates on the transport characteristics o f tetanus toxin in 
motor neuron axons. We have shed some light into why tetanus toxin is protected 
form acidification during its transport in retrograde carriers, allowing for a safe 
passage o f TeNT along the motor neuron axon to reach its final destination, the 
inhibitory intemeuron. During transport, the vATPase proton pump is absent from 
the TeNT organelles. However, the vATPase is involved in a sorting step, directing 
TeNT towards the retrograde transport carriers. The next issue to follow up in this 
regard would be to determine the molecular composition o f the endocytic organelles 
in which TeNT is taken up by inhibitory intemeurons. Here, TeNT is not transported 
but an acidification step does occur, allowing the TeNT catalytic domain to 
translocate to the cytosol, resulting in VAMP2 cleavage. Unfortunately, we were not 
able to successfully obtain a purified inhibitory intemeuron culture. It is therefore 
necessary to develop a new method o f obtaining purified intemeurons to facilitate 
compartmented coculture o f motor neurons and inhititory intemeurons, which could 
help to analyse the transcytosis o f TeNT from one neuron to the other.
TeNT was also applied as a tool to investigate axonal transport characteristics 
in SOD1G93a mice, which display an ALS-like phenotype. We demonstrated, that 
transport defects are already manifested at an embryonal stage. Furthermore, mice 
which are heterozygotes for S0D 1G93A and a mutation in the dynein heavy chain 
(Loa), showed a complete transport recovery, suggesting that this recovery may be 
responsible for the general physiological improvement o f Loa/SODlG93A mice. To 
follow up this research it will be necessary to determine if  there are also axonal
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transport defects present for other organelles, such as mitochondria or lysosomes, to 
exclude a role for potential TeNT specific effects on the cell culture.
During the compiliation o f this thesis I came across data, stating that rats are 
1,000 times more resistant to TeNT than mice (LD50 being 1 jig/kg and 1 ng/kg 
bodyweight, respectively) (Payling-Wright, 1955). To my knowledge, these findings 
have not been investigated further to determine reasons for this differential TeNT 
sensitivity. TeNT still causes spastic paralysis in rats as it does in mice and 
efficiently blocks evoked neurotransmitter release at the neuromuscular junction o f  
both species. However, even though TeNT is a very potent inhibitor o f spontaneous 
neurotransmitter release in mice, it appears that spontaneous release in rats is 
unaffected (reviewed in Poulin et al., 2006). This variation is most likely due to the 
differences in the complement o f VAMP proteins in the rat central nervous system 
compared to mice. For instance, in addition to VAMP2, the VAMP1 isoform has 
been found in rat and chicken; studies on VAMP1 expression in other species, 
including mice are still lacking. Additionally, although cleavage o f rat VAMP2 is 
sensitive to TeNT and BoNT/B proteolysis, rat VAMP1 resists cleavage due to a 
sequence divergence o f the consensus cleavage site (Q-F->V-F) (Poulin et al., 2006). 
Consistent with this, BoNT/F (cleaves VAMP1 and 2) and BoNT/A and /E (cleave 
SNAP-25) have been shown to block synaptic vesicle release in isolated rat 
hippocampal neurons, nevertheless, TeNT is ineffective in this respect (Verderio et 
al., 1999). This demonstrates the involvement o f TeNT resistant VAMP in synaptic 
vesicle release specific to rat hippocampal neurons.
Furthermore, VAMP1 mRNA levels are higher than VAMP2 mRNA in the rat 
spinal cord, while in the brain the opposite is observed (Rossetto et al., 1996).
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VAMP1 mRNA was also shown to be mainly restricted to cells involved in motor 
functions and spinal cord cells, whereas VAMP2 mRNA is more widely expressed in 
nuclei associated with autonomic, sensory and integrative roles (Elferink et al., 1989; 
Trimble et al., 1991). In sections o f rat spinal cord, high levels o f VAMP 1 mRNA 
were detected in the ventral horn, where predominantly motor neurons are located, 
and VAMP2 mRNA concentrated in the dorsal hom, where GABA-ergic 
intemeurons are mainly present (Trimble et al., 1990). From the currently available 
data, we are unable to comment on post-transcriptional regulation o f VAMP 1 and 2, 
but the elevated levels o f VAMP1 mRNA in the rat ventral hom suggest a 
predominance o f this isoform in motor neurons over VAMP2, and elevated VAMP2 
levels in inhibitory intemeurons.
For our experiments we used purified rat motor neurons; the areas o f the 
embryonal spinal cord in which intemeurons are expected to be were surgically 
removed. In these puified rat motor neuron cultures, we observed the presence o f  
stationary acidic TeNT compartments. So far, their physiological relevance is 
unknown and there are no studies available reporting a stationary acidic TeNT 
organelle in vivo or in vitro in motor neuron preparations from other species, 
including mice.
To attribute a role to the stationary, acidic TeNT positive compartments in rat 
motor neurons, it would be interesting to investigate if  these organelles are only 
present in rat rather than mouse motor neurons. Furthermore, it would be important 
to compare the expression levels and the cellular distribution o f VAMP 1 and 2 in rat 
versus mouse spinal cord and purified motor neurons. If the acidic, stationary TeNT 
compartments are a specific feature o f rat motor neurons, we could assign a
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protective function o f those organelles towards intoxication in rats. This hypothesis 
might be supported by the following: Assuming that the acidification o f these 
stationary TeNT organelles causes the translocation o f the TeNT catalytic chain into 
the rat motor neuron cytosol, then the L-chain might be unable to affect synaptic 
vesicle release because it cannot cleave the rat VAMP1 isoform. This in turn could 
explain why TeNT has no effect on spontaneous synaptic vesicle release at the rat 
neuromuscular junction. Additionally, the presence o f the stationary, acidic TeNT 
compartments could reduce the delivery o f the holotoxin to inhibitory neurons where 
VAMP2 is present in high levels, thus explaining why much higher doses o f TeNT 
are necessary to induce paralysis in rats compared to mice. Taken together, in rats, 
the sequence divergence o f the VAMP1 cleavage site partially offers a potential 
protection against the toxin.
I was not able to colocalise VAMP2 with the vATPase in rat motor neurons, 
which are both supposed to be present on synaptic vesicles (data not shown). 
However, a partial overlap of VAMP 1 and vATPase positive structures was observed 
(Fig. 3.18). Regarding these observations, it would be interesting to determine if  
TeNT colocalises with VAMP1 in purified rat motor neuron preparations. If they do 
colocalise, then it might be possible for VAMP1 to be involved in TeNT uptake, 
which would be in agreement with reports o f TeNT uptake being dependent on 
presynaptic activity and small synaptic vesicle endocytosis in rats (Miana-Mena et 
al., 2002; Matteoli et al., 1996).
In summary, I hypothesise that upon internalisation, TeNT might actively 
exclude the vATPase from its endocytic organelle, thereby protecting itself from
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degradation. Furthermore, TeNT would be free to hijack retrograde carriers to reach 
the inhibitory intemeuron.
Future experiments such as those described above should hopefully present us 
with a better understanding o f why different species show diverse sensitivities to 
TeNT intoxication. Furthermore, it is imperative to carefully choose the model 
system for studying TeNT affected neuroexocytosis.
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